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QUILL ON SCALPEL

This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.

The Two-Step Management of Breast Cancer
A dogma has been promoted that in
women with breast cancer “a diagnos
tic biopsy specimen should be studied
with permanent histologic sections be
fore definitive therapeutic alternatives
are discussed with the patient”.1 Only
then is the patient able to decide on
therapy and be returned to the oper
ating room for the appropriate opera
tion. While this may appeal to the
consumer-advocate who has never
been faced with the situation and even
to some clinicians who usually test
their credos with scientific trials, it
fails to withstand analysis by common
sense. Consider these six points:
1. The woman with a newly diag
nosed breast cancer is seldom emo
tionally capable of making a rational
decision.
Recognizing this principle, physi
cians historically have avoided per
sonal involvement in the management
of their own illnesses or those of their
families. Starting with this lack of
objectivity that accompanies personal
involvement, threatened by the diag
nosis of a malignant tumour about
which she usually has an unduly pes
simistic outlook, and often further
frightened by the nature of the pro
posed operation, the patient with a
breast cancer is unlikely to be able
to discuss her therapy rationally.
2. Patients lack the data base and
a comprehension of the disease to dis
cuss it intelligently.
Clinicians who have managed many
patients with breast cancer can attest
to its complexity and variability. The
multiplicity of trials conducted in the
last decade indicates the physicians’
uncertainties in understanding the dis
ease. How then can a patient who
depends on articles in the lay press
have the factual knowledge to com
prehend the problem?
3. What is there to discuss?
In most circumstances, the diagno

sis of breast cancer will be obvious
at the initial consultation with or with
out the assistance of needle biopsy or
mammography. When a preoperative
diagnosis is not confidently made, the
indication for mastectomy, total or
segmental, is not changed by the biop
sy, except perhaps for the grossly rec
ognizable comedocarcinomas. There
fore, what is there to be discussed
that cannot be fully discussed at the
initial visit? Even advocates of the
two-step procedure recommend mas
tectomy with axillary dissection as the
standard therapy. While the role of
segmental mastectomy is still un
known, those who practise it seldom
learn anything from the biopsy that
would change an original recommend
ation for the procedure.
4. Postponing the decision is cruel
and causes the patient to suffer un
necessarily.
Most of us can cope with the def
inite but have trouble managing un
certainty. Surely it is kinder for the
patient to know that if the mass is
malignant, she will awaken from the
anesthetic to find that the surgical
treatment has been completed rather
than to be informed that when time
and opportunity permit, she will be
returned to the operating room for
another procedure, which requires a
second anesthetic.
5. Two anesthetics increase the
risk, slight as it is, of an untoward
event. Even this slight risk is un
justifiable.
6. The two-step procedure is a
waste of operating room time and
hospital beds.
Physicians have the responsibility
to use wisely these costly community
resources. The two-step procedure
abuses operating room time and use
of hospital beds, denying others these
facilities.
Some patients, having read of the

two-step procedure in the lay press,
may propose it. But let us not be
misled by the understandable denial
reaction of the patient who may at
tempt to delay the decisions that are
usually obvious at the initial office
consultation. Having liberated women
from the morbidity of the traditional
Halsted radical mastectomy, we
should not now inflict on them un
necessary confusion and the emotion
al pressures of indecision associated
with the two-step procedure.
J.E. D e v i t t . m d , f r c s [ c ]
Member,
Editorial Board.
Reference
1. Special R e p o rt: treatm ent of p rim ary b re a st
cancer. N E ngl J M e d 1979; 301: 340

Editor’s com m ent .—On June 5, 1979

a consensus panel of the United States
National Cancer Institute agreed that,
when measured by duration of sur
vival, mastectomy with axillary dis
section and preservation of the pec
toral muscles provided benefits equiv
alent to radical mastectomy for stages
I and II disease. The panel also rec
ommended that a “two-step procedure
should be used in most cases, i.e., a
diagnostic biopsy specimen should be
studied with permanent histologic sec
tions before definitive therapeutic al
ternatives are discussed with the pa
tient”.1 In his editorial, Dr. Devitt
gives six reasons for taking issue with
this second recommendation; chiefly
he states that: (a) surgeons do their
own thing anyway; (b) delay causes
the patient emotional suffering and
(c) an identical surgical effort is
hampered by an unnecessary step.
At present, the surgical literature
contains little data to suggest that any
procedure — radical or simple, onestep or two-step — significantly alters
patient survival. Indeed, no procedure
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on the chest wall can realistically be
expected to alter the ultimate growth
of micrometastases that must be pres
ent at the time of extirpation of the
breast. So outcome measured by dura
tion of survival can never be used to
assess the usefulness of a one-step
versus a two-step procedure. The
comfort and desires of the patient,
compassion, concern, empathy and
understanding of the woman's emo
tional problems now become the de
terminants in choosing between the
one-step and two-step procedures.
Rigidity of the system, of the surgeon
or of the operative schedule all con
spire to play against the emotional
needs of women who face the prob
lem of a mass in the breast and are
expected to go to the operating room
uncertain of the outcome (i.e., pos
sible amputation of the breast at the
discretion of a surgeon, without her
psychologic preparation).
The- “first” step may be performed
in the office or rarely through shortstay, day surgery. A needle biopsy,

punch biopsy or even a small open
biopsy will generally give a positive
diagnosis and only those women with
proven carcinoma of the breast need
undergo operation. They can go to
the operating room with a definitive
plan of treatment, with a contract
negotiated between doctor and patient
that permits the nature of the opera
tive procedure to be known before
the operation is carried out.
Adherence to a two-step procedure
thus spares unnecessary fear and an
guish in women who might be oper
ated upon for benign disease, also
saving operating room cost and effort.
It provides the woman with cancer
of the breast an opportunity to pre
pare for amputation of her breast,
not to participate in the decisions
about which treatment may be “bet
ter” than another, but which treat
ment will better serve that woman’s
particular emotional problems created
by the imminent amputation.
Recently, a Hamilton group at
tempted to see whether or not women

responded to their mastectomy for
carcinoma of the breast in a fashion
similar to the “death and dying” steps
set forth by Kiibler-Ross. The study
was terminated because the investiga
tors were unable to place the variable
attitudes of these women into a com
prehensive sequential set of responses.
They concluded that each woman was
different, each has her own particular
set of emotional and psychologic
needs. Some, if not most, may be par
tially satisfied by the time taken and
knowledge imparted in the “two-step”
procedure, needs that are not satisfied
in the one-step, “go and when you
wake up you will find out what has
happened to you”, type of procedure.
The two steps place extra demands
on the surgeon, but are more satisfac
tory for the patient.
C.

Barber M u e l l e r ,

m d , f r c s [c ]

Reference
1. Special Report: treatment of primary breast
cancer. N Engl J M ed 1979; 301: 340

Techniques and Results of Arterial Prosthetic
Bypass for Aortoiliac Occlusive Disease
In order to understand where we are
today in the treatment of aortoiliac
disease, it is useful to remember the
route we travelled.
In 1935, my teacher, Gordon
Murray, was the first to give heparin
to a patient; without this tool, vascular
surgery would have been delayed or
have followed a different path. Cana
dian surgeons are proud that this
major door to elective vascular sur
gery was opened in our country. Pro
gress was slow for the next decade,
but then accelerated. Within a few
years after World War II, the prin
ciples of endarterectomy (dos Santos,
1947;1 Wylie, 19522), excision of a
blocked iliac artery with allograft ar
terial replacement (Oudot. 1951 ;3
Julian, 19524) and bypass grafting
from the aorta to the iliac or femoral
arteries (DeBakey, 19545) had been
established. Vascular surgery was bur
geoning.
Voorhees and colleagues introduced
the first fabric arterial prosthesis in
1952;6 within 5 years very acceptable
Teflon7 and Dacron8 grafts were avail
able. Soon the principle of bypass
grafting, using a prosthetic arterial
graft, had become the most common
476

form of surgical treatment for aorto
iliac obstruction.
The results, with few exceptions,
were spectacular; with these new tools,
we entered the golden age of vascular
surgery.
What Is the Prosthesis of Choice?

The lesson of the 1960s was that
Dacron fabric grafts edged out Teflon
fabric grafts. Why? There was no
clear evidence that one performed
better than the other. The nonwettable
quality of Teflon was said to be bad.
Why so? Whether it was from better
advertising and marketing or from
the chauvinistic but effective advocacy
of certain prominent vascular sur
geons, the market for fabric Teflon
grafts had disappeared by 1970. It is
ironic and educational to watch the
current rising prominence of the polytetrafluoroethylene
(PTFE)
graft,
which is even more “unwettable” than
Teflon.
In the early 1970s, porosity became
the magic selling formula. “High por
osity” became synonymous with “good
healing” and, by implication in many
articles and brochures, with the pro

duction of a normal endothelium.
This was wishful thinking. A true
endothelium created by transporous
migration of granulation tissue has
been described only once in the entire
experience of prosthetic arterial im
plantation in man;9 this “true endo
thelium” was scattered and over less
than one third of the surface of one
axillofemoral graft. Despite the lack
of evidence for their superiority, high
porosity grafts, with an attendant risk
of large blood loss during implanta
tion and often of unproven durability,
were highly popular for a few years.
In the mid-1970s, as porosity be
came perceived as less important, we
were tempted by the concept of a
shaggy or velour surface. An “internal
velour” had some obvious superiority
in lining the moving chambers of an
artificial heart. There is no evidence
that it increased the patency rate of
bypass grafts in the aortofemoral po
sition.
An “external velour” allows the
graft to become more firmly encapsu
lated. The assumption, however, that
such a process improves patency or
makes infection less likely is still un
proven.
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N one the less, the prosthetic arteries
of today are better than those avail
able 20 years ago; they d on’t fray,
they have useful longitudinal m arks
to avoid twisting, they are soft and
com pliant and they are easy to sew.
T o strive for im provem ent is com 
mendable, both for surgeons and graft
m anufacturers. H ow ever, in the quar
ter century since the introduction of
crim ped D acron and T eflon grafts,
there has been little im provem ent in
the patency rates of aortofem oral by
pass grafts.
W e should continue to search for
better prostheses, but at present I ad
vise the prudent surgeon to choose a
graft: (a) from a reputable m anufac
turer, whose sales organization offers
good service and a fair price; (b) in
which the porosity is know n and is
com patible with personal surgical
technique; (c) for w hich the lengths,
diam eters and m arkings on both sides
of the bifurcation are know n and,
again, are suited to personal technique;
and (d) which is currently the stand
ard in his institution. Surgical repair
of aortoiliac obstruction is usually a
delight. An excellent result is con
fidently expected and a planned,
sm ooth, trouble-free operation is a
pleasure to w atch or to perform . Sud
den exposure to a graft of unknow n
quality can be disastrous.

What Are the Proper Anastomotic
Sites?
In the early 1970s, the com m on
fem oral artery replaced the external
iliac as the preferred site for the dis
tal artery anastom osis. Blood was
delivered directly to the proper site,
problem s in the proxim al deep fe
moral artery were sim ultaneously cor
rected and the need for subsequent
groin repair was dim inished.
A ccurate know ledge of the anatom y
of the deep fem oral artery and how
to m anage this vessel correctly becam e
the hallm ark of the experienced vas
cular surgeon, w ho will always achieve
adequate exposure to exam ine prop
erly as long a segm ent of this artery
as necessary, who will divide the la
teral fem oral circum flex veins if ne
cessary and who will always strive to
achieve unobstructed flow into this
all-im portant vessel.
T he deep fem oral artery should al
ways be approached lateral to the su
perficial artery. It is a friable vessel
and must be handled delicately.
Preservation of its lateral circum flex
branch is essential.
Although concurrent obstruction of
the superficial fem oral artery is pres
VOLUME 25, NO. 5, SEPTEM BER 1982

ent in about 40% of patients receiving
aortofem oral bypass grafts, only a few
will require a sim ultaneous dow n
stream repair. U sually this is only
done for patients suffering from in
cipient gangrene. Since the arterial
pressure at the ankle an d flow to the
muscles of the calf will both continue
to rise for 1 to 2 days following an
aortofem oral repair, a delayed dow n
stream repair, if necessary, is the
prudent course for most patients.
T he proxim al anastom osis should
be just below the left renal vein. It
m av be end-to-end or end-to-side.
In the m id-1960s, m anv vascular
surgeons began to p refer the end-toend proxim al anastom osis: it seemed
to provide b etter protection against
dow nstream em bolization and “trash
fo o t”. It allowed b etter graft coverage
and thus few er late problems with
the duodenum . It was hoped it w ould
provide b etter long-term patency.
I prefer to rem ove about l cm of
aorta, cut the trunk of the graft short
and thus have the bifurcation lie in
the same anterior-posterior plane as
the original aorta. T he right limb rises
slightlv to pass in front of the vena
cava; the left lies behind all the veins
and arteries of the inferior mesenteric
axis. W ith this technique, problem s
arising from an ischem ic sigmoid co
lon are avoided and, since the graft
does not im pinge on the duodenum ,
the tragic com plication o f an aortoduodenal fistula is also avoided.
I restrict the use of an end-to-end
proxim al anastom osis to women with
arterial hypoplasia, men with external
iliac stenosis and a concern with
sexual potency, patients with aberrent renal arteries, and those w ith a
large patent inferior mesenteric artery
associated with bilateral iliac artery
occlusion.
I am com fortable with this tech 
nique, but rem ind the reader that this
is still an area of controversy. M any
com petent vascular surgeons still p re
fer a proxim al end-to-side anasto
mosis.

The “Extra-Anatomic” Approaches
T he tran so b tu ra to r route was in tro 
duced by Shaw and Baue in 1963.10
It can start from any m ajor artery
within the abdom en and run to the
deep fem oral artery, the superficial
fem oral artery, or both. The long
term results are excellent and every
vascular surgeon should be fam iliar
with this technique.
The crossfem oral route was in tro 
duced by V etto in 1962.” W hen one
iliac system is open or can be opened
/

by translum inal dilatation, this re la 
tively m inor o p eratio n provides very
reasonable long-term results. I use it
in p atients w ith the ap p ro p riate a n a 
tom y w ho, fo r reasons of age o r
obesity, are n o t suited to the sta n d ard
ao rto fem o ral repair.
T he axillofem oral g raft was in tro 
duced by Blaisdell and H all in 1963.12
It has a tendency to n o ctu rn al c o m 
pression by th e rib cage and m ay r e 
quire rep eated th ro m b ecto m y b u t it,
too. has stood the test of tim e an d
has saved m any lives and lim bs. I t is
my im pression th a t P T F E grafts and
the “externally su p p o rted ” D ac ro n
grafts m ay p rovide b etter results in
this o peration.
I in tro d u ced th e ascending a o rta -to fem oral bypass in 1975.13,14 I t is an
option for th e p atien t in w hom the
abdom inal a o rta ca n n o t be used and
m ay be com bined w ith a co n c u rre n t
card iac o p eratio n . T he p erito n eal c a 
vity is n ot entered. T h e g raft follow s
the m ain ventral anastom otic ro u te o f
the internal m am m ary and in ferio r
epigastric arteries; it lies b ehind th e
rectus m uscle an d in fro n t of the p o s
terio r rectus fascia and p eritoneum . A
g raft in this position is n ot visible o r
palpable an d can n o t be com pressed
by external pressure. T h e o p eratio n
is technically easy an d the long-term
patency has been excellent.

What Results Can Be Anticipated?
T h e sta n d ard ao rto b ifem o ral bypass
is a good o p eratio n . It carries a low
m ortality an d m o rbidity and provides
excellent long-term patency.
In 1981, Stanley C raw fo rd 15 p u b 
lished a m o n u m en tal review o f his
25-year experience w ith alm ost 1000
patients. H e stated: “H ospital m o rta l
ity decreased from 8% in the 1950s
to 3% in th e late 1960s, w here it has
rem ain ed .” T his is tru e in m ost c e n 
tres today.
H alf o f the 3% o f p atients w ho
die in hospital succum b fro m m y o 
card ial in farctio n , the others fro m a
m ixture o f stroke, p u lm o n ary em b o l
ism and m ultiple system failure.
T h e 97% w ho leave hospital c o n 
tinue to su ffer th e ravages of age an d
generalized atherosclerosis; 25% die
in 5 years and 50% in 10 years. T hese
p atients h av e a 10-year d ecrease in
expected survival over the g eneral
population.
T h ere is agreem ent from m any
studies th a t th e expected long-term
patency o f an ao rto fem o ral bypass is
excellent. F ro m a consensus o f rec en t
rep o rts, we can expect paten cy of
85% at 5 years, 70% at 10 years,
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60% at 15 years and 55% at 20
years. This represents a patency attri
tion rate of only 2% a year as com
pared with 5% a year for femoropopliteal saphenous vein bypass.
In more simple terms; 10 years
after an aortofemoral graft, the pa
tient has a 70% chance of it still
working and a 50% chance of being
alive. Ten years following an isolated
femoropopliteal repair with a saphen
ous vein, a patient has a 50% chance
of it still working and a 30% chance
of being alive.
To quote Felix Eastcott in this “by
far the most fruitful field in our spe
cialty”, we have been fortunate in
our generation to have had the tools
to provide a very successful answer
to aortoiliac occlusive disease.
R onald J. Baird, m d , frcs [c ], facs

Member,
Editorial Board.

To Potential Authors

The Canadian Journal of Surgery is
an instrument of communication
available to Canadian surgeons of all
disciplines. Its mission is continuing
medical education, its orientation is
towards its readers. Its authors come
from a company of Canadian sur
geons — from almost all disciplines
— most of whom have never written
before. Your coeditors and the editorial
board of the Journal believe that many
of you have something to say. You
may make clinical observations, you
may describe methods, give impres
sions, provide tables or lists of pa
tients. Some of you may be attracted
to write. If you have a message and
if the content is acceptable, our edi

torial staff in Ottawa will assist in
making your material presentable.
Our function is to help people express
ideas, and we want to encourage
your expression. If you have thoughts
on any surgical subject we will help
put it into the format that will present
your thoughts most favourably. The
coeditors hope that you may be en
couraged to write and are ready to
assist you in making worthwhile con
cepts and ideas acceptable to your
peers.
C.B. M ueller ,

m d , frcs [c ]

L.D. M acL e a n , m d , FRCSfc]

Coeditors
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SESAP III Question
38. Hypomagnesemia is frequently associated with each of the follow
ing diseases EXCEPT
(A)
(B)
(C)
(D)
(E)

hypoparathyroidism
hypothyroidism
cirrhosis
pancreatitis
short bowel syndrome

For the incomplete statement above select the one answer that is best
of the five given. For the critique of Item 38 see page 531 of this issue.
(Reproduced by permission from SESAP III Syllabus: Surgical Education
and Self-Assessment Program No. 3. For enrolment in the Surgical Edu
cation and Self-Assessment Program No. 3, please apply to the American
College of Surgeons, 55 East Erie St., Chicago, IL 60611.)

VOLUME 25, NO. 5, SEPTEMBER 1982 / THE CANADIAN JOURNAL OF SURGERY

CANADIAN ASSOCIATION OF PEDIATRIC SURGEONS

Mechanism of Perforation Occurring
in the Intussuscipiens
during Hydrostatic Reduction of Intussusception
S ta n ley M e r c e r ,

Perforation of bowel during attempted
hydrostatic reduction of an
intussusception almost always
occurs through the distal, apparently
uninvolved bowel. It is probably never
seen except in a group of at-risk
children, under 6 months of age.
It is not related to unduly high
enema pressure, but to involvement
of the blood supply in the intussusceptum and obstruction of the blood
supply with resulting ischemic changes
in the "apparently” uninvolved
intussuscipiens. The authors provide
support for their suggested mechanism
by their findings at operation and
in the resected specimens from seven
children with an irreducible
intussusception and one 5-month-old
child whose bowel perforated during
attempted hydrostatic reduction.
Because children under 6 months
of age are susceptible to perforation,
hydrostatic reduction of intussuscepted
bowel is contraindicated.
La perforation de I’intestin durant
une tentative de reduction
hydrostatique d’une intussusception
survient presque toujours dans
la partie distale, apparemment
intacte, de I’intestin. Ceci n'est
probablement observe que chez
un groupe d'enfants exposes,
ages de moins de 6 mois.
Elle n'est pas due a une pression
exagerement elevee du liquide

From the divisions of *general surgery
and r pathology, the Children’s Hospital
of Eastern Ontario, and the department
of surgery, University of Ottawa,
Ottawa, Ont.
Presented at the 13th annual meeting
of the Canadian Association of
Pediatric Surgeons, Toronto, Ont.,
Sept. 15. 1981
Accepted for publication Apr. 26, 1982
Reprint requests to: Dr. Stanley Mercer,
Chief of surgery. The Children’s
Hospital of Eastern Ontario,
401 Smyth Rd., Ottawa, Ont. K1H 8L1
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m d , f r c s [ c ]* and

B lair C a r p e n t e r ,

de lavement, mais plutot a une
atteinte de la circulation sanguine
dans I’intussusceptum et a
I'obstruction de la circulation
causant des changements ischemiques
dans la partie “apparemment”
intacte. Les auteurs proposent des
arguments a I'appui du mecanisme
suggere, arguments issus de leurs
observations a I’operation et sur
les echantillons reseques chez
sept enfants presentant une
intussusception irreductible
et chez un enfant de 5 mois dont
I'intestin s'est perfore durant une
tentative de reduction hydrostatique.
Comme les enfants de moins de
6 mois sont sensibles a une
perforation, la reduction hydrostatique
est contre-indiquee dans les cas
d’intussusception intestinale.

In the past 7 years we have noted
a marked increase in perforation of
the bowel during attempted hydrostatic
reduction of acute intussusception.
Such perforations almost always oc
cur in an at-risk group — children
under 6 months of age,1 through the
apparently
uninvolved
intussusci
piens2'4 rather than the intussusceptum. This is at variance with frequen
tly stated views.5,6
We have reviewed our findings in
children with irreducible intussuscep
tion who underwent resection in an at
tempt to discover the mechanism of
perforation that occurs during barium
enema, whether diagnostic or thera
peutic.

m d , f r c p [c ] |

for barium enema (for such reasons
as shock and duration of symptoms),
were operated upon. Eight of these
37 children underwent resection for
irreducibility; the other 29 had sim
ple manual reduction of the intussus
ception. Of the children who under
went resection, one was 15 months old
and the other seven were less than
10 months of age. Attempted hydro
static reduction, carried out 72 hours
after the first symptoms of intussus
ception appeared, was followed by per
foration of the right side of the trans
verse colon in a 5-month-old child
who underwent resection. The stand
ard technique of hydrostatic reduction
was used.
Findings

We believe the mechanism of per
foration of the distal bowel in this
and other cases is obstruction of the
bowel’s blood supply with consequent
ischemic changes, the vascular ob
struction being caused by inclusion of
the branches of the superior mesen
teric artery to the ascending and right
half of the transverse colon within the
intussusceptum. The intussuscipiens
itself is not included. The superior
mesenteric artery ends as the ileal
artery and this anastomoses with the
ileocolic artery (Fig. I 7). The anasto
mosis between the ileocolic and right
colic arteries may be incomplete. The
evidence for this suggested mechanism

Patients and Methods

Between January 1974 and Decem
ber 1981, 106 children with acute in
tussusception were seen at the Chil
dren’s Hospital of Eastern Ontario,
Ottawa. In 100, hydrostatic reduction
was attempted; it was successful in
69 children. The 31 in whom it failed,
and 6 children not considered suitable

FIG. 1— Superior mesenteric artery and
branches (after Grant7).
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of perforation, obtained from our
operative findings and examination of
resected specimens, is as follows.
Operative Findings
Before and during reduction, the
arteries and veins of the distal bowel
are involved in the intussusceptum
and are obstructed. At the same time
there is lymphatic obstruction of the
distal bowel, evidenced by dilated lym
phatics and enlarged, congested lymph
glands, seen along the ascending and
right transverse colon after reduction.
(This lymph-gland enlargement has
wrongly been considered as part of a
local infection and as a possible cause
of the intussusception. It is, in fact,
the result and not the cause of the
intussusception.)
Resected Specimens
Resected material from four pa
tients, including the child with perfo
ration, was examined macroscopically
and microscopically. The microscopic
appearances in the intussuscipiens
showed a spectrum of changes, second
ary to vascular and lymphatic ob
struction. Fig. 2 represents one end of
the spectrum. The changes consist of
minor hemorrhage and congestion in
the lamina propria but, apart from
congestion, there are no changes in
the submucosa. Fig. 3 shows hemor
rhage into the lamina propria, edema
and slight hemorrhage in the submu
cosa with gross lymphatic dilatation.
There is no ulceration of the mucosa.
In Fig. 4 hemorrhage in the lamina
propria and submucosa is evident.
There is marked congestion in the
submucosa and some loss of mucosal
epithelium. Fig. 5 at the other end
of the spectrum shows perforation of
the transverse colon with barium on
the internal and external surfaces.
Proximal to the perforation there is
marked hemorrhage into the lamina
propria and submucosa, marked con
gestion in both layers and ulceration
of the mucosa.

of the middle colic arteries) is quite
variable. These arcades are sequential
ly involved in the intussusception be
fore involvement of their parent ves
sels and so the blood supply of the
distal bowel is impaired before it be
comes involved in the intussuscep
tum.
• Perhaps more important, the
origins of these branches from the
right side of the superior mesenteric
artery, which go to the ascending
colon and the right transverse colon,
become obstructed as the superior
mesenteric artery itself is drawn into
the intussusceptum. In this way also
there is interference with the blood
supply of the distal bowel before it
is drawn into the intussusceptum. This
vascular deprivation is related to the
prolonged duration of the intussuscep
tion typical of the at-risk group of
very young children in which perfora

FIG. 2— Intussuscipiens. Hemorrhage
in lamina propria (arrow). Mucosa is
intact. Submucosal congestion without
hemorrhage
(hematoxylin-phloxine-saffron stain, reduced by 57% from x 4 8 0 ).

tions occur. In our series, approxima
tely 50% of patients were under 1
year of age. Resections were required
for seven children because of irreducibility and for one because of per
foration; seven children were less
than 10 months of age. The child
whose bowel perforated at barium
enema was 5 months old. It is pos
sible that the intraluminal pressure
reached in children of this age group,
together with the usual enema pres
sure, is greater than that produced in
the bowel lumen of an older child. No
clear study of this has been com
pleted although we are presently en
gaged in such a study. It has also
been suggested that prolonged direct
pressure of the intussusceptum on the

FIG. 4— Intussuscipiens shows marked
hemorrhage in lamina propria and sub
mucosa. There is congestion in submu
cosa and some mucosal loss (hematoxylinphloxine-saffron stain, reduced by 57%
from x 375).

D iscu ssion

Figs. 2 to 5 illustrate the effect of
increasing obstruction of the blood
and lymphatic supply to the intussus
cipiens. This leads to necrosis of the
bowel wall. We believe that the ob
struction occurs at two levels.
• The terminal arcades of the
ileal, ileocolic, right colic and middle
colic vessels anastomose. The ana
stomosis between the ileocolic and
right colic arterial arcades is often
poor.8 The major blood supply to the
hepatic flexure (the ascending branch
of the right colic or the right branch
482

FIG. 3— Mucosa is intact, but there is
marked hemorrhage in lamina propria
and slight hemorrhage and marked lym
phatic dilatation in submucosa (hematoxylin-phloxine-saffron stain, reduced
by 68% from xlOO).

FIG. 5— P erforated intussuscipiens
(middle arrow). Barium (right hand
arrow) is on outer and upper surface
of colon. There is marked mucosal loss
proximal (left hand arrow) to perfora
tion. There is gross hemorrhage in lamina
propria and submucosa (hematoxylinphloxine-saffron stain, reduced by 68%
from x 50).
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inner wall of the intussuscipiens causes
necrosis. This may be so, but such
necrosis should be limited to the intus
suscipiens in direct contact with the
intussusceptum. We have not seen
evidence of this localized necrosis and
believe that the cause of ischemic
changes in the intussuscipiens is se
quential involvement of the blood
supply of the distal bowel before it
is intussuscepted. These ischemic
changes allow perforation of the in
tussuscipiens without undue hydrosta

tic pressure and without unduly pro
longed attempts at reduction.

4.

5.
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Obliteration of Processus Vaginalis
and Inguinal Hernial Sacs in Children
J .T . M o m o h ,

The configuration of the sac in
100 children presenting consecutively
with inguinal hernia was studied in
an attempt to understand the
mechanism of obliteration of the
processus vaginalis. Seven
ciinicoanatomic varieties were found.
From a review of these, three possible
mechanisms of obliteration of the
processus are postulated: (a)
progressive fibrous obliteration of
the funicular portion of the process
in a cephalad direction beginning
above the epididymis, (b) initial
compression of the funicular portion
of the process into a narrow tubular
structure by surrounding tissue
pressure followed by fibrous
obliteration and (c) initial segmentation
of the funicular portion followed by
variable fibrous obliteration. The
testicular portion of the process, in
any of the above mechanisms,
shrinks to form two membranes with
potential space between them as the
contained fluid is absorbed. The
types of potential hernial sacs resulting
from arrest of any of these forms
of obliteration are also described.

From the pediatric surgical unit,
department of surgery, Ahmadu Bello
University Hospital, Zaria, Nigeria
Presented at the 12th annual meeting
of the Canadian Association of
Pediatric Surgeons, Ottawa, Ont.,
June 3, 1980

m d , fr c s [c ]

Chez 100 enfants qui ont ete
examines consecutivement
pour une hernie inguinale, la
configuration du sac a ete etudiee
dans une tentative pour comprendre
le mecanisme d'obliteration de
I'apophyse vaqinale. Sept varietes
clinico-anatomiques ont ete
retrouvees. De I'etude de celles-ci,
trois mecanismes possibles
d’obliteration de I'apophyse sont
postules: a) ('obliteration fibreuse
proqressive de la partie funiculaire
de I’apophyse en direction cephalique
a partir du dessus de I'epididyme,
b) la compression initiate de la
partie funiculaire de I'apophyse
en une stucture tubulaire etroite,
par la pression des tissus
environnants, suivie d'une obliteration
fibreuse et c) une segmentation
initiale de la partie funiculaire
suivie d’une obliteration fibreuse
variable. La partie testiculaire
de I'apophyse, dans chacun des
mecanismes decrits precedemment,
se resserre jusqu'a former deux
membranes avec possibility d'un
espace entre les deux lorsque le
liquide qu’elle contient est absorbe.
On decrit les types possibles de sacs
herniaires resultant de I'arret de I'une
ou I'autre de ces formes
d'obliteration.

Reprint requests to: Dr. J.T. Momoh,
Department of surgery, Ahmadu
Bello University Hospital, Zaria,
Nigeria, Africa

The embryologic development of the
processus vaginalis and its relation to
the descent of the testis have been
well established.1 It is also accepted
that the development of inguinal her
nias in children is related to faulty
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bliteration of that structure.2,3 How
ever, there are still some fundamental
questions about the processus vagin
alis that remain unanswered. For ex
ample, why do some processes develop
into hernias and others do not, even
though the process remains patent;
what are the factors that militate
against the obliteration of the pro
cessus and what is the actual mech
anism of obliteration?
The review of Rowe and associates2
gave partial answers to the first two
questions but, except for the view
put forward by Warwick and Wil
liams,4 little has been written to an
swer the third question.
In an attempt to establish the mech
anism of obliteration of the processus
vaginalis, the anatomic configuration
of peritoneal sacs found in 100 chil
dren consecutively operated on for
inguinal hernia were studied. In ad
dition, routine contralateral inguinal
exploration permitted examination of
the opposite processus. Two basic as
sumptions were made by the study:
(a) whatever sac was found repre
sented a processus that either had
completely failed to obliterate (as in
a complete congenital hernia) or one
in which the course of obliteration
had been arrested for one reason or
another (as in a funicular hernial sac)
and (b) a study of these configura
tions would give a reliable guide to
the possible obliterative mechanisms
of the processus vaginalis.
Patients and Method
The children studied ranged in age
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from 1Vi months to 12 years; 94
were boys and 6 were girls. At opera
tion the external oblique fascia and
external ring were opened widely to
permit adequate study of the configu
ration of the sac. Patients noted to
have a unilateral hernia also under
went contralateral inguinal explora
tion to search for a patent processus
vaginalis. Two boys had had unilateral
herniotomy done at other hospitals
before presenting to us with a second
hernia; therefore, we explored only
186 groins in the 94 boys.
R esu lts

In the 186 groins explored 128 sacs
were found, 28 in the contralateral
groin of those with unilateral hernias.
In the six girls sacs were found in
nine groins. These children were ex
cluded from subsequent analysis be
cause of the small number. From a
study of the anatomic configuration
of the sacs an^l a review of the initial
clinical presentation of the children
we noted seven major clinicoanatomic
groups: a complete congenital hernia
in 35.9% (46 of 128) (Figs. 1 and 2),
funicular hernia in 31.2% (40 of 128)
(Fig. 2b), hernia with encysted hydro
cele in 14.1% (18 of 128) (Fig. 3),
communicating hernia-hydrocele in
7% (9 of 128) (Fig. 4), hernia with
hydrocele of the spermatic cord in
1.6% (2 of 128) (Fig. 5), capillary
and fibrosing hernia in 3.9% (5 of
128) and 1.6% (2 of 128) respect
ively (Fig. 6) and scrotal hydrocele
in 3.2% (4 of 128) (Fig. 7).
Among those with detectable her

nias, the clinical presentation was in
termittent inguinal or inguinoscrotal
swelling when the sac was in the
position shown in Fig. 2. Children
presented mainly with persistent scro
tal swelling with or without a thick
ened spermatic cord on palpation
when the sac was as in Figs. 3, 5 and
7. Types depicted in Fig. 4 presented
with scrotal swelling which emptied
slowly on firm, gentle pressure or at
night when the patient was recum
bent. Types in Fig. 6 presented with
thickened spermatic cord only.
Of interest in the present context
was the finding that the capillary and
fibrosing sac and the variant of funi
cular sac that were all located within
the confines of the internal and ex
ternal rings were found exclusively in
the contralateral groins of children
presenting with unilateral hernia.
This suggests that these sacs were in
the process of obliteration and would
not likely have presented later in life.
D iscussion

Warwick and Williams4 suggested
that closure of the processus vaginalis
begins both at the deep inguinal ring
and just above the epididymis, gradu-

ally extending until the whole of the
intervening portion of the process is
converted into a fibrous cord. From
our study this appears to be a very
uncommon mechanism of closure. In
only one patient could we identify a
constriction ring just beyond the in
ternal ring. Moreover, if this mech
anism was frequently in operation we
would have expected more examples
of hydrocele of the spermatic cord in
our study.
A close look at the anatomic con
figurations of sacs found in our pa
tients points to three possible mech
anisms of obliteration of the pro
cessus vaginalis (Fig. 8).
• The first mechanism (Fig. 8, A)
involves a constriction progressing to
complete closure, which develops in
the process proximal to the epididy
mis. This is followed by a progressive
obliteration of the sac in a cephalad
direction towards the internal ring,
until a fibrous cord of variable thick
ness is the only remaining vestige.
Interruption of this course leads to
potential funicular, communicating
hernia-hydrocele or encysted hydro
cele varieties of hernia. The large
proportion of patients in all age
groups with funicular hernia indicates

F IG . 5— H ernia with hydrocele of cord
( 2 ).

FIG . 1—Complete congenital hernia.

F IG . 2—(a) Com plete congenital h er
nia (46 sacs), (b) Funicular hernia (40).
N um bers represent children who had
these types of hernia.
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FIG . 3— H ernia with encysted hydro
cele (18). P F = preperitoneal fat.

F IG . 6— (a) Capillary hernia (5). (b)
Fibrosing sac (2).

FIG . 4— Com m unicating hernia-hydro
cele (9).

FIG . 7— (a) True hydrocele (2). (b)
Large internal ring with plug of peri
toneal fat (1). (c) Sliding hernia (1).
C f I I — cecum and term inal ileum.
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that this is the most common mode
of obliteration irrespective of the
child’s age.
• The second possible mechanism
(Fig. 8, B) involves compression of the
entire length of the processus vaginalis
into a narrow channel by surrounding
tissue. This is then followed by pro
gressive fibrous obliteration in a cephalad direction, beginning just above
the epididymis. Interruption of this
obliterative process leads to sacs found
in either the communicating herniahydrocele or the capillary or fibrosing
funicular hernia.
• The third possible mechanism
(Fig. 8, C) involves segmentation of
the funicular portion by one or more
constricting rings, some of which may
close completely to form cysts of the
cord. This is then followed by fibrous
obliteration which may or may not be
as orderly as in the mechanisms de
scribed above. When obliteration is
incomplete the end result is a poten
tial hernia with encysted hydrocele,
a hernia with hydrocele of the cord
or a hydrocele of the cord alone.
Mechanisms B and C are less com
mon than A; however, they are more
likely to be operative in older chil

dren since in our series the types of
hernia that can be associated with
their arrest were found in children 1
year of age and older.
Irrespective of the mechanism of
obliteration of the funicular portion,
the testicular portion of the process
shrinks to form two opposed mem
branes with a potential space be
tween them as the contained fluid
is taken up by the surrounding
lymphatic vessels. When this fails, a
hydrocele results and where there is
failure of closure of the funicular por
tion as well, a complete congenital
hernia results. The rare occurrence of
scrotal hydrocele alone in children
suggests that fluid retention in the tes
ticular portion is always indicative of
patency of the funicular process.
I thank Mrs. Sue Renner of the med
ical illustration unit for the drawings,
and Mallam Lamidi for secretarial help.
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FIG. 8 -Mechanisms of obliteration of processus vaginalis.
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Operation de KasaV pour atresie des voies
biliaires extra-hepatiques: cure ou palliation?
H erve B lanch ar d ,

m d , f r c s [ c ], fa a p ,
et

L’operation de Kasai, porto-enterostomie
ou porto-cholecystostomie, represente
actuellement I'unique forme de
traitement chirurgical de I'atresie
des voies biliaires extra-hepatiques
de type non corrigeable. Sur 17 patients
operes a I'Hopital Sainte-Justine,
11 ont eu une excretion evidente
de bile. Une evolution de 12 a 60 mois
apres I’intervention, montre que
huit patients sont vivants avec une
excretion biliaire.
Des 17 patients operes, 12 ont
presente des complications infectieuses
et hemorragiques. Six des huit
patients vivants presentent des
manifestations cliniques et biologiques
de souffrance hepatocytaire.
(.'excretion de bile et la regression
de I'ictere ne semblent pas mettre
ces patients a I’abri d'une aggravation
progressive de leur maladie.

P ierre B roch u , m d , f r c p [c ], A rie L. B e n so u ssa n ,
P h il ip p e M o n t u p e t , m d

Parmi les maladies hepatiques evolutives, I’atresie des voies biliaires extrahepatiques est la cause la plus frequente de deces chez les enfants atteints d’affection hepatique.1
Avant 1974, tous les patients ex
plores chirurgicalement a I’Hopital
Sainte-Justine pour une atresie des
voies biliaires extra-hepatiques sont
decedes en moyenne 14 mois apres
l’exploration.
L’operation de Kasai,2 porto-ente
rostomie, porto-cholecystostomie et ses
variantes, introduite dans notre centre
hospitalier en 1974, a ete pratiquee
chez 17 enfants souffrant d’une atre
sie des voies biliaires extra-hepatiques.
Malgre des resultats initiaux encourageants, 1’evolution de ces patients
apres 6 ans nous laisse perplexes
quant a leur guerison definitive.
Patients et methode

The only surgical treatment currently
available for patients with extrahepatic
biliary atresia is portoenterostomy
or portocholecystostomy, the Kasai
operation. Seventeen such patients
were operated upon at the Hopital
Sainte-Justine; 11 had bile excretion.
Eight are still alive 12 to 60 months
after operation. They have good to fair
bile excretion. Twelve of the
17 patients had infectious or
hemorrhagic complications and
hepatic deficiency is evident in 6 of
the 8 living patients.
The progressive deterioration of
liver function in the majority of the
patients still alive raises the
question of whether the Kasai
procedure should be considered a
curative or only a palliative procedure.

Division de chirurgie generate
pediatrique et de pathologie, Hopital
Sainte-Justine, Universite de Montreal,
Montreal, PQ
Presente au 13e congres annuel de
l’Association canadienne de chirurgie
pediatrique, Toronto, Ont.,
le 15 septembre, 1981

De mars 1974 a aout 1980, 17 en
fants (13 filles et 4 gargons) ages de
45 a 105 jours ont eu une operation
de Kasai' pour atresie des voies bi
liaires extra-hepatiques. Seize patients
avaient un poids normal a la naissance. Un gargon etait de petit poids
pour Page de la grossesse.
La bilirubinemie totale etait en
moyenne de 171 ^u.mol/1 et la biliru
binemie conjuguee de 120 /zmol/1. Le
dosage des transaminases seriques a
ete, en moyenne, de 155 U/m l pour
la SGPT (normale: 10 a 90 U/ml)
et de 217 unites pour la SGOT (nor
male; 20 a 90 unites). La concentra
tion moyenne de la phosphatase alcaline a ete de 395 U /l (normale: 15 a
175 U /l). Le coagulogramme de depistage etait normal.
L’excretion fecale de 72 heures du
rose Bengale marque a iode-131 mesuree seulement chez les gargons etait
inferieure a 10% de la dose injectee.
Une biopsie hepatique par aspiration
faite chez tous les patients, se revela
compatible avec le diagnostic d’atresie
des voies biliaires extra-hepatiques.

md

sans rapport avec des causes infec
tieuses, genetiques et metaboliques.
L’exploration chirurgicale montra
que les 17 patients presentaient une
atresie des voies biliaires extra-hepa
tiques du type non corrigeable (type
III de la classification japonaise2).
Chez 11 patients, la voie biliaire extrahepatique etait transformee en cordon
fibreux.
La cholangiographie peroperatoire
a ete possible chez six patients. Cinq
avaient une vesicule et un choledoque
distal ne communiquant pas avec le
permeables. Le sixieme, une vesicule
permeable et un kyste du choledoque
distal ne communiquant pas avec le
duodenum (fig. 1).
Des malformations internes et externes furent notees chez six patients
(tableau I).
Une porto-enterostomie2 a ete faite
chez 14 patients: Kasai I: 6, Kasai II:
2, Suruga: 5, Sawaguchi: 1. Huit de
ces 14 patients eurent une enterosto-

Accepte pour publication le 10 mai, 1982
Les demandes de tires-a-part doivent
etre adressees au Dr Herve Blanchard,
Departement de chirurgie, Hopital
Sainte-Justine, 3175, chemin
Ste-Catherine, Montreal, PQ H 3T 1C5
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Resultats

L’indication operatoire est basee essentiellement sur l’existence d’une hyperbilirubinemie conjuguee persistante
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FIG. 1— Cholangiographie peropera
toire (six cas). (a) Vesicule et choledoque
Dermeables (cinq cas). (b) Vesicule per
meable et kyste choledoque (un cas).
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mie decompressive. Chez trois patients
ayant une vesicule et un choledoque
permeables et d’assez bon calibre,
nous avons opte pour une porto-cholecystostomie.2
L’examen histologique du cone fibreux hilaire montra des petits canaux
biliaires dans 12 specimens. Dans un
specimen, les canaux etaient visibles
macroscopiquement. Quatre speci
mens, non satisfaisants, n’ont pu etre
interpretes histologiquement.
L’examen histologique des biopsies
hepatiques chirurgicales montra une
fibrose marquee a moderee dans 14
specimens. La fibrose etait minime
dans deux echantillons et dans un cas
il s’agissait de cirrhose.
Evaluation des resultats fonctionnels

Les resultats fonctionnels, evalues
sur 1'abaissement de la bilirubinemie
totale et conjuguee, la regression totale ou partielle de Fictere et d’autres
facteurs observables (couleur des
selles et des urines, excretion de
HIDA i irque au technetium-99) permettent de classer les 17 patients en
trois groupes.
Le groupe A, bon, comprend six
patients vivants, anicteriques ayant
une bilirubinemie totale inferieure a
25.6 /rmol/l.
Le groupe B, intermediaire, cornpte

cinq patients ayant excrete de la bile,
une regression partielle de Fictere et
une bilirubinemie totale variant de
25.6 a 85.5 /xmol/1. De ces cinq pa
tients, deux ont eu un arret d’excretion biliaire 45 a 90 jours apres l’intervention. Reoperes, il y eut reprise
de Fexcretion biliaire chez un patient.
Trois patients du groupe B sont
decedes respectivement de cholangite
severe avec septicemie et choc, d’insuffisance hepatique due a la cirrhose
et d’arret d’excretion biliaire 3 Vi mois
a 3 ans apres Fintervention.
Le groupe C comprend six patients
qui n’ont jamais excrete de bile.
Sur les 17 patients operes, 11 excreterent de la bile. Huit patients sont
vivants 12 a 60 mois apres Finterven
tion.
Correlation entre l'histologie
du cone fibreux hilaire et du foie,
Fexcretion biliaire et survie

Nos donnees (tableau II) ne semblent pas montrer qu’il existe de cor
relation evidente entre l’existence de
petits canaux biliaires, Fexcretion de
bile et la survie. Par contre, unc fi
brose hepatique moderee a marquee
chez 14 patients et une cirrhose tran
che chez 1 patient n’empecherent pas
Fexcretion de bile chez 11 patients
dont 8 sont encore vivants. Une fi

Tableau 1-Anomalies associees - 6117
Systeme

No.

Anomalie

Cardio-vasculaire

Communication inter-ventriculaire
Artere hepatique preduodenale
Veine porte preduodenale
Malrotation
Luxation congenitale handles

Digestif
Musculo-squelettique

Tableau II--Correlation: histologie - excretion - survie
Excretion bile
Specimen
Cone fibreux
Canaux presents
Examen non satisfaisant
Foie
Fibrose marquee-moderee
Fibrose minime
Cirrhose

No.

Present

Absent

No.
survivants

13
4

7
4

6
0

6
2

14
2
1

10
0
1

4
2
0

7
0
1

brose hepatique minime chez deux
patients ne favorisa nullement Fexcre
tion de bile.
Complications

Des 17 patients operes, 12 presenterent des complications (tableau III).
La plus frequente et la plus redoutable fut l’angiocholite (54.5%). De
frequence a peu pres egale dans les
groupes A et B, elle fut plus severe
et plus resistante au traitement chez
les patients du groupe B.
Des hemorragies severes au niveau
de l’enterostomie de decompression
furent observees chez trois patients.
Des huit patients vivants, quatre du
groupe A et les deux du groupe B
ont des manifestations cliniques et
biologiques d’une souffrance hepatocytaire continue et progressive mais
les preuves histologiques manquent
(tableau IV).
Les causes de deces sont presentees
au tableau V.
Discussion

D ’etiologie indeterminee, l’atresie
des voies biliaires extra-hepatiques
semble etre une maladie acquise. Son
primum movens serait un processus
inflammatoire qui, selon son degre
de severite, causerait une obstruction
ou une destruction partielle ou totale
des voies biliaires extra-hepatiques.1,2
Du point de vue experimental,
Okamoto et collaborateurs3 ont produit la malformation par devascularisation complete des voies biliaires ex
tra-hepatiques chez les chiots.
Ito et collaborateurs4 causerent des
lesions semblables a l’atresie des voies
biliaires extra-hepatiques de l’enfant
en injectant par voie intra-peritoneale
de la sporidesmin, produit de Pithomyces chartarum, a des lapines gestantes et a des lapereaux.
Des malformations, en majorite
vasculaires, sont observees chez 25%
des patients.1,5 Aucun test ne permet
de differencier de fagon absolue l’atre
sie des voies biliaires extra-hepatiques
des autres syndromes cholestatiques
du nouveau-ne et du nourrisson.
Tableau IV-Complications resultant de
revolution de la maladie: 8 vivants

Tableau III-Complications post derivation
Groupe
Groupe
Complication
Cholangite
Hemorragie par stomie
Prolapsus stomie
Arret excretion

No./no. total

A

B

C

Complication

6111
3/8
1/8
2111

3

2
2

—

—

1
1
1
-

Alteration des
tests hepatiques
Ascite
Hemorragie digestive

2
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A
B
(6 vivants) (2 vivants)
4
3

2
2
1
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L’indication operatoire se basera sur
les faits cliniques suivants: nouveau-ne
ou nourrisson de poids normal a la
naissance avec hyperbilirubinemie
conjuguee persistante, hepato-splenomegalie, selles acholiques et bilirubinurie. Tout test ou investigation
diagnostique susceptible de retarder
l’intervention de plus de 72 heures
devrait etre omis.6
L’importance de Page au moment
de la chirurgie dicte cette celerite et
cette attitude agressive. L’age in
fluence aussi bien les resultats fonctionnels immediats que le prognostic
a long terme. L ’importance de l’intervention precoce est bien illustree par
la serie de Kitamura et collaborateurs.7 Cette serie de 144 patients
montre line survie globale de 26%
apres 5 ans. Des patients operes durant les premiers 60 jours de vie,
35% sont vivants, de 60 a 91 jours
39% sont vivants et de 91 a 120 jours
17% ont survecu. Aucun patient opere apres 120 jours n'a survecu. L ’enquete, en cours, de la section chirurgicale de l’A.A.P. (American Academy
of Pediatrics) semble confirmer ces
faits.8
L'histopathologie du cone fibreux
hilaire a ete deroutante. A l’instar
de Shandling, nous n’avons pas trouve de correlation significative entre
la presence, le nombre et le calibre
des canaux biliaires et l’excretion de
bile.8
L ’bistologie du foie ne semble pas
avoir une influence determinante sur
1’excretion eventuelle de la bile. Elle
laisse presager, par contre, 1’evolution
ineluctable vers la cirrhose et ses com
plications.71' ’"
L ’angiocholite postoperatoire, dans
sa forme severe et iterative, exerce
une action nefaste non seulement sur
l'excretion biliaire mais encore sur les
lesions pre-existantes du parenchyme
hepatique.12 Cette complication n’est
pas l’apanage exclusif des patients
ayant eu une operation de Kasai' de
type I. Elle est signalee tout aussi
bien chez les patients qui ont eu une
operation de Kasai du type II ou une
derivation externe type Sawaguchi.
Nous 1’avons meme observee chez un

de nos patients du groupe A qui a
eu une porto-cholecystostomie.
Dans notre serie, l’enterostomie de
compressive n’a jamais prevenu, ni
diminue la frequence ou l’intensite
des episodes de cholangite. Par contre,
elle fut le siege d’hemorragies severes
chez trois des huit patients enterostomises.
Dans notre experience, l’antibiotherapie prophylactique cyclique nous a
semble plus efficace que l’enterostomie dans la prevention de la cho
langite.
L’operation de Kasai est gratifiante
si on accepte comme criteres de succes l’excretion de bile et la regression
de l’ictere. Mais ces criteres de succes
ne sont pas synonymes de cure; car
la cirrhose evolutive et ses complica
tions qui surviennent a long terme
assombrissent les espoirs et attestent
le caractere factice de la guerison.
Conclusions

Echec chirurgie initiale
Cholangite et sepsie (groupe B)
Arret excretion - echec
reintervention (groupe B)
Insuffisance hepatique (nroupe B)
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Symposium on the Treatment of Inflammatory
Bowel Disease in Children and Adolescents

Medical Management
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Children and adolescents with
inflammatory bowel disease experience
problems that their adult counterparts
do not share. Although there are
some similarities, the goals of
therapy are different. The general
medical management of these patients
consists of stabilization in the acute
phase and control of the disease
to allow the patient to grow and lead
as normal a life as possible in the
chronic phase. Nutritional therapy is a
very important aspect of this
management, but drugs such as
steroids and sulfasalazine and,
under special circumstances, other
medications are useful adjuncts.
Supportive psychotherapy is also
important.

steroides et la sulfasalazine et
dans certaines circonstances,
d'autres medicaments sont des
adjuvants utiles. Une psychotherapie
de soutien est aussi importante.

Medical Therapy

The goals of therapy are to stabilize
the patient in the acute phase and to
control the disease in the chronic
phase. By doing so, the patient may
achieve normal growth and sexual
maturation. Finally, it is important
that the physician supports the pa
tient and family and helps them accept
the disease, get through periods of
ill health and lead as normal a life
as possible.
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Although there are similarities in the
medical management of ulcerative
colitis and Crohn’s disease, two factors
influence the relative importance of
medical therapy in the two diseases:
1. While surgical treatment can
cure ulcerative colitis, the risk of re
currence following surgery for Crohn's
disease and the propensity for this
disease to affect multiple areas of the
intestine prevent surgery from being
curative.
2. The incidence of Crohn’s disease
appears to be rising.1 Since mid-1975,
we have seen 23 new cases of inflam
matory bowel disease in children and
adolescents at the Children’s Hospital
of Winnipeg. Until 1978, we were
seeing an average of two new cases
each of Crohn’s disease and plcerative
colitis annually. We have had no new
cases of ulcerative colitis since 1978,
but in the first 8 months of 1981, we
had five new cases of Crohn’s disease.
Medical therapy is probably more
important in Crohn’s disease than in
ulcerative colitis and the demand for
it appears to be increasing.
Some of the problems children and
adolescents with inflammatory bowel
disease experience are similar to those
of adults. Intestinal and extraintestinal
symptoms are similar. Although poor
weight gain may be a problem at all
ages, poor linear growth and delay in
sexual maturation are unique to chil
dren and adolescents. The illness may
cause a child to limit normal activity
and may contribute to a feeling of
being different from other children.
A child who has lost considerable
weight or looks Cushingoid because of
steroid therapy or otherwise feels dif
ferent may have a serious psychoso
cial problem, as a complication of the
disease.
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Les enfants et les adolescents
souffrant de maladie inflammatoire
abdominale font face a des problemes
inconnus de leur contre-partie adulte.
Bien qu'il existe des ressemblances, les
buts du traitement sont differents.
Les grandes lignes du traitement
medical de ces patients consistent a
obtenir une stabilisation durant
la phase aigue et a maitriser la
maladie de fagon a permettre au
patient de grandir et de mener une vie
aussi normale que possible durant
la phase chronique. La therapie
nutritionnelle constitue un aspect
tres important de ce traitement,
mais des medicaments tels que les

Acute Phase

Depending on the severity of the
symptoms in the acute phase, it may
be necessary to correct fluid and elec
trolyte deficits and acid-base imbal
ance. Blood and blood products may
also he required for those who have
substantial blood loss. Nutritional de
ficiencies that may have arisen be
cause of such conditions as malab
sorption, poor intake and vomiting
may also require correction. While antidiarrheal and antispasmodic drugs, at
this stage, may provide symptomatic
relief, their use may precipitate a
deterioration in the clinical state of the
child, particularly in those who have
severe disease. Psychotropic drugs are
probably not beneficial in most pa
tients with inflammatory bowel disease
but may help those who have some
underlying psychiatric disorder or may
require sedation for other reasons.
Antibiotics are of little value for the
management of the primary disorder,
but should be reserved for infections
that may occur as a result of the
primary disease, such as sepsis or
peritonitis. Anti-inflammatory drugs
are the mainstay of therapy. A variety
of other drugs and therapies have
been tried but have not been studied
in controlled trials or have not gained
widespread use.
Amongst the anti-inflammatory
drugs, steroids have proven of value
for both ulcerative colitis and Crohn’s
disease. The National Cooperative
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Crohn’s Disease Study that was un
dertaken in the United States recently
showed that 78% of patients treated
with steroids had some form of re
mission during the 17-week study
period and 60% remained in remis
sion during this time.2 Of placebotreated patients, 50% had some form
of remission but only 30% had a
sustained remission during the study.
This study also showed that systemically administered steroids were more
valuable for patients with small bowel
involvement than for those with dis
ease confined to the colon. Systemic
steroids are also effective in inducing
remissions in ulcerative colitis.3 Topi
cal steroids in the form of enemas are
valuable in patients with ulcerative
colitis.4 They are of less value for
patients with Crohn’s colitis since the
inflammation is transmural. Adoles
cents do not like to use enemas hut
eventually get accustomed to them.
While the prepackaged steroid enemas
are convenient, they sometimes can
not be retained long enough to be of
value, but 100 mg of hydrocortisone
added to 100 ml of normal saline in an
intravenous bag can be run into the
rectum slowly and is usually retained
longer. While enemas are most ef
fective in left-sided colitis, more ex
tensive disease can be effectively
treated as well. There is some risk
of steroid absorption, particularly in
patients who have a severely inflamed
bowel,4'5 so it is advisable to discon
tinue the enemas once remission has
been induced.
Sulfasalazine has also been widely
used in the management if inflam
matory bowel disease. It is effective
in inducing remission in ulcerative
colitis.6 The National Cooperative
C rohn’s Disease Study demonstrated
that sulfasalazine was better than
placebo in inducing a remission, parti
cularly if the disease primarily invol
ved the colon.7 It was not beneficial
for small bowel disease. Its mode of
action is unknown but 5-aminosalicylic acid (5-ASA) produced by colonic
bacterial degradation of sulfasalazine
appears to be the active component.8
Recent studies have suggested that
5-ASA acts as a prostaglandin syn
thetase inhibitor, since prostaglandin
E2 concentrations in colonic tissue
from patients with ulcerative colitis
are elevated, and in vitro studies have
shown that these levels are reduced
by 5-ASA.9 However, the role of pro
staglandin E2 in the pathogenesis of
ulcerative colitis is unknown. A more
recent study suggested that 5-ASA
does not act as a prostaglandin syn
thetase inhibitor but that its mode of
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action may be one of immunosup
pression.10 Sulfasalazine enemas may
be effective in inducing remissions in
ulcerative colitis.8 A recent study using
high-dose 5-ASA enemas in the treat
ment of ulcerative colitis showed en
couraging results.11
The value of azathioprine and its
related drug, 6-mercaptopurine, in
treating Crohn's disease is controver
sial.1214 The National Cooperative
Crohn’s Disease Study showed that
azathioprine was no better than place
bo in inducing a remission.14 Other
studies of 6-mercaptopurine and aza
thioprine have shown that the drugs
are effective but only after at least
3 to 4 months of therapy.13 This is
not practical in the acute phase of
management. However, in selected
cases, these drugs may allow steroid
dosage to be reduced. Higher doses
for a longer period might be more ef
fective but the side-effects would pre
clude any clinical value. These drugs
have also been advocated in ulcera
tive colitis particularly as adjunctive
therapy with steroids and for mainte
nance therapy.15’16
Chronic Phase
The maintenance of good nutrition
is one of the most important if not
the most important component of the
rapy in the chronic phase of inflam
matory bowel disease.17,18 Intensive
psychoanalysis and psychotherapy in
these patients is unnecessary, unless
they have some underlying psychiatric
disorder; most simply need a lot of
support. Clearly, the family plays a
very important role in this. A parent
who becomes emotionally distraught
every time the child suffers a recur
rence is of considerably less help than
one who is calm. The physician’s role
is also extremely important in this
regard. A physician should initially be
available to discuss the disease in an
open and frank manner and allow the
child to ask questions. Physicians tend
to deal primarily with the parent and
only secondarily with the child; it is
often more valuable to deal with the
child directly but to keep the family
informed. With this approach patients
are more willing to talk about their
concerns, have a better understanding
of the disease and are more willing
to cooperate in the management of
the disease. It is extremely important
to reassure both child and parents that
although inflammatory bowel disease
is a chronic condition and may present
major problems and although there is
no specific cure, except perhaps sur
gery for ulcerative colitis, there is a

great deal that we can do. A team ap
proach involving the primary physi
cian, gastroenterologist, nurse, sur
geon, dietitian, pharmacist, psychia
trist, stomal therapist and social
worker gives the child the added con
fidence that whenever a problem
arises, there will always be someone
available with whom to talk. Further
more, patients may relate better to
some members of the team than to
others. There must, however, be one
member of the team who is ultimately
in charge; ideally this should be the
primary physician.
Membership in the Ileitis/Colitis
Foundation may be helpful to some
patients. The literature distributed by
this organization proves that the pa
tients are not alone and that there are
answers to questions they may have
been reluctant to ask their physician.
For some, close association with
another patient also proves valuable.
Not all adolescents, however, benefit
from this type of relationship and
would rather forget about their dis
ease until they need help.
Drugs are also valuable in the
chronic phase of therapy. Sulfasala
zine reduces the frequency and se
verity of recurrences of ulcerative
colitis.19 It is not as valuable as a
prophylactic in Crohn’s disease. The
National Cooperative Crohn’s Disease
Study showed that neither prednisone
nor sulfasalazine was helpful in pre
venting recurrences.2 Long-term use of
steroids should be avoided if possible
because of their side-effects, such as
the effect on growth. On the other
hand, some evidence suggests that
steroids, in adequate amount, may
actually allow the patient to grow once
the disease is suppressed by the medi
cation.18’19 The price for this approach,
however, is the side-effects that high
doses of steroids may cause. Adoles
cents do not like the round face,
hirsutism and striae even though they
know they may feel better with the
medication.20 For those who need
steroids continuously, alternate day
doses as low as required to suppress
disease activity should be the goal
since the risk of side-effects is less.21
Other drugs used in the chronic
phase have not been extensively eval
uated. Metronidazole appears to be
particularly useful in the management
of perianal involvement in Crohn’s dis
ease.22 Its beneficial action may be
due to its effect on anaerobic bac
teria. In one recent study, it was shown
that levamisole, an immunologic sti
mulant, was useful in Crohn’s disease
by sustaining a remission that had
been induced by other forms of thera-
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py.23 A recent study of disodium cromoglycate suggested it may be useful
in maintaining remission and in pa
tients with mild ulcerative colitis.24
Other studies25’26 have not confirmed
its value but it may be useful in se
lected cases. Various other forms of
therapy have been attempted over the
years but have either lost favour or
have not been extensively studied or
used.
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2. Nutritional Therapy
M icheline Ste -M arie ,

Malnutrition contributes substantially
to the severity and morbidity of
inflammatory bowel disease in children.
Causes of malnutrition include
decreased oral intake, excessive
nutrient losses, increased nutritional
requirements and malabsorption.
Nutritional therapy is used to correct
specific deficiencies, delayed growth
and puberty, and as primary therapy
to achieve total bowel rest in patients
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with disease that is resistant to
conventional medical treatment. Total
parenteral nutrition has been used
successfully in patients with
nonfistulous Crohn’s disease and
in those with retarded growth. Results
are not as encouraging in patients who
have Crohn's disease with fistula
and in patients with ulcerative
colitis. Continuous elemental enteral
nutrition seems promising, but more
controlled studies are needed to
assess critically the value of this
form of therapy.
La malnutrition contribue de facon
marquee a la gravite et a la
morbidity des maladies inflammatoires
intestinales chez I’enfant. Les causes
de malnutrition comprennent
une reduction de I'apport oral,
une perte nutritionnelle excessive,
des besoins nutritionnels augmentes
et la malabsorption. La therapie
/

nutritionnelle est utilisee pour
corriger des carences specifiques,
un delai de croissance ou le retard
de la puberte, et comme traitement
primaire pour mettre I'intestin
au repos complet chez les patients
dont la maladie est resistante
au traitement medical traditionnel.
L'alimentation parenterale totale
a ete employee avec succes chez des
patients ayant une maladie de Crohn
non fistuleuse et chez ceux qui
avaient un retard de croissance.
Les resultats ne sont pas aussi
encourageants dans les cas de
maladie de Crohn fistuleuse
et chez les patients souffrant de
colite ulcereuse. L'alimentation
elementaire continue par voie
intestinale semble prometteuse,
mais d'autres etudes controlees
sont requises pour evaluer de
facon critique I'utilite de cette
forme de traitement.
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Although it has long been known that
malnourished individuals are less able
to cope with disease, the impact of
malnutrition on the onset, course and
complications of inflammatory bowel
disease was not recognized until a
few years ago. Physicians always re
commended a good diet to these pa
tients, forgetting that many of them
could not digest food and quite a few
could not even eat. Malnutrition in
children is even more serious because
it influences growth and development.
This paper will briefly review the
causes of malnutrition in inflammatory
bowel disease in children, the indica
tions for nutritional therapy and the
techniques that can be used.
Causes of Malnutrition

Why do such patients suffer from
malnutrition? Several reasons can be
evoked; they may act singly or to
gether to establish severe debilitation
and morbidity.1
Decreased oral intake may be sec
ondary to anorexia or abnormalities
of taste in patients with active dis
ease. Some patients voluntarily eat
less because eating causes nausea,
exacerbation of abdominal pain and
diarrhea or because they have mouth
ulcers. Sometimes, patients will limit
their food intake to one or a few
foods that they believe do not ex
acerbate their symptoms.
Excessive nutrient loss is found
mostly in patients with extensive
Crohn's disease of the small bowel
and in those with severe colitis. In
the first category of patients malnu
trition develops because of protein-IOsing enteropathy, steatorrhea and loss
of electrolytes and minerals. Gastro
intestinal bleeding in patients with
colitis can aggravate the losses sec
ondary to protein-losing enteropathy.
Crohn’s disease and ulcerative coli
tis are high-energy illnesses and can
rapidly deplete nutrient reserves.
Active disease, fever, fistulas and in
fection consume an enormous amount
of energy; because nutrient reserves
are low or absent and oral intake is
decreased, malnutrition develops rap
idly in such patients. Nitrogen require
ments are increased during cortico
steroid therapy because of increased
excretion; finally, growth is an im
portant protein-calorie consumer in
children, particularly adolescents.
Absorptive defects are more pre
valent in patients with Crohn’s dis
ease than in those with ulcerative coli
tis. Defects have been described at
all stages of the digestive and absorp
tive processes. Patients with jejunal
496

involvement are most susceptible to
malabsorption. Severe ileal disease or
ileal resection leads to loss of bile
salts, contraction of the bile-salt pool
and decreased secretion of bile salts
leading to fat malabsorption.
Strictures, fistulas, enteroenterostomies or surgically produced blind
pouches cause stasis of intestinal con
tents and subsequent bacterial over
growth; as a consequence, vitamin B12
malabsorption and steatorrhea devel
op. Diffuse granulomatous and in
flammatory changes disrupt the in
testinal mucosa’s absorptive functions,
not only of fat but of most other
nutrients. Extensive disease, fistulous
bypass of several intestinal loops and
multiple resections decrease the sur
face area available for absorption.
Extensive lymphatic involvement in
Crohn's disease adds to the impair
ment of fat absorption caused by mu
cosal disease and decreased secretion
of bile salts. Finally, calcium, folate
and fat-soluble vitamin malabsorp
tion may be induced by the various
drugs used for therapy.
Indications for Nutritional Therapy

Nutritional therapy in inflamma
tory bowel disease is used to correct
total protein-calorie malnutrition and
specific deficiencies. Many children
with Crohn’s disease have delayed
growth and sexual maturation. No
specific endocrine abnormality has
been demonstrated in these patients;2
since energy and protein deficiencies
may he primarily responsible, nutri
tional therapy is indicated.
In view of the relentless chronic
course of these diseases and their dis
couraging response to various medical
and surgical treatments, nutritional
therapy has been promoted as primary
therapy, especially for Crohn’s dis
ease. In these patients, nutritional the
rapy may be indicated: (a) when short
howel syndrome occurs resulting in a
decreased absorptive area; (b) in pa
tients with acute flare-up of the dis
ease, when complete bowel rest is
desirable to promote closure of fi
stulas and reduced inflammation of
the bowel wall and (c) in patients
about to undergo operation whose nu
tritional status must be improved.3
Some physicians even consider
that bowel rest and nutritional therapy
with the judicious use of anti-inflam
matory drugs during the acute phase
may be the treatment of choice to in
duce long-term remission. Patients
will benefit even more from this
therapy if nutritional deficiencies are
recognized early in the course of the

disease and corrected as soon as they
are identified.
Nutritional deficiencies are more
prevalent in patients with Crohn’s dis
ease than in those with ulcerative
colitis.1,1 Weight loss and protein defi
ciency may be found in up to 80%
of patients with Crohn’s disease and
60% of patients with ulcerative coli
tis. Anemia due to folate deficiency,
iron or vitamin B,2 malabsorption is
also common. Calcium, potassium and
magnesium deficiencies resulting lar
gely from diarrhea have been de
scribed mostly in patients with Crohn’s
disease (up to 30%). Deficiency of
lipid-soluble vitamins, especially vita
min D, are also common in Crohn’s
disease (up to 75%). Metabolic bone
disease may result from vitamin D
deficiency, negative calcium balance
and concomitant corticosteroid thera
py. Zinc deficiency may be important
in the pathogenesis of anorexia, ab
normal taste sensation and possibly
retarded growth and delayed sexual
maturation.
Increased intestinal protein loss, as
a result of protein-losing enteropathy,
diffuse granulomatous involvement of
the intestinal mucosa and gastrointes
tinal bleeding is documented in up to
70% of children with Crohn’s disease.
Carbohydrate intolerance (particularly
of lactose) secondary to bacterial over
growth or mucosal dysfunction, or
both, is present in about 20% of
children with inflammatory bowel dis
ease. Steatorrhea is found in about
33% of the children. Low serum
levels of folate, iron and calcium and
an abnormal Schilling test result are
also common. Therefore, it is ex
tremely important to assess the nutri
tional status of every child with in
flammatory bowel disease so that nu
tritional deficiencies can be corrected
rapidly.
Methods of Nutritional Therapy

Of the various methods of nutri
tional therapy, the simplest is an ade
quate diet with or without oral sup
plements. Continuous and intermit
tent enteral alimentation, mostly
nocturnal, is more invasive but com
plications are few. Gastrostomy should
be reserved for patients who cannot
cope with a nasogastric tube. Needle
catheter jejunostomy is a relatively
new technique and needs to be eval
uated in patients with inflammatory
bowel disease. Parenteral nutrition
through either peripheral vein or cen
tral venous catheter has been used
extensively, and enthusiastic reports in
the literature have stimulated greater
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use of this method including total
parenteral nutrition at home.
Restrictive diets are not indicated
especially in children; no foodstuff
has been shown to be harmful to the
intestinal mucosa in inflammatory
bowel disease with the possible ex
ception of lactose in those patients
who have proven lactase deficiency.
Appetizing meals with preferred foods
will increase caloric intake in an
agreeable fashion. Vitamins, iron and
calcium supplements can be added if
necessary.
Oral supplements are indicated if
patients cannot increase their caloric
intake by diet alone. These formulas
have high caloric value and may in
duce early satiety thus making it im
possible for children to reach their
daily energy requirements, which may
reach up to 4000 cal/d. The relatively
high osmolarity of these formulas
sometimes aggravates diarrhea.
Several studies have been published
describing the benefits of total paren
teral nutrition either in hospital or at
home; most of the patients studied
were adults although several studies
included adolescents. A few dealt ex
clusively with the pediatric population.
If we analyse the data from some of
these series (92 patients), some results
are extremely encouraging, others not.
When total parenteral nutrition was
used as primary therapy in nonfistulous Crohn’s disease,514 improve
ment of nutritional status was achieved
in all. Temporary remission occurred
in more than 80% of patients but
long-term remission was less common
(66%); this is probably a very opti
mistic figure since in a few of these
studies the follow-up did not exceed
3 months. Patients with localized dis
ease of recent onset responded better
than other groups.
Results were not as encouraging in
patients with ulcerative colitis.6’7,911,14’15
In 38 patients nutritional repletion was
accomplished in 34%. Temporary re
mission was obtained in only 33%.
It appears that total parenteral nutri
tion in patients with ulcerative colitis
is best used to prepare malnourished
patients for operation and to supply
postoperative nutritional support.
When total parenteral nutrition was
used in patients with Crohn’s disease
with fistulas (84 patients with 91 fi
stulas),5'6,9,1,'14'1<i’17 spontaneous, defini
tive closure of fistulas was rarely at
tained in hospital and long-term heal
ing without the use of corticosteroids
was achieved in only 20% of patients.
Nutritional repletion was accompli
shed in 17%. Total parenteral nutri
tion seems to provide temporary relief

of symptoms, decreases the discharge
from the fistula and improves the
nutritional status; the long-term bene
fits are unproven.
The prevalence of growth retarda
tion in children and adolescents with
inflammatory bowel disease is about
17%.18 In the 10 studies from which
this figure comes, growth retardation
was usually defined as height below
the third percentile. Children with
Crohn’s disease are more severely af
fected (up to 58%) than those with
ulcerative colitis (up to 22%). The
pre-eminent causative factor is caloric
insufficiency superimposed on pro
tein, vitamin and mineral deficiencies.
Nutritional therapy for growth retar
dation is usually successful when con
trol of the disease is effective. Hence,
in children who have been medically
or surgically treated and are asympto
matic, growth often accelerates. This
may be due to increased caloric intake
brought about by the sense of well
being.
When oral supplements cannot be
used for nutritional rehabilitation, to
tal parenteral nutrition can be tried.
In four recent studies notable weight
gain and linear growth were achieved
in all patients.13,18‘20 This growth re
sponse has been sustained up to 2
years after initial therapy. The dura
tion of total parenteral nutrition
ranged from 2 weeks to several con
secutive months. Patients in the study
of Strobel and associates13 have been
followed up for more than 2 years
and still continue to show a positive
growth response. These children were
receiving total parenteral nutrition at
home.
Total parenteral nutrition is not
without complications and is an ex
pensive form of treatment. Prepara
tion of solutions and patient monitor
ing can be time-consuming; quite a
few children are reluctant to submit
to repeated venipuncture. Recent
ly, continuous enteral alimentation
with an elemental diet has been shown
to induce clinical remission and to
achieve resumption of growth in chil
dren with Crohn’s disease.
Morin and associates21 submitted
four patients to continuous elemental
enteral nutrition for 6 weeks. All pa
tients achieved remission, their nutri
tional status improved and they gained
height and weight. One patient had
to be operated upon 2 months after
therapy. The other three had a flareup of their disease 4(4 months after
therapy and reverted to their abnor
mal growth pattern. It is possible that
repeated courses of enteral alimenta
tion may sustain longer remission or
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that nocturnal enteral alimentation,
or both, may also be beneficial in
these children when they are in re
mission at the end of the continuous
enteral alimentation period.
There are problems associated with
the use of elemental diets.22 Problems
secondary to diet composition include
gastric retention and distension, diar
rhea and fluid balance. Most of the
formulas are unpalatable necessitating
their long-term administration through
a nasogastric tube. Azotemia, hepatotoxicity, gastrointestinal bleeding and
skin rash have also been reported.
Most of the available studies on en
teral hyperalimentation in inflamma
tory bowel disease are uncontrolled;
furthermore, it has never been shown
that such elemental diets are more
beneficial to these patients than a
normal diet prepared in a blender and
fed by continuous gastric drip. There
is an urgent need for carefully de
signed and controlled studies to prove
the efficacy of this form of therapy.
Summary

It is now well established that nu
tritional therapy is of primary im
portance in treating inflammatory
bowel disease. The nutritional status
of children with Crohn’s disease or
ulcerative colitis should be investi
gated early so that nutrition rehabili
tation may be achieved before the
devastating effects of malnutrition in
crease the severity and the morbidity
of these diseases.
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3. Surgical Management of Ulcerative Colitis
A rnold G. Coran,

M o st patients with universal ulcerative
colitis ultimately require a colectomy
either to treat the inflammatory
process or to prevent the subsequent
development of a malignant tumour.
Since the introduction of total
proctocolectomy and ileostomy for
the definitive surgical management
of ulcerative colitis, this procedure
has become the standard operative
therapy for this disease. The
description of the eversion technique of
ileostomy in 1952 improved the
life-style of patients with an ileostomy
and made the total proctocolectomy
a more attractive procedure.
Nevertheless, many patients are
emotionally disturbed by having an
incontinent ileostomy and often
will delay their surgery because of the
associated psychologic trauma.
Because of this, the Kock pouch or
continent ileostomy has been
introduced and advocated during
the past decade. This procedure has
met with notable success but has
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found less application in the younger
patient. However, even the continent
ileostomy is associated with a certain
amount of psychologic trauma because
of the abdominal stoma. Therefore,
the endorectal pull-through has
recently been used for the management
of ulcerative colitis. First introduced
in 1948, this procedure allows total
removal of the diseased bowel,
maintains continence and eliminates
the need for an ileostomy. During
the last 3V2 years, the author has used
the endorectal pull-through to treat
24 patients with ulcerative colitis and
1 with familial polyposis. The results
are encouraging in that all patients
are continent and the average daily
stool frequency is 6 to 10. These
results and those of others support
the continued use of this new surgical
approach to the management of
ulcerative colitis.
La plupart des patients souffrant
de colite ulcereuse disseminee
necessitent eventuellement une
colectomie, soit pour traiter le
processus inflammatoire ou pour
prevenir le developpement subsequent
d'une tumeur maligne. Depuis
I’avenement de la procto-colectomie
totale et de I'ileostomie pour le
traitement chirurgical definitif de la
colite ulcereuse, cette intervention
est devenue I’operation standard de
cette maladie. La description en
1952 de la technique d'ileostomie par
eversion a amiSliore le style de vie
des patients porteurs d'une ileostomie
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et fait de la procto-colectomie totale,
une intervention plus attrayante.
Neanmoins, plusieurs patients
eprouvent des difficultes emotionnelles
a I'idee d'avoir une ileostomie
incontinente et souvent vont retarder
leur chirurgie a cause du traumatisme
psychologique qui y est relie. Ceci
a amene I’introduction, au cours
de la derniere decennie, de la poche
de Kock ou ileostomie continente;
cette solution a ete largement
preconisee. L'operation a eu un succes
remarquable mais elle a trouve
moins d'applications chez le sujet
jeune. Toutefois, meme I'ileostomie
continente cause un certain degre de
traumatisme psychologique a cause
du stoma abdominal. En consequence,
I'anastomose transanale a recemment
ete utilisee dans le traitement de
la colite ulcereuse. Apparue en 1948,
cette operation permet de resequer
completement la partie de I'intestin
malade, conserve la continence et
elimine la necessity d'une ileostomie.
Durant les derniers 31/2 ans, I'auteur
a utilise I’anastomose transanale
chez 24 patients souffrant de colite
ulcereuse et chez 1 porteur d’une
polypose familiale. Les resultats sont
encourageants puisque tous les
patients sont continents avec une
frequence quotidienne moyenne
de I'evacuation des selles de 6 a 10.
Ces resultats et ceux d'autres
auteurs militent en faveur de
('utilisation de cette nouvelle approche
chirurgicale dans le traitement de
la colite ulcereuse.
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Ulcerative colitis was first described
in 1859 by Sir Samuel Wilks, a path
ologist and physician at Guy’s Hos
pital in London. However, no attempt
to treat the disease, in either its acute
or chronic phases, was made until
1902, when Weir performed a tube
appendicostomy at Roosevelt Hospital
in New York.1 In 1913 the first ileos
tomy for ulcerative colitis was per
formed in the United States.2 It be
came the procedure of choice until
1948 when Cattell3 recommended a
three-stage operation consisting of an
initial ileostomy, followed by a sub
total colectomy with exteriorization of
the sigmoid mucous fistula and a sub
sequent abdominoperineal resection
of the rectum. Shortly thereafter, the
procedure was modified to two stages
in which an initial ileostomy and sub
total colectomy were followed by an
abdominoperineal proctocolectomy. In
1952, Goligher4 introduced a onestage operation consisting of an endileostomy and a proctocolectomy. The
eversion technique of ileostomy con
struction by Brooke5 in 1952 notably
improved ileostomy management and
made the procedure of total procto
colectomy and permanent ileostomy
attractive to patients with ulcerative
colitis.
Sphincter-saving operations in the
definitive management of ulcerative
colitis have been sought extensively
during the past 25 years. In 1948,
Ravitch6 proposed a technique in
which the colon was resected, the
rectal mucosa removed and an
ileoanal anastomosis created. In 1966,
Aylett7 reviewed his experience with
300 patients who had undergone
a subtotal colectomy and an ileoproctostomy for ulcerative colitis. Only
5% of these patients subsequently re
quired conversion to a permanent ileo
stomy.
Indications for Operation
Americans who have inflammatory
bowel disease number between 200COO and 400 000. Fifteen thousand to
30 000 new cases are diagnosed each
year and 20% of the patients are
less than 20 years old. Although a
substantial number of patients with
ulcerative colitis never require opera
tion for their disease, many ultimately
require a definitive operative proce
dure. The medical management of ul
cerative colitis is aimed at relieving
symptoms. Although corticosteroids
and sulfasalazine sometimes induce
complete remission and even cure of
ulcerative colitis, this happens relative
ly infrequently.

Our indications for operation are:
(a) persistent signs of disease after 2
years of adequate medical therapy,
including sulfasalazine and cortico
steroids; (b) inability to wean the pa
tient from high-dose corticosteroid
therapy; (c) growth retardation or
delay in the development of sec
ondary sex characteristics, secondary
either to the disease itself or to the
corticosteroid therapy and (d) the risk
of carcinoma of the colon in patients
with long-standing ulcerative colitis.
The incidence of carcinoma of the
colon is about 3% during the first
decade of the disease and, thereafter,
increases at the rate of 20% per de
cade.8,9 The carcinomas arising in ul
cerative colitis tend to be multiple
and much flatter than those of classic
carcinoma of the colon, making their
radiologic detection more difficult.
Moreover, they tend to be mucinsecreting and anaplastic, carrying a
much poorer prognosis than in classic
carcinoma of the colon. For these
reasons we recommend a total colec
tomy for anybody who has had uni
versal ulcerative colitis longer than
10 years. Less common indications
for surgery are unremitting hemor
rhage and free perforation of the
colon.
Types of Operation
Three operations are available for
the definitive management of ulcera
tive colitis in which the entire dis
eased colon and rectum are removed.
Lesser operations consisting of sub
total colectomy and ileoproctostomy
have been advocated for years and
have been quite successful in the man
agement of the basic disease process;
however, they all leave diseased rec
tum behind.7,10 The three definitive
operations are total proctocolectomy
with permanent end-ileostomy, total
proctocolectomy with permanent endileostomy and a continent ileal re
servoir (Kock pouch), and total colec
tomy and endorectal removal of the
rectal mucosa together with an ileoanostomy. Total proctocolectomy with
ileostomy is the commonest operation
and has an excellent record of suc
cess over the past 25 years. The con
tinent ileostomy, initially described by
Nils Kock, is an important contribu
tion to the surgical treatment of ul
cerative colitis and circumvents some
of the psychosexual problems associ
ated with conventional ileostomies.11,12
The Kock pouch is less applicable to
the child and young teenager and is
more commonly used in adults. We
have not used the Kock pouch.

Ileoanostomy following colectomy
and excision of rectal mucosa, as orig
inally described by Ravitch,6 has been
used infrequently in ulcerative colitis,
although this sphincter-saving opera
tion has been used notably more often
during the past 3 years. The endo
rectal pull-through procedure for the
treatment of Hirschsprung’s disease
was initially popularized in 1964 by
Soave13 and in 1968 by Boley and
colleagues.14,15 In 1976, we16 described
a modification of the endorectal pullthrough for Hirschsprung’s disease
that we have used successfully in
over 60 infants and children. In 1969,
Glotzer and PihF7 used this technique
in two adults with ulcerative colitis;
one subsequently required conversion
to a permanent ileostomy, but the
other had a good result. Because of
our success with the modified endo
rectal pull-through in the treatment of
classic Hirschsprung’s disease, in 1974
we began to use the same operative
approach for the management of
children with total colonic Hirsch
sprung’s disease. Our experience with
six children with total colonic and
partial small intestinal aganglionosis
who had undergone an endorectal
pull-through procedure following a
total colectomy has been excellent. All
patients are totally continent and are
having two or three formed bowel
movements daily.18 One girl with
aganglionosis extending to the distal
jejunum, who underwent a total colec
tomy and ileectomy followed by an
endorectal pull-through and a jejunoanostomy, is totally continent and has
four to six soft stools daily, 7 years
following operation. The encouraging
results in this small group of children
prompted us to consider this operative
approach in 1977 for children and
adults with ulcerative colitis. At that
time, Martin and associates19 pub
lished their experience with 17 pa
tients who had chronic ulcerative col
itis; 15 had satisfactory results. This
important paper prompted several
other surgeons to try this operation
in both children and adults. In 1978,
Parks and Nicholls20 described a mod
ification of the endorectal pullthrough. They added a reservoir to
the procedure in order to decrease
the stool frequency; however, a num
ber of their patients were unable to
defecate spontaneously and required
a rectal tube for stool evacuation.
Their more recent experience in a
larger group of 35 patients has been
better. The reservoir is still part of
their operative approach, but the
pouch is placed deeper in the rectal
cuff than previously and this appears
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to have decreased the incidence of
incomplete stool evacuation. In 1980,
Fonkalsrud21 performed the operation
initially described by Parks and
Nicholls on five patients with ulcera
tive colitis. Only one of these patients
has had intestinal continuity restored;
he has 4 to 12 stools daily and is
totally continent. Peck22 described 29
patients who underwent a rectal mu
cosal replacement operation which in
volved insertion of an ileal graft. This
was done on 12 patients for familial
polyposis and on 17 for ulcerative
colitis. The operation is far more com
plicated than the standard endorectal
pull-through; however, in 25 patients
who have had intestinal continuity re
stored, the results have been quite
satisfactory with complete fecal con
tinence and an average stool fre
quency of six per day.22 Telander and
Perrault23 reported on 12 children and
young adults with chronic ulcerative
colitis who underwent a standard sub
total colectomy with rectal mucosec
tomy and ileoanal anastomosis. Fol
low-up ranged from 7 to 27 months.
All patients have rectal c.ontinence
and satisfactory stool frequency.
In 1977, we began to use the en
dorectal pull-through as the preferred
operation for the definitive manage
ment of ulcerative colitis in children
and adults. The procedure has been
used on 25 patients, 23 of whom have
had their temporary ileostomy closed.
The last two patients are awaiting
closure of their ileostomy. The opera
tion is performed either as a one-stage
total colectomy, rectal mucosectomy
and ileoanal anastomosis together with
a loop ileostomy or as a two-stage
procedure in which initially a sub
total colectomy and ileostomy are per
formed and a sigmoid to colon mu
cous fistula is established, followed
several months later by a rectal mu
cosectomy and an ileoanal anasto
mosis together with a temporary loop
ileostomy. The two-stage procedure
is usually carried out in the sicker
patients receiving high-dose cortico
steroids, in whom the risk of a colec
tomy and an endorectal pull-through
at one operation is too high. The
temporary loop ileostomy is closed
about 2 months after the pull-through
procedure. Twenty-four of the 25 pa
tients have ulcerative colitis and one
adult has familial polyposis. The tech
nical details of our operation18 are de
scribed in a movie in the library of
the American College of Surgeons.
There have been no deaths from the
operation and the complication rate
has been quite low. The first patient
to undergo this procedure had a small
500

cuff abscess that required drainage in
the early postoperative period. Two
other patients had intestinal obstruc
tion due to adhesions following clo
sure of the ileostomy. They were
successfully treated with an enterolvsis. All patients have excellent rectal
continence and have an average of 6
to 10 bowel movements of semiformed stool daily. In some, the daily
stool frequency is as low as 3 to 4,
and in others it reaches 20. Most im
portant. however, is that stool fre
quency improves appreciably during
the first postoperative year. The first
patient in this series underwent an
ileostomy at the time of drainage of
her cuff abscess and has not asked to
have the ileostomv closed although on
physical examination her pull-through
seems excellent. Recently a 16-yearold boy requested conversion to an
end-ileostomy 18 months after his
pull-through procedure because of
stool frequency as high as 18 per day.
He had never been incontinent and
requested the conversion because of
marked interference with his life
style. The only other conversion to
an ileostomy has been in a 27-year-old
man who did well for 18 months
after his pull-through procedure, with
stool frequencies in the range of six
to eight per dav. He then experienced
increasing stool frequency associated
with abdominal cramps that were not
relieved by various medications. He
found that these markedly interfered
with his work and family life, so he
requested an end-ileostomy, which
was recently carried out.
Our results with this series of pa
tients have encouraged us to continue
to recommend this aproach to chil
dren and adults with ulcerative col
itis. If the patient or referring physi
cian is not anxious to have the pullthrough procedure done at the time
of colectomy, we strongly recommend
that a subtotal colectomy be per
formed and a mucous fistula of the
sigmoid colon be established, together
with an end-ileostomy so that the
pull-through procedure can be done
at a later date if the patient desires.
Obviously, if the entire rectum is re
moved at the time of colectomy, a
sphincter-saving operation cannot be
performed later.
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4. Evolution of the Kock Continent
Reservoir Ileostomy
Z ane Cohen ,

A continent reservoir ileostomy was
constructed in 85 patients, 9 of whom
were adolescents. Indications for
the procedure included organic problems
related to the ileostomy as well as
psychologic and sexual difficulties
related to an external appliance.
Fifty-eight patients had conversion
from a conventional ileostomy.
Twenty-five patients underwent total
proctocolectomy and Kock ileostomy.
An intussuscepted “nipple valve”
was used in all cases.
Follow-up ranged from 4 to 10 months.
There were no operative deaths.
Eighty-two patients are completely
continent with regard to both flatus
and stool. Only two patients w ear an
external appliance. No one has
requested a return to a conventional
ileostomy. No reservoirs have been
removed. Ten of the initial 17 patients
(59% ) required at least one additional
surgical procedure for early or late
complications, the most frequent of
which were intestinal obstruction,
sliding or prolapse of the nipple valve
and fistula. Technical modifications
have reduced this morbidity; they
included using SGIA staples across
the nipple valve and a fascial
sling around the outlet. These modifica
tions have been used in 28 additional
patients and in 5 from the original
series. Ten of these 33 patients
(30%) have required intra-abdominal
operation for revision, 5 because of
sliding of the nipple valve. Further
modifications using a Marlex mesh
sling have been made in 40 additional
patients and in 7 patients from
the original series. Six of these 47
patients (11% ) have undergone or
will undergo intra-abdominal operation
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for revision. Only one case of
nipple valve sliding has occurred
in this group. Marlex mesh has
now been replaced by Prolene mesh.
The benefits of the continent
ileostomy are substantial. The author's
results have continued to improve
with experience and with the technical
modifications outlined.
Quatre-vingt-cinq patients, dont
9 adolescents, ont regu une ileostomie
continente a reservoir. Les
indications operatoires incluent des
problemes organiques relatifs a
I'ileostomie ainsi que des difficultes
psychologiques et sexuelles reliees a
un appareil externe.
La conversion d'une ileostomie
conventionnelle a ete pratiquee
chez 58 patients. Vingt-cinq
patients ont subi une
procto-colectomie totale et une
ileostomie de Kock. Une “valve
a ecrou'' invaginee fut utilisee
dans tous les cas.
La surveillance postoperatoire va
de 4 a 10 mois. II n'y a eu aucun
deces peroperatoire. Ouatre-vinqt-deux
patients ont une continence complete
pour les gaz et pour les feces.
Seulement deux patients portent
un appareil externe. Aucun n'a
demande le retour a une
ileostomie conventionnelle. Aucun
reservoir n'a ete enleve. Dix des 17
(59% ) premiers patients ont
necessite au moins une intervention
chirurgicale additionnelle pour
des complications precoces
ou tardives, les plus frequentes
etant (’obstruction intestinale,
le glissement et le prolapsus de la
valve a ecrou, ou une fistule.
Des modifications techniques
ont reduit cette morbidite;
ceci comprend I'emploi d'aqrafes
SGIA en travers de la valve
a ecrou et d'une bandelette
aponevrotique autour de I'orifice.
Ces modifications ont ete appliquees
a 28 patients additionnels et a 5
de la premiere serie. Dix de ces 33
patients (30% ) ont necessite
une operation intra-abdominale
de revision dont 5 a cause du
glissement de la valve. D’autres
modifications faisant appel a une
bandelette de tissu a mailles Marlex
ont ete utilisees chez 40 patients

additionnels et chez 7 de la
premiere serie. Six de ces 47
patients (11 % ) ont subi ou vont
subir une operation de revision.
Un seul cas de glissement de la valve
a ecrou est survenu dans ce groupe.
Le tissu a mailles Marlex a
maintenant ete remplace par
du tissu Prolene.
Les avantages de I’ileostomie
continente a reservoir sont
considerables. Les resultats
continuent d'ameliorer avec
('experience e t les modifications
decrites.

Children with ulcerative colitis still
suffer from long-standing disability,
severe growth retardation, delayed
development of secondary sex char
acteristics, interference with emotional
maturation and occasionally malignant
tumours of the colon.1 The reluctance
of the physician, the patient and the
patient’s family to accept the need for
a permanent, continuously worn ap
pliance, despite the very tolerable life
it permits, is well known to all. In
troduction of the continent reservoir
by Nils Kock has helped to overcome
much of the reluctance to elect opera
tion. Moreover, the psychologic and
sexual barriers associated with the
conventional ileostomy have been
mostly removed by the continent ileo
stomy, which obviates the need for an
external appliance. In this paper I dis
cuss the indications and contraindica
tions for the continent reservoir ileo
stomy, its evolution, the results that
can be achieved and the long-term
biologic effects.
Indications and Contraindications
Indications for the continent ileo
stomy include ulcerative colitis proven
by tissue examination, ileostomy dys
function and peristomal skin irritation
and ulceration. In our series of pa
tients, most of the conversions to a
continent reservoir ileostomy were be
cause of psychologic and sexual dif
ficulties related to an external ap
pliance. This is a valid indication for
the procedure.
There are definite contraindications
to the procedure. At the moment, we
do not offer it to patients with Crohn’s
disease or to those who are severely
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debilitated. Local or systemic sepsis
and emergency surgery are also con
traindications. Previous resection of a
large segment of small bowel pre
cludes using an additional 45 to 50
cm of small bowel for construction
of the reservoir ileostomy. We would
not perform this procedure in children
less than 12 years of age.
Preparation of the patient and the
family is most important. In all
cases, the nature of the disease is
documented from previous medical
records as well as from original mi-

croscopic sections, if available. Ro
entgenograms after a small bowel
enema are made to rule out occult
small bowel disease. A thorough ex
planation of the benefits and possible
complications of the procedure are
outlined to both the patient and family.
Literature is given to the patient and
a movie is shown on the subject, if
the patient wishes. Most importantly,
however, each candidate is put in
touch with patients who have already
undergone the procedure so that per
sonal contact can be made with
further dissemination of information.
Evolution of the Procedure
The Kock ileostomy was first used
in 19692 (Fig. 1). At that time an
antiperistaltic outlet was used. This
was changed to an isoperistaltic outlet
in 1971 (Fig. 1). With both types of
outlet incontinence developed in a
high proportion of cases.3 So in 1973,
Professor Kock developed the “nipple
valve” which is an intussuscepted
segment of distal ileum.4 With this
modification the continence of the
reservoir improved. However, be
cause of “dessusception” of the nipple
valve, many patients experienced dif
ficulty in intubating the reservoir, and
incontinence was still a problem. Pro
fessor Kock further modified the pro
cedure to reduce the complication of
nipple valve sliding.4 This included
separating the mesenteric masses, us
ing a rotational suture, cauterizing the
serosa of the nipple valve segment and
stripping the peritoneum and fat on
the mesentery to decrease the bulk of
mesentery being intussuscepted.

Because of reported improved re
sults with these modifications,4 we be
came interested in the procedure and
the following account is of our total
experience during the past 4 years
using various modifications of the
technique.
Patients
A continent reservoir ileostomy has
been constructed in 96 patients and I
shall report the results in 85 patients
who have been followed up for longer
than 4 months. Nine of the 85 were
adolescents between the ages of 15
and 20 years whose standard ileostomy
has been converted to a Kock ileo
stomy. Few publications have outlined
the results of the continent ileostomy
in pediatric patients. Therefore, the
following account will illustrate the
overall results that can be achieved
regardless of age.
Initial Technique
Between August 1977 and Novem
ber 1978, using Kock’s technique4 and
that described in our original publica
tion,5 17 patients had a continent ileo
stomy constructed. Eleven patients
had conversion from a conventional
ileostomy, 4 had a continent reservoir
ileostomy constructed in association
with a proctocolectomy, 1 had con
version from a right colostomy and in
1 a reservoir ileostomy, previously
revised at another centre, was recon
structed.
There were no deaths in this group.
There were four cases (23%) of in
testinal obstruction and two entero-

1973

FIG. 1—Kock ileostomy: 1969 with
antiperistaltic outlet, 1971 with isoperi
staltic outlet and 1973 with intussuscepted segment of ileum forming “nipple
valve”.
510

FIG. 2—Creation of 4- to 5-cm nipple valve by intussuscepting terminal ileal
segment.
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cutaneous fistulas (12%) that required
surgical intervention in the early post
operative period. Also, there were
late complications that required opera
tion, including sliding of the nipple
valve in three patients (18%) and com
plete prolapse or eversion of the valve
in one (6%). The revision rate for
these initial 17 patients was 59%.
More critical evaluation of the com
plications shows that 4 of these 10
patients required two additional opera
tions and 2 of the 4 required four
additional operations to correct the
complications.
Despite the high operative revision
rate, none of the patients requested
a return to a conventional ileostomy

and all were extremely satisfied with
the eventual result. Sixteen of these
17 patients never wore an ileostomy
appliance and 1 wore an external ap
pliance only occasionally. (The prob
lem that led the last patient to wear
an appliance later resolved sponta
neously and she ceased to wear the
appliance.)
Modification of the Initial Technique

Because the functional results were
excellent we continued to offer the con
tinent ileostomy to selected patients
and turned our attention to modifying
the procedure to correct the problems
of intestinal obstruction, fistula for
mation, sliding of the nipple valve and

/

FIG. 3—Nipple valve is secured in position with three to four rows of staples
using Auto Suture GIA stapler.

prolapse that had plagued us earlier.
To correct these problems the reser
voir was repositioned to prevent af
ferent limb obstruction,5 SGIA staples
(Auto Suture Company, Division of
United States Surgical Corp., Nor
walk, Conn.) were used across the
valve to secure it in position and a
strip of fascia taken from the anterior
abdominal wall was sewn in place
around the base of the outlet to pre
vent prolapse.6
These modifications were used in
28 additional patients and in 5 of the
17 patients from the original series,
between November 1978 and May
1980. Eighteen of the 28 patients had
a conventional ileostomy converted
and 10 reservoir ileostomies were
created in association with proctoco
lectomy.
There were no deaths in this group.
Major early complications requiring
surgical intervention were perforation
of the reservoir in one patient and
pelvic abscess in another. Other early
complications that occurred but for
which surgery was not necessary were
wound infection in two patients, ab
scess and external fistula in one, fluid
and electrolyte disturbances in two
and inflammatory changes within the
reservoir in two patients. Late com
plications requiring further abdominal
surgery continued to be appreciable.
Sliding of the nipple valve occurred in
five patients, fistulas formed in two
and there was intestinal obstruction
in one. The operative revision rate in
this group of patients was 10 of 33
(30%).
Although the rate had decreased
from 59% to 30%, sliding of the
nipple valve continued to be a major
problem and led to further modifica
tions in the surgical technique.
Further M odifications

Karen
Youmj

FIG. 4— Strip of Marlex mesh is used as sling around base of outlet to secure
nipple valve.
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The surgical technique used to June
1981 is as follows. The construction
of the reservoir itself is unaltered. Ap
proximately 45 cm of distal ileum is
used.6 Initially, the most distal 15 cm
limbs are sutured together on their
posterior aspect using absorbable su
ture material. The limbs of the “U ”
are then opened along the antimesenteric border and the incision is
carried 2 to 3 cm further on the
afferent limb. The distal ileum is then
intussuscepted over a 4- to 5-cm seg
ment to create the nipple valve (Fig.
2). The nipple valve is secured in
position with three to four rows of
staples using the SGIA stapler with
out the blade (Fig. 3). The intestinal
plate is folded over on itself to create
the reservoir and the sides are com-
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plcted using two layers of absorbable
suture material. Each corner of the
reservoir is passed alongside the me
sentery so that the reservoir will be
positioned within the pelvis and the
afferent limb will enter from the medial
aspect. A strip of Marlex mesh is then
passed through a previously created
window in the mesentery at a posi
tion approximating the base of the
outlet (Fig. 4). The reservoir is
sutured to the lower edge of the
Marlex using absorbable suture and
the corners of the Marlex are secured
to the anterior rectus sheath using
2-0 Prolene (Fig. 5). The medial aspect
of the reservoir is then anchored to
the medial aspect of the undersurface
of the ileostomy opening. The excess
outlet is trimmed away and the stoma
is made flush with the skin (Fig. 6). A
no. 30 French ileostomy catheter (A.B.
Medena, Kungsbacka, Sweden) is
placed within the reservoir and at
tached to a straight drainage system.
This technique was used in 40 pa
tients and in 7 of the 17 patients from
the original series who required re
operation. Of the 40 patients, 29 had
conventional ileostomies converted to
the continent reservoir type and 11
procedures were done in association
with proctocolectomy.
There were no deaths. Using these
most recent modifications we had
only one patient with sliding of the
nipple valve. However, there were
three with fistula that required further
operation and one other with a fistula
who is awaiting surgical inter
vention. One patient with intestinal
obstruction due to adhesions re
quired two further operations. There
were three peristomal infections, which
healed spontaneously. Partial prolapse
of the nipple valve occurred in four
patients and required manual reduc
tion and local peristomal revision to
correct the problem. In this latest
series, 6 of the 47 patients required
abdominal revision operations. The
reoperation rate has therefore been
reduced to approximately 13%.

ber of peristomal infections and enterocutaneous fistulas has increased. This
is most likely due to the introduction
of Marlex mesh into the surgical tech
nique. The other common complica
tion in the latest series was partial
prolapse of the nipple valve; this re
quired local surgical revision. In an
effort to reduce these complications,
Prolene mesh has been substituted for
the Marlex mesh. The Prolene mesh
is more inert, more flexible and less
likely to cause erosion and subse

quent fistula. To reduce the incidence
of nipple valve prolapse, the ileostomy
opening is made considerably smaller.
With these small modifications in 11
additional patients operated on since
lune 1981. no further cases of peri
stomal infection, fistula or prolapse
have been seen.
L o n g -T erm E ffects

Bacteriology

Construction of a continent ileos-

FIG . 5— Corners of Marlex mesh are sutured to anterior rectus sheath to secure
mesenteric side of outlet and valve.

O v erall F u n c tio n a l R esults

Of 85 patients, 1 committed suicide
6 months after operation, so 84 pa
tients were available for follow-up.
Of these, 82 (97.5%) never wear an
ileostomy appliance and 2 (2.5%) al
ways wear an ileostomy appliance.
Of these two, one is awaiting further
surgical revision because of the de
velopment of a fistula.
F u r t h e r Im p ro v em e n ts

Although sliding of the nipple valve
has almost been eliminated, the num
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F IG . 6— Reservoir is anchored to abdom inal wall and stoma is made flush with
skin.
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5. Surgical Treatment of Crohn’s Disease
A .L . B ensoussan ,

m d ,*

J.N. L e to u r n e au ,

Of 93 children with Crohn's disease
treated at the Hdpital Sainte-Justine
between 1967 and 1979, 39 were
operated on. Ten had abscesses
and anal fistulas drained and in 29
the bowel was resected. The mean
age of the children was 13 years. The
average time between onset and
diagnosis for both the medical and
surgical groups was 13 months.
Medical treatment failed in 25 patients
after an average time of 22 ± 17
months. Fourteen patients had an
initial laparotomy, with a false
diagnosis of appendicitis in 8,
abdominal tumour in 2 and Meckel's
diverticulum in 1. Indications for
operation were: intestinal obstruction,
bowel fistula, intra-abdominal abscess,
gastrointestinal hemorrhage, growth
failure and toxic megacolon.
There were no deaths and only
two postoperative infections. Crohn's
disease seems to be becoming more
frequent, more severe and starting
earlier in life. Three to 6 weeks
of preoperative preparation with
enteral and parenteral nutrition allows
operation to be performed under
safer conditions. Although the
recurrence rate after operation
is still high, there is no doubt that
the children enjoy a better quality
of life, growth and a 50% chance
of being disease-free 10 years later.
Ouatre-vingt treize enfants atteints de
maladie de Crohn ont ete traites a
I'Hopital Sainte-Justine entre 1967 et
1979; 39 ont ete operes. Dix ont eu de
multiples drainages d’abces et fistules
anales et 29 ont eu une resection
intestinale a un age moyen de 13 ans.
Le temps moyen entre le debut
des symptomes et le diagnostic a ete

m d ,*

C.C. M orin , MDf

le meme chez les malades traites
medicalement ou chirurgicalement
(13 mois). Le traitement medical a ete
essaye chez tous les patients mais
chez 25 patients il a ete inefficace
au bout d'un delai moyen de
22 mois ± 1 7 . Quatorze patients
ont eu une laparotomie d'emblee
avec un faux diagnostic d ’appendicite
chez 8, de tumeur chez 2 et de
diverticule de Meckel chez 1.
Les indications operatoires ont ete:
obstructions intestinales, fistules
digestives, abces intra-abdominaux,
hemorragies digestives, nanisme
et megacolon toxique.
Aucune mortality n’est a deplorer.
Les complications infectieuses
postoperatoires sont au nombre de
deux seulement. La maladie de Crohn
semble plus frequente, plus severe
et commence a un age plus jeune.
Une bonne preparation de 3 a 6
semaines avec une nutrition enterale et
parenterale permet une chirurgie
dans d'excellentes conditions. Bien
que la recidive soit frequente, il n’y a
pas de doute que les enfants operes
jouissent d’une meilleure qualite
de vie, d’une acceleration de la
croissance et peuvent esperer ne pas
avoir de recidive dans 5 0 % des cas
sur une periode de 10 ans.

The treatment o f inflammatory bowel
diseases still represents a major chal
lenge. In recent years many meetings
have been devoted to the subject and
many large series have been reported
in Canada and the United States.
Patients and Treatm ent

Reprint requests to: D r. A .L . Bensoussan,
Hdpital Sainte-Justine, 3175 Cote
Ste-Catherine, M ontreal, PQ
H 3 T 1C5

Between 1967 and 1979. 147 chil
dren with inflammatory bowel disease
were seen at Hopital Sainte-Justine in
Montreal; 93 (52 boys, 41 girls) were
treated for Crohn’s disease. The age
at diagnosis ranged from 7 to 19 years
(mean 13.4 years). A family history
of the disease was found in 12.9%.
The average time from onset of symp
toms to diagnosis was 13 months.
This time was the same for those
treated medically and surgically but
differed according to the site o f the
disease: 9 months for the 24 children
with ileal disease and 13 months for
the 57 with ileocolic and the 3 with
colonic involvement; it was longer, 31
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months, for the 9 with diffuse dis
ease.
Thirty-nine patients were operated
on: 10 for perineal abscess and anal
fistula; 29 (14 girls and 15 boys) un
derwent bowel resection. The mean
time from diagnosis to operation was
22 ±
17 months. In 14 patients
operation was performed early (Table
I) and the diagnosis was incorrect in
12. Definitive operation was carried
out in three. In four patients no addi
tional procedure was performed when
Crohn’s disease was found.
Among the 24 patients with ileal
disease only 4 underwent ileal or ileo
cecal resection (at a mean age o f 15.5
years) because o f skin fistula after
initial laparotomy, severe enteropathy,
bowel obstruction and growth failure.
Among the 57 children with ileo
colic involvement, 19 had a right
ileocolectomy, at a mean age o f 14
years. The reasons for operation were
intestinal obstruction (eight children),
skin fistula (three), growth failure
(three), gastrointestinal hemorrhage
(two) and right psoas abscess, pre
vious bypass procedure and perfor
ation o f toxic megacolon (one each).
Six additional procedures were done:
drainage o f abdominal abscess in five
and partial sigmoid resection in one.
Total ileocolectomy was done in
six patients, at a mean age o f 15
years. Five children had colic resec
tion for intestinal obstruction or in
tractable disease after failure o f med
ical treatment, and one had an emer
gency operation for toxic megacolon.
Ileorecta! anastomosis was done once,
but generally a temporary ileostomy
and closure o f the rectal stump (Hart
mann procedure) were performed.

Table I-Diagnosis before Initial
Operation in 14 Children
Diagnosis

No. of
children

Acute appendicitis
Lymphoma
Ovarian cyst
Recurrent anal fistula
Meckel's diverticulum
Right psoas abcess
Instestinal obstruction

8*
1
1
1

It
It
It

"Appendectomy was carried out in 5.
tDefinitive procedure done.
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Results

Among the 14 patients who had an
early laparotomy, 4 had no additional
procedure; 1 had no complications
and is receiving medical treatment
and the others had postoperative com
plications (cutaneous fistula in 2,
intra-abdominal abscess in 1) that
were initially treated medically, with
parenteral nutrition, but finally by
definitive operation. Seven appendec
tomies were done, five before referral
to our hospital and two at our institu
tion. None of these patients had a
cutaneous fistula in the postoperative
course even when the cecum was in
volved. Four out of these seven pa
tients underwent bowel resection 3 to
6 years after failure of medical treat
ment, one is under medical treatment
and two are free of symptoms.
All four children who underwent
ileal or ileocecal resection had a
smooth postoperative course. One pa
tient is free of disease after 9 years,
two are asymptomatic without treat
ment hut with radiologic changes
that were noted 4 and 5 years re
spectively after operation, and one
had a true recurrence 6 months after
the operation and is receiving med
ical treatment.
No postoperative complications oc
curred in 16 of the 19 children who
had a right ileocolectomy. Three had
to be reoperated on for intestinal
adhesions (30 days postoperatively),
bladder fistula (surgical closure 8 days
postoperatively) and a postoperative
flare-up with multiple perforations of
the ileum. For the last child a prox
imal ileostomy was created, which
was closed 8 months later. This boy
is now free of disease, 3 Vi years after
closure of the proximal ileostomy.
Four children were lost to follow-up.
Twelve are free of disease at follow-up
ranging from 6 months to 4 years.
Three had a recurrence within 2 years
and are being treated medically. None
have been reoperated on. The mean
weight gain of these children was 13
kg, and the mean height gain was
9 cm.
The postoperative course was
smooth in four of six children who
had a total colectomy. Aggressive an
tibiotic treatment cured a supposed
subphrenic abscess in one of them.
The patient with toxic megacolon ex
perienced a stenosis of the ileostomy
and a wound abscess; 3 months later
a new ileostomy was constructed and
finally the rectum was removed 8
months later by a perineal approach.
The rectal disease did not improve
in three patients and a secondary
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proctectomy was done 6 to 21 months
later. Two patients were free of dis
ease for 3 and 4 years respectively
and one has had occasional discharge
from his perineal wound in the 3
years since operation but no recur
rence of the Crohn’s disease. Ueorectal anastomosis was done in three
children, in one during the early lapa
rotomy and in two after 1 year. Two
of them had a recurrence of the rectal
disease while under medical treatment,
and one was operated on only 3
months ago. However, these patients
achieved a good increase in weight
and height.
The cumulative recurrence rate in
the medical group was 15% during
the first year, 42% during the second,
62% during the third and 92% at 6
years. In the surgical group the cumu
lative recurrence rate was 11% dur
ing the first year, 26%, 41% and
55% during the second, third and
fourth years respectively.
Discussion

It is our impression that the fre
quency of Crohn’s disease in children
is increasing; for the last 2 years a
new patient has been seen at our
institution every 3 weeks.
Operation in Crohn’s disease is re
served for the management of com
plications; 70% to 90% of patients
undergo operation during their life
time and 30% to 60% will be oper
ated on during childhood.
Three categories of patients are
operated upon: those with chronic
complications, those with acute com
plications and those with a surgical
abdominal emergency at the onset of
the disease. The definition of intract
ability varies, but we believe the dis
ease is intractable once it interferes
with the patient's life-style because of
recurrent obstruction, pain, bleeding,
draining fistula or inflammatory mass
or when steroids are given, causing
severe side-effects.
Careful preoperative care helps in
preventing death and reducing mor
bidity. Total parenteral nutrition fol
lowed by continuous elemental en
teral diet achieves complete bowel
rest, treats malnutrition, brings elec
trolytes into balance and provides
perfect bowel cleansing. This routine
preparation over a 3-week period was
carried out in our institution for every
elective operation. Plasma and blood
were given when needed and steroids
were started intravenously the day
before operation. Antibiotics were
given before and during the proce
dure.
A midline abdominal incision pro
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vides the best exposure for explora
tion and resection and greater free
dom in choosing stoma sites. Resec
tions must be limited to gross lesions
and demarcation can be made by
noting the creeping mesenteric fat and
induration of the bowel wall. For this
purpose frozen sections are helpful.
End-to-end anastomosis is always the
first choice. When internal fistula is
found, only partial resection of the
normal bowel is required. All ab
scesses must be evacuated and cavities
drained with a sump catheter.
The usual postoperative care is
given. Steroids are administered intra
venously for 4 days, then by mouth
in decreasing doses to zero.
Acute complications such as pro
fuse hemorrhage, toxic megacolon and
perforation are clear indications for
operation. Toxic megacolon can be
associated with bleeding, perforation
and septicemia. Physical examination
is less reliable because of the effects
of massive steroid therapy. Resuscita
tion must be aggressive and include
gastric aspiration, blood and plasma
replacement and administration of an
tibiotics. Frequent physical examina
tions and repeated plain roentgeno
grams will help to assess colonic dila
tation. Timing of operation is based
on the evolution of the disease. Oper
ation is mandatory if there is no im
provement after 1 or 2 days of in
tensive therapy, if there is any dete
rioration and if the diameter of the
transverse colon reaches 7 to 10 cm
on the plain roentgenogram.
Operation must be carefully done in
order to avoid iatrogenic perforation.
Peritoneal fluid samples are taken for
culture. Generally, it is safer to per
form a terminal ileostomy with clo
sure of the rectal stump after remov
ing the colon. Generous lavage helps
to clean the abdominal cavity and
frequently abdominal drainage is nec
essary. In the case of profuse and
persistent bleeding, one must make
sure that it is not of rectal origin and
then proceed with operation after re
suscitation.
Perforation is uncommon in Crohn’s
disease and is an indication for imme
diate operation.
Patients with acute complications
must be treated vigorously in the post
operative period. They must be sup
plied with parenteral followed by con
tinuous enteral nutrition.
Some children present with an
acute abdominal condition as the first
manifestation of the disease. In these
children a good history and a care
ful physical examination do not al
ways avoid a false diagnosis. Unnec-

THE CANADIAN JOURNAL OF SURGERY

T

8

essary operation is performed most
frequently when an incorrect diagnosis
of acute appendicitis is made.
Three aspects of this disease are
still subjects for debate: the recur
rence rate, the rectal involvement and
the growth failure.
According to the literature, the re
currence rate seems to increase with
the length of follow-up: 10% after
1 year, 40% after 5 years, 50%
after 10 years. The recurrence rate
is not related to the age of the child
at the first operation. However, the
location and extent of the disease at
the initial operation are of prognostic
importance. Ileocolic involvement is
associated with a greater rate of re
currence requiring reoperation.
In our series no proctocolectomies
were done at the first operation, but
in four of six patients the ileostomy
became permanent and the rectal
pouch had to be removed. In the
adolescent, preservation of the rec
tum and the hope for a reanastomosis
is an important psychological support.
If resection of the rectal pouch
becomes necessary later, it is more
easily accepted. So, at the pri
mary operation the level of rectal sec
tion should be low enough to leave
the rectum below the peritoneal re

flection. It can be removed later, if
needed, by a perineal aproach.
The growth failure is the result of
limitation of food intake, malabsorp
tion, protein loss and hypermetabol
ism. Wesson and Shandling1 have
shown that the growth response to
operation varies with the age and the
stage of puberty. In fact, growth fail
ure is rarely the sole indication for
operation, as pointed out by Guttman.2 According to Castile and asso
ciates,3 patients requiring operation are
shorter than those treated medically.
Important increase in growth was
noted immediately after operation,1’2’4
but in adulthood both medically and
surgically treated patients were the
same height and appreciably shorter
than normal. In the routine medical
management of children with Crohn’s
disease, caloric supplementation must
begin at the time growth failure is
first noted. A prospective study is
presently being conducted in our insti
tution, using a 3-week course of con
tinuous elemental diet as the sole
treatment in order to induce remis
sion. Usually this treatment leads to
a resumption of growth which lasts
about 3 months. Repeated courses of
elemental, enteral nutrition at home
may be beneficial. If this attempt

fails, operation will be performed and
may lead to some catch-up in growth.
Conclusions
Crohn’s disease in children seems
to be occurring more frequently, to
be more severe and to be starting
earlier.
Good preoperative care with en
teral or parenteral nutrition allows
operation to be performed under safer
conditions with very little morbidity
and mortality.
Although the recurrence rate after
operation is still high there is no
doubt that patients enjoy a better
quality of life, growth acceleration
and a 50% chance of being free of
disease 10 years later.
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6. Panel Discussion
Chairman: R. Postuma*
Panelists: A. B ensoussan, Z. C ohen , A. C oran, S. M oroz, M. Ste -M arie

Dr. Postuma: The frequency of in
flammatory bowel disease in adoles
cent patients appears to be increasing.
We are seeing more patients with
Crohn’s disease, usually with very ex
tensive involvement of the small bowel
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and colon and with associated proteincalorie malnutrition.
There are presently a number of
controversies in the management of
these patients: Should malnutrition be
managed with home parenteral nutri
tion or is the continuous elemental
diet preferable? Is growth retar
dation and delay of sexual matura
tion an indication for surgical inter
vention in the absence of clearly iden
tifiable obstruction? For how long
should steroid therapy continue before
surgical treatment is considered? In
the surgical treatment of ulcerative
colitis should one use the Kock pouch
or the endorectal pull-through pro
cedure?
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These are some of the questions we
should try to answer in this discussion.
Question: In the October 1979 sup
plement of Gastroenterology, a fantas
tic review of the treatment of Crohn’s
disease was presented, and one of the
main points made was the futility of
using steroids to prevent exacerbation
in patients who are in remission. Ob
viously the use of steroids is of in
terest in acute disease as we have been
told. Why is it that so many patients,
who come to us in an extreme state
obviously requiring operation for
Crohn’s disease that has been present
for weeks or months, have had some
times years of steroid therapy? Why
do we see those patients still in 1981?
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Dr. Moroz: That is an excellent ques
tion. Before the National Cooperative
Crohn’s Disease Study was initiated,
the management of this disease was
really anybody’s guess. It was thought
that the use of steroids on a long-term
basis might be of some value, but
the study findings do not support this.
I don’t really know why people persist
with steroids. I suppose they hope that
the patient will ultimately go into
remission so that surgery will be
avoided, because in Crohn’s disease it
is associated with numerous compli
cations. We have been impressed, in
the few such patients that we see,
that those we have operated on have
done much better following the opera
tion than before, despite large doses
of steroids that had been used in an
attempt to keep the disease under
control. Medical people have partly
been influenced by the surgeons; sur
geons have been reluctant to operate
because the patients have been able
to manage without operation. But as
surgical techniques have improved
(and you just heard that the expe
rience with surgery seems to be bet
ter), perhaps the patients about whom
you have been talking won’t be ap
pearing on your doorstop in future.
They will have had shorter courses
of steroids. I hope I have answered
your question.
Question (Dr. Deschamps): In Mar
tin’s article on endorectal pull-through,
he states that extensive preparation
should be done before operation in
order to facilitate the procedure. How
important is this and how do you
carry this out?
Dr. Coran: Well, Martin, in his article
and when speaking with him, men
tioned that many of this patients were
placed on parenteral nutrition for
about a month, mainly with the idea
of decreasing the amount of inflam
mation in the rectum. We followed
his advice in our first series of
patients and found very little' change
in the status of the rectum. Patients
became better just as any patient with
inflammatory bowel disease will when
they have bowel rest and get good
nutritional support such as total
parenteral nutrition. On the other
hand, if one diverts the fecal stream
with an ileostomy, which we are
doing now, we find the inflammatory
process in the rectum markedly im
proved and it is far easier to do the
dissection. The dissection is quite dif
ficult when there is a lot of inflamma
tion. The difference in the volume of
blood transfusion required in these two
groups of patients has been quite im
pressive.
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Are Hartmann pouch. It is almost im
there any people with ulcerative colitis possible, and I have tried it already,
who have such severe disease that you to go back in and do an endorectal
cannot do the endorectal dissection? dissection when the rectal stump has
Dr. Coran: Yes, I think there are. In been closed and dropped below the
our series, I had one patient about 35 pelvic floor. You can’t do it, at least
years old who had had disease for 25 I can’t do it. So, if you are going to
years, and had such severe inflam do a subtotal colectomy, you must
matory strictures and fibrosis in the leave the patient with a mucous fis
rectum that we could not do the dis tula of the rectum somewhere in the
section. I think there will be such a mid-sigmoid colon, and a permanent
group of patients, but mainly in the ileostomy, which I have done as part
older age group. There are adults who of a three-stage procedure. The ques
have strictures of the rectum in which tion that comes up after that is:
dissection is quite difficult, but in “What happens if the patient con
tinues to bleed from the rectum?” —
most the dissection can be done.
Question: My question is for Drs. that is very well managed with cort
Coran and Cohen. In 1981 an ado enemas.
lescent comes to us requiring a Dr. Cohen: Surprisingly, I wouldn’t
colectomy. The parents know about disagree with too much that Dr. Coran
proctocolectomy and endorectal pull- said. We are very interested in endo
through. Which procedure should we rectal pull-through, but I think it’s
recommend at this stage? This may be never going to be a technique that
an unfair question, but it’s realistic everyone is going to do. It’s a highly
because those are the questions that specialized technique. It’s also a tech
nique that will be filled with compli
well-informed patients ask.
Dr. Coran: Well, let me take two cations when you first do it, the same
aspects of that question. The expe as the continent ileostomy, although
rience now accumulated around the maybe less so than the continent ileo
country with the endorectal pull- stomy. I would not disagree at all
through for ulcerative colitis — name with maintaining someone’s rectum. I
ly, Martin’s experience, our expe think you can staple it off and leave
rience, that of the Mayo Clinic and it within the peritoneal cavity, but I
that of the group at St. Mark’s Hos agree that it shouldn’t be done too
pital in London (Parks and Nicholls) low; recently, we had the experience
— shows clearly that this operation of attempting to do an endorectal
works. Now, you may say you don’t pull-through that was below the pelvic
want a patient to have 20 bowel move reflection and it was extremely diffi
ments a day for 2 or 3 months, and cult to do. I would like to make a
that is a legitimate objection, but the couple of comments though about the
fact is that many of the patients do results that are coming in regarding
quite well. On the other hand, if you this procedure. Dr. Coran’s results are
proceed
with
the
conventional by far the best that I have ever heard.
standard approach for ulcerative At a recent meeting of the American
colitis, you have burned all your Society of Colon and Rectal Surgeons,
bridges. If you do a proctocolectomy, some people from the Mayo Clinic
you can never do the pull-through were not at all pleased with their ileo
procedure. But, if you do the endo anal surgery. In fact, their functional
rectal pull-through and your patient results were poor. They have now
happens to be dissatisfied with the gone to balloon dilatation of the ileal
frequency of bowel movements, you segment above the ileoanal anasto
can always go back and do a proct mosis to create some type of reser
ectomy and form a permanent ileo voir function above the anastomosis;
stomy. I have been asked this ques it is the feeling of the majority of the
tion several times, principally by surgeons in that society that a straight
general surgeons around our state. ileoanal endorectal pull-through is
Because they do not know how to do not the operation of choice. A reser
the endorectal pull-through and are voir of some type, such as Parks’,
faced with either taking care of their which is similar to a Kock pouch with
patients with ulcerative colitis in their out the valve, or the Japanese folded
hospital or referring them, I have sug J-type loop (they have actually three
gested that if they are not sure that modifications of that) is necessary so
this is a good operation, which I can that the frequency of bowel move
understand because the data are not ments will be reduced. So, although
all in, they should just do a subtotal we are very interested in the proce
colectomy and an ileostomy. If you dure, we would not recommend an
are going to do a subtotal colectomy ileoanal anastomosis in our adult
for this disease, do not construct a patients. Parks has now done more
Question (Dr. Filler, Toronto):
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than 50 operations and it is only his
earlier patients who have had to in
tubate their anus in order to empty
the pouch; that is because he made
the outlet a little too long when he
was bringing it through the rectal cuff
and anastomosing it to the anus.
When he modified that technique
recently, to make the outlet much
shorter — in the 3- to 5-cm range —
he had much better results with spon
taneous evacuation and no inconti
nence or anal soilage at night. In
summary, we are very much in favour
of endorectal pull-through. I think that
it is a procedure that is going to be
promoted and is here to stay, but it
is a highly specialized technique and
we would prefer to do it with some
type of reservoir function.
Dr. Coran: Could I just say some
thing about the reservoir and Parks’
experience. Parks spent a couple of
days with us in Michigan. He has
operated on 50 patients and the results
are much better now; but one must
realize that he is placing inside that
endorectal pull-through — for those
of you who have done this opera
tion — a segment of bowel that has
30 cm or so of suture line in the
small bowel. Often we were worried
about exactly what the blood supply
was like at the very end of that bowel.
I am concerned about the potential
complications. I wonder how many
of these reservoirs he’s had fall apart,
if any, because I have not seen the
latest report; but that to me is a very
worrisome thing, just as I am con
cerned about the length of the suture
line in a Kock pouch. The J-loop that
the Japanese have described and that
Fonkalsrud is now using gives a fre
quency of bowel movements no dif
ferent from that in our experience
with a straight endorectal pullthrough; that is an average of six to
eight bowel movements daily, and the
incidence of incontinence is greater
than ours; we’ve had none. So I am
not sure that a reservoir is the answer.
I think the point is that at the moment
we don’t know how good any of these
operations are, and it’s very impor
tant that each institution looking at
this problem and whose results are
reasonable, continue to do the same
operation and not jump from one to
the other, as I have seen happen, so
that in 10 years we can evaluate which
is the best operation. Telander, who
is the pediatric surgeon at the Mayo
Clinic, is the one who introduced the
endorectal pull-through there and has
done it in over 30 teenagers and young
adults. The results I described from
the Mayo Clinic are solely his, and

his results with the straight endorectal
pull-through are excellent. I think they
are similar to our results in Michigan.
Many of the other general surgeons
at the Mayo Clinic have taken it up
and their results have been variable.
Dr. Postuma:
In our experimental
work we noticed the pouch dilates
tremendously, in one animal by a
factor of 4, so that in the long-term
the pouch might be a problem.
Comment (John Patrick, Montreal): I
have spent 5 years resuscitating
severely malnourished children, in
John Woodlow’s unit in the West
Indies, and I want to make a com
ment about your assessment of natu
ral growth, and make a request that
you distinguish between wasted and
stunted individuals, because there is
an important point at issue. I find that
I can use the same techniques they
used in malnourished children, in
wasted children with Crohn’s disease
and achieve weight gains of up to 1 kg
a day in, say, a 30-kg teenager. For
instance, the last child in my series
put on 10 kg in 15 days; but it is
very dangerous to push calories once
expected weight and height have been
reached. You can certainly kill chil
dren with primary malnutrition by
doing that, but it is a very worthwhile
procedure whilst they are wasted.
Dr. Ste-Marie: I agree with that
completely. I think that the primary
thing is really to be on the lookout
for signs of malnutrition and then
assess to what extent this malnutrition
exists. Is it simply a marasmic type of
malnutrition or is the growth stunted?
Then you should start to rehabilitate
these patients slowly. I agree with
you.
I have a question for Dr. Coran.
Has the physiology of your so-called
distal ileum been studied, because the
fact of so many bowel movements
makes me think that there might be
a disturbance of bile-salt reabsorption
at this level, and I wonder if the bilesalt kinetics have been studied and,
if so, if there is an increased bilesalt excretion, and would something
like cholestyramine be helpful in these
patients?
Dr. Coran: I don't know of any study
in which the physiology of the distal
pull-through rectum has been looked
at. We’ve looked at all these patients
who have had a long enough follow-up
in terms of the histology. One of my
thoughts was that possibly the piece
of ileum sitting in the rectal cuff might
change its histologic pattern from that
of small-bowel mucosa to colonic mu
cosa and thereby enhance its ability
to absorb water. We’ve biopsied all

these patients on a yearly basis, both
to look at that problem and also to
be sure that no other active disease
was present, and have not seen any
changes. It looks like normal, typical
ileum such as is seen with an ileo
stomy. A clinical observation that we
have made is that during the 2-month
period, when the patient has an ileo
stomy in place after the pull-through
has been done, the ileostomy drainage
is typical. It’s relatively liquid in many
of the patients, it’s not really firmed
up. When you close the ileostomy and
patients begin to have bowel move
ments from below, for some reason
the material becomes thicker, indicat
ing at least to me that there is some
increased water absorption by merely
allowing the material to sit in this
small rectal pouch, but we’ve never
proven that with any kind of experi
mental study.
Dr. Cohen: I think this is certainly
one of our concerns in construction
of any kind of reservoir — the Kock
pouch or the reservoir brought down
to the anus — and I think that we
have shown in studies that the bilesalt loss is increased, and whether
this loss is detrimental or not. It is
not excessive but is certainly in
creased. In modifying the Kock pouch
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reservoir by making it into a triple
loop with three 15-cm lengths, that
extra 15 cm does make a difference.
We have also done studies in patients
who have had a 15-cm resection plus
creation of a Kock pouch. Their bilesalt losses are excessive, and that is
why we believe that previous bowel
resection is a contraindication to the
form ation of a Kock pouch reservoir.
So, I think there is a fairly fine line
there as far as how much bowel
function there is.
Question (Dr. Ciatworthy): I wanted
to ask you about severe perirectal dis
ease in patients with granulomatous
colitis. We have been troubled with
this in three teenagers. Have you seen
these patients recover? They don’t
have excessive disease above the peri
rectal area and their disease is lim
ited. How would you handle these
patients?
Dr. Ste-Marie: I can tackle that be
cause, unfortunately, it seems to me
that now quite a few younger patients
present with severe rectal and sigmoid
problems, and you really want to

spare them any kind of definitive
surgery if you can. We have started,
as I said in my paper, on a regimen
of continuous elemental enteral nutri
tion, and for the first 4 or 5 days
we give them steroids intravenously
and then we stop completely. We con
tinue with 2 to 6 months of continu
ous enteroalimentation. That is not as
terrible as it sounds because there
are feeding tubes available that are
extremely soft and can stay in place
for more than 2 months without
being changed. The first patient
we treated this way, 4 years ago,
had extensive perianal involvement of
the rectum, the sigmoid and the des
cending colon; he became totally
asymptomatic for 3 Vi years. Radiologically the disease was still there, but
he was asymptomatic and he grew
and matured sexually. So this is
the way that we are looking at the
problem. In other words, we are trying
our best to induce remission and we
have been successful in four or five
patients at least that I have followed
in the past 5 years.

Comment (Dr. Filler): Just one word
about the Mayo Clinic experience, be
cause Telander presented a paper co
vering this problem last May. The
problem was not different from what
Dr. Coran described, that is, that with
the endorectal pull-through, there were
many bowel movements, certainly at
the outset, which was distressing for
many patients; in my small experience,
the first month or so is really tough
for these children. In an effort to elimi
nate the difficulties of the first month,
to make a reservoir at the bottom end,
dilatation was used, first with a Foley
balloon catheter and then with a spe
cial balloon designed to fit the
contour of the lower rectum. The
results of those dilatations were
quite good, although what it really
did was cut down the frequency of
the bowel movements. The other com
plications were really not very im
pressive, as Dr. Coran said.
Dr. Postuma: I want, on behalf of
the audience, to thank the panel again
for an excellent presentation.

BOOK REVIEWS
AMBULATORY SURGERY A N D THE
BASICS OF EMERGENCY SUR
GICAL CARE. Edited by Mark W.
W olcott. 699 pp. Illust. J.B. Lippincott
Company, Philadelphia, 1981. Price
not stated, paperbound. ISBN 0-39750480-2.

This tightly edited textbook represents
a significant revision of its predecessor,
the fifth edition of “Ferguson’s Surgery
of the Ambulatory Patient,” published in
1974, the first edition of which appeared
in 1942. This up-to-date publication con
sists of 33 chapters prepared by 31 con
tributors. The major addition to this
text is the emphasis on the early and
appropriate management of various
forms of trauma, both major and minor.
This book is particularly timely in view
of the recent development of the field
of emergency medicine.
The first chapter establishes the fact
that this book is aimed at the surgeon
or house officer for use in either the
physician’s office, the hospital-based
surgical clinic, the ambulatory surgery
unit or the emergency room. The
following chapter contains an index of
all the procedures that can be carried
out in an ambulatory surgical centre,
such as the Surgi-Center in Phoenix,
Arizona. I have always been impressed
by how much more major surgery is
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done on ambulatory patients in the
United States than in Canada. There
is an excellent description of the design
and staffing of such an ambulatory
surgery unit.
The book is well written and readable
and there are many helpful illustrations.
In addition, there are many cleverly
drawn sketches; some of these we rec
ognize from previous editions but most
are new and complement the accom
panying text. There is a bibliography at
the end of each chapter. Many “how to
do it” sections are included, such as
placement of a subclavian or internal
jugular catheter, emergency insertion of
a chest tube, pericardiocentesis and
the technique of producing local anes
thesia for repair of inguinal hernias.
There are many useful tables summariz
ing such topics as the diagnosis of
gastrointestinal bleeding, tetanus pro
phylaxis, choice of antibiotics for or
ganisms found in surgical infections and
the Glasgow coma scale.
This book’s greatest use will likely be
for those physicians or surgeons who
first come in contact with the trauma
patient. Chapter 4, the book’s longest,
at 100 pages, deals with the initial
evaluation and treatment of major
trauma. It is followed by a new chapter,
dealing with minor trauma — soft-tissue

injuries and foreign bodies. Chapters on
pain and coma have been added, and the
section on snake and insect bites has
been given its own chapter.
On the whole, this is a crisp, up-todate volume that should be of value
to those interested in this field. It may
also be useful as a reference for teach
ing nurses and other paramedical per
sonnel. Certainly every emergency de
partment should have this book as a
ready reference guide. I predict that
this book will have the same popularity
as its predecessors.
E.D. M onaghan,

md , frcs [c ], facs

Department of surgery,
Royal Victoria Hospital,
McGill University,
Montreal, PQ
ATLAS OF COMPUTED BODY TO
MOGRAPHY. Normal and Abnormal
Anatomy. Lee C. Chiu and Rolf L.
Shapiro. 199 pp. Illust. University
Park Press, Baltimore, 1980. $19.95,
paperbound. ISBN 0-8391-1532-6.

A collection of individual articles origin
ally published in CT — The Journal of
Computed Tomography, this atlas con
tains a useful index and an excellent
continued on page 568
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A New Approach to Antibiotic Therapy in Colon
Surgery Based on Bioassay Tissue Concentrations
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The authors investigated the kinetics,
in serum and tissues, of clindamycin,
metronidazole, cefoxitin and
moxalactam given during colon surgery
in the dog. Colon, rectus muscle and
subcutaneous fat samples were
taken at times of maximal
contamination during the initial
operation and at a second operation,
9 days after the first, when septic
complications were most likely to
occur in the healing tissues. Bioassay
was used to measure the amount of
active antibiotics in serum and tissues.
Clindamycin achieved therapeutic
levels in all tissues except those of
the fresh wound, thus making it a
better therapeutic than prophylactic
agent. Metronidazole achieved
therapeutic levels in both fresh and
healing tissues. Cefoxitin and
moxalactam did not achieve adequate
levels in either fresh or healing
tissues.

I’operation initiate, et aussi apres
9 jours, durant une operation
secondaire au moment oil les
complications septiques etaient les
plus probables dans les tissus
cicatrisants en phase postoperatoire.
Les essais biologiques ont ete utilises
pour mesurer le niveau d’antibiotique
actif dans le serum et les tissus.
On a retrouve ces niveaux
therapeutiques de clindamycine dans
tous les tissus sauf les nouveiles
plaies, done le rendant un meilleur
agent therapeutique que prophylactique.
On a retrouve le metronidazole a des
niveaux therapeutiques dans les
nouveiles plaies et les tissus
cicatrisants. On n'a pas retrouve de
niveaux satisfaisants de cefoxitin
et moxalactam ni dans les nouveiles
plaies, ni dans des tissus en voie
de guerison.

Reprint requests to: Dr. Rea A. Brown,
Rm. 1522, The Montreal General
Hospital, 1650 Cedar Ave., Montreal,
PQ H3G 1A4

An important concept in the prophy
laxis of septic complications in colon
surgery is the administration of anti
biotics to obtain adequate tissue levels
before contamination takes place. An
tibiotics are virtually useless as pro
phylactic agents if administered more
than 3 hours after the period of bac
terial contamination has ended.1 It is
accepted that the rate of wound
infection following bowel surgery
without antibiotic prophylaxis ranges
from 30% to 4 0 % Bernard and
Cole,6 Polk and Lopez-Mayor7 and
others3'5'6"10 have shown that preopera
tive administration of antibiotics does
decrease the rate of wound infection
postoperatively. Although many dif
ferent antibiotic regimens are used,
many of them include an antibiotic
that is effective against anaerobic or
ganisms.3'6'9
We investigated four antibiotics
(clindamycin, metronidazole, cefoxi
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Les auteurs ont etudie la cinetique,
dans le serum et les tissus, de
clindamycine, metronidazole, cefoxitin
et moxalactam, donne durant une
chirurgie du colon chez le chien. Des
echantillons de colon, de muscle
grand droit et de la graisse souscutanee ont ete pris a des intervalles
de contamination maximale durant
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tin and moxalactam) with good invitro activity against colonic flora and
determined their serum levels; tissue
levels were measured when infectious
complications actually occurred. We
measured the level of penetration into
colonic tissues at the time of surgical
manipulation and into the wound at
the time of closure. We also deter
mined the level of antibiotic penetra
tion into healing tissues, such as the
colon at the site of anastomosis and
the 9-day-old abdominal wound, in
which septic complications may have
developed. The clinical implications
in terms of prophylaxis and therapy
are clear.
Characteristics of the Antibiotics

Clindamycin
This is a bacteriostatic agent; it acts
on the 50 S subunit of the bacterial
ribosome thereby inhibiting protein
synthesis. It is effective against Sta
phylococcus aureus, Peptococcus,
Clostridium and Bacteroides spp,
although resistant strains of the last
three have been isolated.11'13 It is high
ly bound to serum protein,14’15 having
a serum half-life of about 3 hours.16
Important side-effects of clindamycin
include diarrhea and pseudomembran
ous colitis. Tedesco and colleagues17
reported an incidence of 21% diar
rhea and 10% pseudomembranous
colitis associated with clindamycin
therapy. It is now agreed that pseudo
membranous colitis is generally asso
ciated with a toxin produced by over
growth of Clostridium difficile 3*
This toxin is found more frequently
when symptoms are severe: from 15%
to 20% in patients with mild uncom
plicated diarrhea and up to 97% in
patients with pseudomembranous col-
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itis.20 Gianella and colleagues21 found
that clindamycin inhibits the transport
of intestinal water, causing watery
diarrhea without actual colitis.
In our laboratory, 2 of 97 clinical
isolates of Bacteroides fragilis were
resistant to clindamycin at a concen
tration of 5 /zg/ml. The minimal in
hibitory concentration of clindamycin
for most anaerobes, particularly B.
fragilis, is 1 /zg/ml.
Metronidazole
Metronidazole was first introduced
as an antitrichomonal agent22 but is
also effective against Entamoeba,
Giardia and anaerobic bacteria.23 It
is minimally bound to serum protein,
and its half-life in man is 7 to 8
hours.23,2,1 Reduction of its nitro group
gives an intermediate compound that
binds to critical sites in susceptible
cells.23,25 Resistance to metronidazole
is related to a decrease in the nitro
reductase content of the organisms.25,26
The rate of anaerobic wound infection
following prophylactic use of an ade
quate dosage of metronidazole in elec
tive colon surgery is negligible.27'29
Furthermore, when given intravenous
ly, metronidazole levels in the bowel
lumen are comparable to those
achieved by oral administration. In
terestingly, it is also effective in treat
ing colitis due to C. difficile.30 It is
mutagenic in the Ames bacterial test
and in certain laboratory strains of
mice. Retrospective surveys do not.
however, demonstrate carcinogenicity
in man.23 The minimal inhibitory con
centration of metronidazole for many
anaerobes is typically 0.1 /zg/ml.
Cefoxitin
Cefoxitin is a cephamvcin antibiotic
that is resistant to hydrolysis by f}lactamases.31 Its half-life is 40 to 60
minutes and it is 70% to 75% pro
tein-bound. It inhibits bacterial cellwall synthesis, resulting in bacterial
lysis and death. In vitro, it is effective
against a large proportion of isolates
of S. aureus. Streptococcus (except S.
faecalis), Escherichia coli, B. fragilis
and Clostridium spp. It lacks activity
against Pseudomonas spp.32 The mini
mal inhibitory concentration for anae
robes given in the literature ranges
from 4 to 8 pug/ml. In our laboratory,
27 out of 97 isolates of B. fragilis
tested at a concentration of 10 /zg/ml
of cefoxitin were resistant to it.
Moxalactam
Moxalactam is a semisynthetic j3lactam, third generation cephalo
sporin. Its wide spectrum of effective
ness includes Enterobacter spp. and a
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large proportion of isolates of Pseu
domonas aeruginosa and B. fragilis
(which are generally resistant to the
older cephalosporins).33 It is ineffec
tive against enterococci.34 It also shows
activity against S. aureus, with the
exception of methicillin-resistant iso
lates. but is less active than cefamandole34 in this respect.
It acts by interfering with the syn
thesis of bacterial cell walls. It is 38%
bound to serum protein35 and its elim
ination half-life is 2V4 to 3 hours. The
minimal inhibitory concentration for
B. fragilis in the literature ranges from
8 to 16 /zg/ml. In our laboratory, 97
strains of B. fragilis were tested and.
at a concentration of 10 /zg/ml, 52%
were resistant to moxalactam.
Material and Methods

Operative Procedure
Conditioned mongrel dogs were
subjected to 3 days of mechanical
bowel preparation and liquid diet. Af
ter anesthesia was induced with Nem
butal, a single dose of the test anti
biotic, equivalent to 10 mg/kg, was
given intravenously. Blood samples
were taken at 5-minute intervals after
the initial dose, up to 30 minutes
and then at each subsequent tissue
sampling. The abdomen was en
tered through a midline incision
and the descending colon was
mobilized. At 30 minutes after the
antibiotic was given, a colotomy was
performed using electrocautery, a fe
cal sample was taken, if present in
adequate amounts. At 60 minutes,
the colotomy was extended. At 90
minutes, the segment of colon was
resected and a primary anastomosis
was performed in two layers using
3-0 chromic and 4-0 silk. Rectus mus
cle and subcutaneous fat samples were
taken from the abdominal incision at
the time of closure after peritoneal
irrigation with normal saline.
No other antibiotics were given
until 9 days after the operation, when
a second operation was performed.
After induction of anesthesia, the

same dose of the same antibiotic was
given. The abdomen was re-entered
through the same midline incision. At
60 minutes, the colon was resected
at the site of anastomosis, and rectus
muscle and subcutaneous fat samples
were taken.
The mucosa and muscularis muco
sae of the colon were separated im
mediately upon resection. All tissue
samples were wiped clean of gross
blood and feces.
Microbiology
Each tissue sample was weighed
and culture medium was added to
give a dilution factor of approximately
3 ml culture medium per gram wet
weight of tissue. This was then ground
at high speed using a Polvtron homogenizer
(Brinkmann
Instruments,
Westbury, NY). The tissue homogen
ates and blood samples were then
centrifuged. Standard, known concen
trations of the test antibiotic were as
sayed, using assay discs furnished by
the individual pharmaceutical com
panies and a standard, twofold tube
dilution procedure in horse serum.
Assay discs were impregnated with
0.1 ml of the standard concentrations
of antibiotic, tissue supernatant or se
rum. The discs were applied in tripli
cate to blood agar previously plated
with test organisms (Table I), and in
cubated at 37°C for 18 hours. The
diameter of the zones of growth inhi
bition were then read to the nearest
millimetre and the concentrations
(/zg/ml) of unknown samples were
derived from linear regression anal
ysis. For tissue samples, the concen
trations were then multiplied by the
dilution factor (/zl/g) to obtain the
final concentration (/zg/g).
Results and Discussion

Assay Method
One major advantage of the bioas
say is that it measures the amount of
active antibiotic available for anti
microbial activity. It does not meas
ure intermediate products of the drug

Table 1 -Culture Media and Test Organisms Used for Each Antibiotic
Antibiotic

Culture medium

Clindamycin

Tryptic soy broth

Metronidazole

Thioglycolate

Cefoxitin

Tryptic soy broth

Moxalactam

Tryptic soy broth

Test organism
/(-hemolytic
Streptococcus pyogenes
ATCC 14289
Clostridium sporogenes
M and B
Escherichia coli
ATCC 29891
£ coli
NCTC 10418

Incubation condition
Aerobic, 37°C, 18 h

Anaerobic, 37°C, 18 h
Aerobic, 37"C, 18 h
Aerobic, 37°C, 18 h
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that are not always active and can be minimal inhibitory concentration,
detected by chromatography, spectro and this was the criterion we used.
photometry, radioimmunoassay and
Clindamycin
other methods.
The antibiotics we studied vary
According to our data there was
greatly in their respective degrees of active mucosal uptake of clindamy
protein binding. It is generally agreed cin, with active secretion into the lu
that the protein-bound portion of the minal contents (Table II). The muco
drug has no antimicrobial activity.36 sal levels were significantly higher
The bioassay method measures only than those of the corresponding se
the active, unbound portion that dif rum levels throughout the 30- to 90fuses out to produce the zones of minute period (P < 0.001, Student’s tgrowth inhibition of the plated or test, paired, two-tailed) (Fig. 1). The
ganism.
levels obtained in the mucosa and
Choosing the medium is important, muscularis mucosae of the intact colon
because preparation of standard during this period were above the the
curves in a medium different from rapeutic level of 10 /zg/ml. In the
that used for test samples may cause fresh wound, there were no detectable
under- or overestimation of the anti levels in the rectus muscle and sub
biotic concentrations due to differen cutaneous fat at the time the abdom
tial protein-binding and varying dif inal incision was closed (mean 160
fusion rates.37 The appropriateness of minutes after the antibiotic was giv
our choice of diluent medium was en), as well as at 45 minutes. Even
verified with the most highly protein- though clindamycin does not pene
bound antibiotic, clindamycin. Stand trate the fresh wound at the time of
ard known concentrations of this an closure, the fact that high levels are
tibiotic were prepared in horse serum
as well as in tryptic soy broth. The
zones of growth inhibition for each
concentration were essentially ident
ical for both, yielding excellent posi
tive correlations (r > 0.9).
Little is known experimentally
about actual therapeutic levels of an
antibiotic needed in tissues to cure an
infectious complication. However, a
clinically successful outcome is more
likely to occur at serum concentra (intact colon, first operation) (u.g/ml or
tions aimed at 10 times that of the a g /g ). A rrow indicates therapeutic level.

Table II-C lin d a m y c in L e v e ls* ± Standard D eviation
Sam ple, p g /g t
Tim e (mean)

R ectus muscle

Subcutaneous fa t

Initial operation (fresh w oound)
(45 min)
Initial operation (fresh w ound)
(160 min)
Secondary operation (healing w ound)
at closure (45 min)

N il d etectable^

Nil detectable

N il detectable

N il detectable

7 .3 ± 2.5

11.3 ± 4 .5

'L u m in al contents, initial operation (30 min) = 35.3 ± 14.1 pglg.
(M e a n ± standard deviation.
4 < 0.1 pglm l.

Table I I I - M etronidazole Levels*
Sam ple, pg/g
Tim e (mean)
Initial operation (fresh w ound)
a t closure (130 min)
Secondary operation (healing w ound)
at closure (60 min)

R ectus muscle

Subcutaneous fa t

14.1 ± 3.2

3.7 ± 0 .2

13.4 ± 3.0

9 .7 ± 1.5

'L u m in al contents, initial operation (30 min) = 3 .2 ± 0 .6 pglg.
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achieved in the mucosa and muscu
laris, offering protection to an ob
vious source of contamination, might
make this drug a useful prophylactic
agent. Hojer and Wetterfors,38 in a
double-blind study with doxycycline,
also found high levels in the bowel
wall despite low levels in the subcu
taneous fat; the incidence of wound
infection in the treated group was
low (3 of 39), compared with the
placebo group (16 of 43).
Others have also found poor
wound penetration by clindamycin
given as a single dose. Alexander and
colleagues,14 using a single intraven
ously administered dose equivalent to
15 mg/kg, found that it penetrated
wound fluids slowly, reaching a peak
concentration of 9 /zg/ml at about
2'/i hours. However, Bagley and as
sociates,39 using multiple intravenous
doses of clindamycin before sampling
(300 mg q6h for 36 hours) found a
constant pool of clindamycin in the
wound fluid collected from suction
drainage following lymph-node dis
section. The concentration in the
wound fluids remained between 4
and 5 /zg/ml throughout the 1- to
6-hour interval following infusion of
the last dose of clindamycin.
Comparison of the concentrations
of antibiotic at the mucosa and mus
cularis levels in the intact colon (first
operation) with those at the anasto
mosis (second operation) revealed no
significant difference at either site.
All tissue samples were taken at 60
minutes after the antibiotic was giv
en. Therapeutic levels were obtained
in the intact colon as well as the site
of anastomosis.
Clindamycin also penetrated the
tissues of the healing wound; the
levels obtained in these tissues were
within the therapeutic range. Because
the values obtained in the tissues ap
proximated corresponding serum lev
els, we initially thought that this was
a reflection of the increased vascu
larity of the healing wound. However,
this may not be entirely true, since
with other antibiotics studied the tis
sue and serum levels in the healing
wound were not similar. Perhaps with
the increased permeability of the ves
sels during the inflammatory process
of healing, clindamycin, a highly pro
tein-bound antibiotic, is drawn out
of the intravascular space and binds
to proteins in the interstitial compart
ment, thus creating an equilibrium.
Metronidazole

This agent proved effective both
prophylactically and therapeutically
(Table III). Therapeutic levels were
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attained in the intact colon in 30 to
90 minutes (Fig. 2), at the site of
anastomosis, as well as in the tissues
of fresh and healing wounds. The se
rum kinetics of this antibiotic, with its
prolonged duration of excretion, sug
gests an enterohepatic circulation, as
was found by Populaire and asso
ciates22 in the rat, though not by
Templeton40 in the mouse. Effective
doses of metronidazole are secreted
into the luminal contents, as Dion
and colleagues10 have found.
C e f o x itin

Mucosal levels of cefoxitin began be
low the corresponding serum levels,
but equilibrated with serum levels by
90 minutes (Fig. 3). Levels in the
muscularis mucosae also started be
low those in serum, but surpassed
the serum levels by 90 minutes. How
ever, because of the higher minimal
inhibitory concentration, the thera
peutic level should be at least 40
/u,g/ml. Thus, even though the tissue
levels were above the minimal inhi
bitory concentration, therapeutic lev
els were not attained (Table IV).
Although cefoxitin also penetrates
the anastomotic site, as it does both
the mucosa and muscularis of intact
colon, therapeutic levels are not
achieved. This antibiotic also does
not penetrate the tissues of the fresh
wound, nor does it attain therapeutic
levels in the healing wound. Part of
the reason for this may be the dose
and frequency of administration. We
gave a single dose intravenously,
equivalent to 10 mg/kg before tissue

and serum sampling. Other authors,
using higher doses and for a longer
time, obtained much higher serum and
tissue levels41 with good clinical re
sults.42-4'1
Moxalactam

When a single intravenous dose
equivalent to 10 mg/kg was given,
moxalactam did not maintain thera
peutic levels in colonic tissues, nor in
the tissues of the wound (Fig. 4, Table
V). This suggests that either a larger
initial dose or an additional intraoper
ative dose is needed to maintain ade
quate tissue levels, especially since
the levels in intact colon decreased
during the 30- to 90-minute period
after administration of the antibiotic.
Although there was no significant dif
ference between the levels obtained at
the anastomotic site and in the in
tact colon, they were below therapeutice levels. Moxalactam levels ob
tained in the healing tissues of the
wound were also below therapeutic
range, due to the higher range of its
minimal inhibitory concentration.

The two cephalosporins, cefoxitin
and moxalactam, do not attain thera
peutic levels in fresh and healing tis
sues of the colon and wound with the
dosage and timing we used, nor do
they achieve therapeutic levels in the
luminal contents.
References
1. B urke J F : The effective period of preven
tative antibiotic action in experim ental in
cisions and derm al lesion. Surgery 1961;
50: 161-8
2. G oligher JC , G raham N G , D e D ombal
F T : A nastom ic dehiscence after anterior
resection of rectum and sigmoid. B r J
Surg 1970; 57: 109-18
3. N ichols RL, B roido P, C ondon RE, G orbach SL, N yhus LM : Effect of preopera
tive neom ycin-erythrom ycin intestinal prep
aratio n on the incidence of infectious com 
plications following colon surgery. A n n Surg
1973; 178: 453-62
4. W ashington JA ii , D earing W H , J udd ES.
E lveback LR: Effect of preoperative an ti
biotic regim en on developm ent of infection
after intestinal surgery: prospective, ra n 
dom ized, double-blind study. Arm Surg
1974; 180: 567-72
5. K eighley M R, C rapp A R , B urdon D W ,
C ooke W T, A lexander-W illiams J : P ro 
phylaxis against anaerobic sepsis in bowel
surgery. B r J Surg 1976; 63: 538-^41

Conclusions

Clindamycin maintains therapeutic
levels in both the intact colon and
the healing colonic tissue at the site
of anastomosis. It has poor penetration
into the luminal contents.
Metronidazole provides therapeutic
levels in the colon, wound and the
luminal contents, in both fresh and
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(intact colon, first operation). Arrow
indicates therapeutic level.

Table IV-Cefoxitin Levels*
Sample, /uglg
Time (mean)

_______________________________ Rectus muscle

Initial operation (fresh wound)
at closure (160 min)

Nil detectable

17.6 ± 2.4

15.0 ± 1.8

Secondary operation (healing wound)
at closure (60 min)

FIG. 2—Metronidazole concentrations
(intact colon, first operation). Arrow
indicates therapeutic level.

Subcutaneous fat

Nil detectable)

’ Luminal contents, initial operation (30 min) = 11.3 ± 1.6 uglg.
t<0.6 pglml.

Table V-M oxalactam Levels*
____

FIG. 3—Cefoxitin concentrations (in
tact colon, first operation). Arrow indi
cates therapeutic level.
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_______

Sample, pglg_________________

Time (mean)
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Subcutaneous fat
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Nil detectablef
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SESAP III Critique
ITEM 38
Little is known about the metabolism of magnesium. However, in hypothyroidism, serum magnesium
levels are usually elevated. They may be decreased in hypoparathyroidism, cirrhosis, pancreatitis, and
short bowel syndrome.
The symptoms and signs of hypomagnesemia are primarily those of hyperactivity of the central
nervous and neuromuscular systems. Coarse tremors, hyperreflexia, hyperirritability and personality
changes, fasciculation of skeletal muscle, positive Chvostek’s and Trousseau’s signs, and convulsions
have all been reported to be associated with magnesium deficiency. Magnesium is an essential
component of virtually all enzymes and is necessary for the transfer of high-energy phosphate radicals
from adenosine triphosphate (ATP).

m
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Peripheral Arterial Transluminal Dilatation:
Early Results
K .W .

Johnston,

Over a 3-year period, 275 transluminal
dilatations were performed for the
treatm ent of peripheral arterial
occlusive disease. The results have
been evaluated prospectively using
radiologic, clinical and noninvasive
criteria. The cumulative success
rates for all dilatations were 63 ±
4% (mean ± 1 standard error) at
1 year and 53 ± 5% at 2 years,
but varied depending upon the site
of the dilatation and the extent of
the arteriosclerosis. The results are
best in patients who have short,
localized stenoses or occlusions,
especially in the iliac arteries.
Sur une periode de 3 ans, 275
dilatations de la lumiere vasculaire ont
ete pratiquees dans le traitement
de (’occlusion des arteres peripheriques. Les resultats ont ete evalues
de maniere prospective a I'aide de
criteres radiologiques, cliniques et
d'epreuves de laboratoire non
invasives. Les taux cumulatifs
de succes pour toutes les dila
tations ont ete 63% ± 4%
(moyenne ± I’ecart type) apres 1 an
et de 53% ± 5% apres 2 ans;
toutefois, ils variaient avec le site
de la dilatation et I'etendue de
I'arteriosclerose. Les meilleurs resultats
sont obtenus chez les patients qui
ont des occlusions ou des stenoses
courtes et localisees, des arteres
iliaques particulierement.
Percutaneous transluminal dilatation
is a controversial procedure. Although
it has been used successfully since
From the departments of surgery and
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19641 to treat selected patients with
peripheral arterial occlusive disease
and has been quite popular in Eu
rope,2 only recently has the tech
nique become popular in North
America. The increased interest in
this method can be traced to the in
troduction o f a new balloon dilating
catheter by Griintzig and H o p ff in
1974.3
The balloon catheters are made o f
polyvinyl chloride or specially treated
polyethylene and have a very low
compliance. Consequently, as the in 
flation pressure is increased, the
balloon maintains its cylindrical shape
and the diameter specified by the
manufacturer even at high inflation
pressures. I f a correct balloon diame
ter is chosen, there is little risk that
the vessel w ill be overdistended and
ruptured, even if a high inflation pres
sure is necessary fo r dilatation.
Transluminal dilatation is success
ful in certain patients, is associated
with a low morbidity and mortality
and a short hospital stay. The
cost o f the procedure is low. In spite
o f its advantages, it is often difficult
to decide between transluminal dila
tation and vascular reconstructive
surgery because the long-term results
o f dilatation are not yet known.
The purpose o f this paper is to de
scribe the short- and long-term re
sults o f transluminal dilatation in the
treatment o f patients with peripheral
arterial occlusive disease and to dis
cuss the role o f this method.

md, frcp [ c]

terial stenosis was localized, less than
10 cm long and accessible to dilata
tion, and especially those who were
poor surgical risks because o f under
lying medical disease. A Griintzigtype, balloon, dilating catheter4 was
used; the technique was standardized.5
The short- and long-term results
were evaluated by radiologic, clinical
and noninvasive vascular laboratory
criteria. Dilatations were considered
successful only if the follow ing criteria
were met: the pressure gradient meas
ured prograde across the stenosis at
the time o f arteriography was reduced
to less than 10 mm H g or decreased
by at least 40 mm Hg; the patient's
symptoms improved by at least one
clinical grade; the ankle to brachial
systolic pressure ratio increased by
at least 0.10; the Doppler pulsatility
index increased by more than 20%
and the treadmill exercise distance
doubled.
A small microcomputer was used
to store the essential patient data and
to calculate the results by life-tab'e
analysis. Information on new patients
was added to the registry and updated
after each patient follow-up visit.

Results
Overall
Fig. 1 shows the overall results for
all dilatations; at 12 months the suc1

001
8 0-

Methods

<j> ?0

A t the Toronto General Hospital,
our experience with transluminal dila
tation began in July 1978. Over the
3 years to July 1, 1981, 275 peri
pheral arterial dilatations were per
formed for the treatment o f claudi
cation, ischemic rest pain, night pain
or gangrene. Selected for this proce
dure instead o f vascular reconstruc
tive surgery were patients whose ar
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FIG. 1— Overall results for all 275
transluminal dilatations. Vertical bars
indicate ± 1 standard error.
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cess rate was 63% and at 24 months
53%.
Common Iliac Segment
In Fig. 2 the results for 97 com
mon iliac artery dilatations show that
the cumulative success rates were
88% at 12 months and 83% at 24
months. There was no significant dif
ference between the results of dilata
tion of common iliac artery stenoses
and recanalization of completely oc
cluded common iliac arteries.
External Iliac Segment
At 12 months the cumulative suc
cess rate for 51 external iliac dilata
tions was 71% and at 24 months
48% (Fig. 3). Where both the com
mon and external iliac arteries on the
same side were dilated (20 instances'),
the results were not very satisfactory
(Fig. 4).
Femoropopliteal Segment
In the femoropopliteal segment
there was a substantial difference be
tween the results obtained for dilating
stenoses and complete occlusions
(Figs. 5 and 6). The success rate for
dilatation of 50 femoropopliteal sten
oses was 60% at 12 months and 52%
at 24 months (Fig. 5). By comparison.
33 occluded femoropopliteal stenoses
were recanalized. The success rate at
12 and 24 months was only 17%
(Fig. 6).

Other Segments
Twenty-four peripheral arteries
were dilated. Six of seven aortic dila
tations were successful, but the re
sults of common femoral, deep femo
ral and tibial artery dilatations have
not been very satisfactory.
Morbidity and Mortality
Our complication rate has been
quite low. Although two patients died
of myocardial infarction within 1
week of the procedure, both had
severe coronary artery disease. Their
deaths were temporally related to the
dilatation but no other relationship to
the procedure could be established;
this reflects the fact that dilatations
were often carried out on patients
for whom vascular operations carried
a prohibitive risk. Small local hema
tomas at the puncture site were com
mon but usually resolved. Acute
ischemia, presumably related to
thrombosis at the site of the dilata
tion, occurred in two cases. In both
the ischemia was not severe and with
heparinization the patients returned
to predilatation status. Peripheral em
bolism was not a frequent or clinically
important complication. Perforation
of the vessel, rupture of the balloon
and other rare complications did not
occur in this series.
Comment

As documented by our objective
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data, transluminal dilatation is suc
cessful in selected patients. When
successful, the low morbidity and
mortality of the procedure, the short
hospital stay and the low cost are of
great advantage. In our hands, it now
has an important role in the manage
ment of certain patients with peri
pheral arterial occlusive disease.
This procedure may be of value in
three situations. First, in multilevel
disease, when the most important le
sion is in the femoropopliteal or
femorotibial artery segment, trans
luminal dilatation is a useful adjunct
to operation since it can be used to
correct a minor localized lesion and
improve the inflow before a distal
vascular reconstruction is carried out.
Second, transluminal dilatation may
be valuable in treating certain post
operative complications of saphenous
vein grafting, such as valve cusp
hyperplasia, intimal hyperplasia or
atherosclerosis. Third, transluminal
dilatation may be an alternative to
vascular reconstructive surgery in
some cases. The decision between
transluminal dilatation and operation
must be made by weighing several
factors including the patient’s gen
eral health and disability, and the
site, extent, severity and accessibility
of the arterial stenosis.
Our results show that the risks of
transluminal dilatation are low; how
ever, in experienced hands, the mor
bidity and mortality of standard vas
cular reconstructive procedures is also
quite low. Except for localized lesions,
in our experience, operation pro
duces better hemodynamic results and
is usually more durable than trans
luminal dilatation. Nevertheless, the
results of transluminal dilatation are
acceptable and the procedure has the
advantage that it can be repeated.

FIG. 2—Common iliac artery dilata
tions, including stenoses and occlusions
(n = 97).

FIG. 4— Common and external iliac
artery dilatation on same side at same
time (n = 20).

We acknowledge the financial support
of the Toronto General Hospital Foun
dation. the assistance of Mrs. Maureen
Rae and Mrs. S. Ungaro, the collabora
tion of the referring physicians and the
secretarial help of Mrs. Denise Reynolds.

FIG. 3—External iliac dilatations (n
= 51).

F’lG. 5—Results of dilatation in 33
femoropopliteal stenoses.

FIG. 6—Results of dilatation in 50
femoropopliteal occlusions.
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Protection of ischemic Myocardium:
the Roles of Nutrition and Myocardial Glycogen
C. W lTTNICH, DVM, R.C.J. CHIU, MD, PH D, FRCS[C], FACS AND A.H . M c ARDLE, PH D

The ischemic myocardium utilizes
glycogen as metabolic substrate. The
effects of oral nutrition on the levels
of glycogen in the myocardium and of
myocardial glycogen content on
myocardial tolerance to ischemia were
studied.
Rats were divided into groups and
fed (a) rat chow, (b) rat chow plus
5 % dextrose, and elemental diets
(c) Flexical (Mead Johnson) or
(d) Vital (Ross Laboratories). Another
group was starved. All fed groups
gained weight normally while the
starved rats lost 2 3 % of their body
weight. Compared with the effect
on rat chow, myocardial glycogen
levels were elevated in the Flexical
and starvation groups, while Vital
depressed the level (P < 0.01). Thus,
both caloric intake and diet affected
myocardial glycogen content. Elevation
of myocardial glycogen content after
starvation contrasted with glycogen
disappearance from the liver.
The level of myocardial glycogen
and left ventricular function after global
ischemia were correlated in dogs
under cardiopulmonary bypass
conditions. During 30 minutes of
normothermic aortic cross-clamping,
hearts with a preischemic myocardial
glycogen content greater than 0.4
g % had less asystole or ventricular
fibrillation. Their left ventricular
function (stroke work index, myocardial
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contractility) upon reperfusion was
substantially better than those with a
myocardial glycogen level of less
than 0.4 g % .
Dietary manipulation and the
nutritional status can thus affect the
myocardial glycogen content and may
be useful in protecting the myocardium
from ischemia.
Le glycogene est le substrat
metabolique du myocarde ischemique.
Les auteurs ont etudie les effets du
contenu myocardique en glycogene
sur la tolerance de cet organe a
I'ischemie.
Les rats furent divises en groupes
et nourris respectivement avec a) de
la moulee pour rats, b) de la moulee
pour rats avec glucose (5%), une
de deux dietes elementaires, c) Flexical
(Mead Johnson) ou d) Vital (Ross
Laboratories). Un autre groupe fut
soumis au jeune. Le gain ponderal
fut normal dans tous les groupes
dietetiques. Les rats malnourris
perdirent 2 3 % de leur poids
corporel. Compare aux rats nourris
a la moulee, le contenu myocardique
en glycogene etait augmente chez les
rats soum is au jeune ou nourris au
Flexical, tandis que le Vital diminuait
le contenu myocardique en glycogene
(P < 0.01). L'apport calorique ainsi
que le contenu dietetique affectent
done tous deux le niveau du glycogene
myocardique. L'elevation du glycogene
myocardique apres une periode de
jeune contraste avec sa disparition du
foie.
Nous avons constate une correlation
entre le contenu myocardique en
glycogene et la fonction ventriculaire
gauche apres ischemie globale chez
des chiens sous circulation extracorporelle. L'incidence d’asystolie et
de fibrillation ventriculaire durant une
periode de 30 minutes de clampage
aortique normothermique etait moindre
pour les coeurs ayant un contenu
myocardique en glycogene pre-

ischemique superieur a 0.4 g % . Leur
fonction ventriculaire gauche (exprimee
par I'indice d'ejection et la
contractilite myocardique) etait aussi
amelioree de fapon significative par
rapport aux coeurs ayant un contenu
myocardique en glycogene
pre-ischemique inferieur a 0.4%.
Les manipulations dietetiques et
I'etat nutritionnel peuvent done
affecter le contenu myocardique en
glycogene et pourraient etre employes
pour proteger le myocarde envers
I'ischemie.

The major energy reserve for the is
chemic myocardium is glycogen,
whose level can be correlated with
the ability of the cardiac muscle to
withstand anoxia and ischemia.1"9 The
synthesis, degradation and amount of
glycogen in the myocardium may be
affected by the nutritional status of
patients, and substrate utilization by
the myocardium may be altered. In
creasing myocardial tolerance to is
chemia may protect the heart from
global ischemia during cardiac surgery
and reduce infarct size during coro
nary occlusion. The effects of pre
operative nutritional supplementation
on myocardial glycogen levels and on
cardiac function during and after an
ischemic episode continue to be con
troversial. We decided to investigate
the effects of diet manipulation on
myocardial glycogen content and to
determine the extent to which existing
glycogen levels in the normal heart
may affect cardiac performance after
global ischemia.
Materials and Methods
Experiment l — Nutritional Studies
Male Sprague-Dawley rats, weigh
ing 200 to 250 g, were randomly al
located to four groups: those fed (a)
rat chow (RMH 1000; Agway Manu
facturers, Syracuse, NY) (26 rats), (b)
rat chow plus 5% dextrose (21), (c)
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Flexical (Mead Johnson Canada, Ot
tawa, Ont.) (21) and (d) Vital (Ross
Laboratories, Montreal, PQ) (21).
The composition of each diet is listed
in Table I. The diets were fed ad
libitum for 21 days. Another group
of 26 rats was submitted to proteincalorie malnutrition by starving for
7 days. Weight changes and the
daily caloric intake were recorded
for each group. The rats were individ
ually housed in wire cages under iden
tical conditions. After the feeding or
starving, the rats were killed by stun
ning and cervical dislocation. Samples
of liver and heart were taken imme
diately for biochemical analysis of
tissue glycogen and DNA. The sam
ples for glycogen were quick-frozen,
weighed and processed according to
the method of Good and associates.10
The method of Schneider" determined
DNA content. The data were analysed
using the unpaired, two-tailed r-test.
Experiment 2 —
Myocardial Performance
The correlation between myocardial
glycogen levels and cardiac perform
ance after global ischemia was studied
in 13 mongrel dogs of both sexes,
fed standard dog chow without
additional dietary manipulation. The
dogs were anesthetized with sodium
pentobarbital (30 mg/kg), intubated
and ventilated mechanically. After a
midline sternotomy and ligation of
the azygous vein, normothermic car
diopulmonary bypass was instituted,
using snared cannulas in the superior
and inferior venae cavae for venous
drainage and a femoral artery cannula
for oxygenated blood return.
Biopsy specimens of the right ven
tricular myocardium were taken to

determine glycogen content before
aortic cross-clamping and at the end
of bypass. To study myocardial func
tion, a Swan-Ganz catheter was in
troduced through the right jugular
vein and advanced to the pulmonary
artery; pulmonary artery and wedge
pressures were monitored. Cardiac
output was determined with an Ed
wards cardiac output computer and
thermodilution techniques. A left ven
tricular pressure line was attached to
a transducer and Grass polygraph with
an electronic differentiator to meas
ure myocardial contractility (dp/dt).
Electrocardiographic monitoring was
done throughout. From these data,
the stroke work index was derived
using the formula: stroke work index
= stroke work -t- surface area (m 2),
where stroke work = systolic pres
sure X cardiac output -r- heart rate.
After 30 minutes of normothermic
aortic cross-clamping, the myocar
dium was reperfused for 30 minutes
more and then the animal was taken
off cardiopulmonary bypass. The ac
tual indices of dp/dt, which reflect
myocardial contractility, and stroke
work index were recorded before and
after cardiopulmonary bypass. These
values were then expressed as per
centage recovery.

per gram wet weight of the myocar
dium, indicating atrophy of the myo
cytes.
The effects of various diets on tis
sue stores of glycogen are shown in
Figs. 1 and 2, where it can be seen
that the liver responded to additional
carbohydrate (dextrose) or fat (Flex
ical) by significantly (P < 0.001)
increasing its glycogen store. The
group fed Vital maintained liver gly
cogen levels comparable to those of
the control, chow-fed group. Myocar
dial glycogen did not demonstrate this
pattern. Additional carbohydrate in
the diet did not significantly influence
the concentration of myocardial gly
cogen as it did liver glycogen. The
two elemental diets, Vital and Flexi
cal, both altered myocardial glycogen
levels from control values in opposing
ways: Flexical raised the level 1.5
times (P < 0.01) and Vital lowered
it (P < 0.01).
The myocardial glycogen levels of
the starved group were elevated to
double the control values in contrast
to the liver glycogen which was near
ly totally depleted (Fig. 3).
Experiment 2
The correlation between myocardial
glycogen content before the ischemic
period and the myocardial perform-

Results

Experiment 1
The rats receiving the various diets
gained weight normally (1 to 3 g/d).
Table II shows the daily caloric in
take for the four groups. The starved
rats lost 23% of their original body
weight and there was a significant
(P < 0.01) increase in the DNA value

Table I—Diet Composition, g% Dry Product
Diet
Chow (RMH 1000)
Chow + dextrose (5%)
Flexical*
Vital*

Fat

Carbohydrate

Protein or
protein equivalent

6.30
6.30
14.90
4.11

57.40
62.40
66.96
70.25

14.50
14.50
10.10
15.80

FIG. 1—Liver glycogen content with
different diets; n = accepted standard
value. Flexical elevated and Vital low
ered glycogen level (P < 0.001).

'Flexical and Vital are elemental diets with protein in hydrolyzed form.

Table II--Range of Daily Dietary Intake*
Diet
Chow
Chow + dextrose
Flexical
Vital

Cal/d

Fat, g

Carbohydrate, g

Protein, g

Total intake, g

59.1-87.2
68.3-97.2
60.0 80.0
7 9 .6 - 89.3

1.1—1.6
1.1—1.6
2.0-2.7
0.8-0.9

9 .8 -1 4 .9
12.5-17.9
9 .0-12 .0
14.8-16.6

2.5—3.8
2.5—3.8
1.4-1.9
3.3—3.7

17.0-26.0
19.7-29.0
12.0-16.0
18.8-21.2

*Rats require 6 0 - 90 Cal/d.

FIG. 2— Myocardial glycogen con
tent with different diets. Differences be
tween Flexical and Vital are significant
(P < 0.001).
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ance during 30 minutes of normothermic aortic cross-clamping in dogs was
evident when the results were grouped
according to the preischemic myo
cardial glycogen levels, greater than
or less than 0.4 g% (Figs. 4 and 5).
Hearts having higher myocardial gly
cogen levels before ischemia con
tinued to beat during aortic cross
clamping, with an electrocardiograph
ic pattern near normal. Those with
lower levels had a higher incidence
of anoxic arrest or ventricular fibril
lation during the 30-minute normothermic period of aortic clamping. Of
the 13 dogs studied, 10 had reliable
complete hemodynamic
measure
ments. Of these, hearts with the high
er myocardial glycogen levels also
had significantly (P < 0.05) better
recovery of cardiac function after
bypass, with a higher percentage re
covery of both stroke work and myo
cardial contractility. Thus, at least in
normal hearts, those with higher gly
cogen levels before ischemia were
better able to tolerate the global
ischemia.
D iscussion

The myocardium utilizes 60%
fatty acids, 28% glucose, 11% lac
tate as well as ketones, if necessary,
to produce energy under normal cir
cumstances.12 This pattern of sub
strate utilization has been questioned
by a number of authors13"20 whose
work clearly indicates that, even in
normal hearts, substrate utilization by
the myocardium depends on a variety
of factors including substrate avail
ability, hormones and intrinsic regu
latory enzymes.
Anaerobic glycolysis occurs under
conditions of myocardial ischemia, re
sulting in near-total reliance on avail
able glucose and glycogen stores to
supply the energy demands of the
heart.21'24 The rate of glycolysis cor
relates well with the initial glycogen

concentration. High levels of glycogen
favour increased glycogenolysis dur
ing anaerobic metabolism. It has been
frequently reported1"9 that hearts with
a higher myocardial glycogen content
show better tolerance to ischemia and
hypoxia. Thus, increasing the heart’s
store of glycogen through nutritional
manipulation would be useful in myo
cardial protection.
Very little data exist on clinically
feasible methods of dietary prepara
tion of the heart other than by intra
venous hyperalimentation or glucoseinsulin-potassium administration and
even less data are available on the
effects of such measures on myocar
dial glycogen content.25'30 If, indeed,
myocardial glycogen acts as an energy
reserve during ischemic and anoxic
periods,1’2,4,6 a safe oral dietary regi
men that increases myocardial stores
of glycogen should increase the toler
ance of the heart to both global and
regional ischemia.
The results of this study indicate
that dietary manipulation of myocar
dial glycogen is possible. Nutritional
management for 16 to 21 days was
chosen because this interval had been
reported31 to provide optimal nutri
tional support leading to clinically sig
nificant changes in body composition
and cardiac function and appropriate
metabolic responses to injury.
The rat studies utilized currently
available hospital elemental diets. The
two elemental diets tested, Flexical
and Vital, provide equal calories per
millilitre of oral intake. Only the
source of these calories from carbo
hydrate or fat differs; Flexical is high
er in fat (free fatty acids, medium
chain triglycerides) and Vital has less
fat and more carbohydrate to provide
the needed calories. The fat content
of rat chow (RMH 1000) is mostly
animal fat, which must be broken

down by the gastrointestinal tract be
fore absorption. Once absorbed into
the blood stream only relative con
centrations matter. At present, pair
feeding studies are being carried out
to explore the significance of these
observations.
It is known that starvation increases
the myocardial levels of glycogen.32’33
The increase we found in the starved
rats cannot be accounted for by myo
cardial atrophy alone, since the gly
cogen to DNA ratio, which reflects
glycogen content per cell, was also
elevated in these animals. Starvation
not only causes insulin resistance,34
thereby decreasing glucose transport
across cell membranes, but also elev
ates free fatty acid and ketone con
centrations in the blood.35-36 These are
the principal substrates for the non
ischemic myocardium. Lipolysis in the
cardiac cell then inhibits glycolysis
and glycogenolysis.37 The normally
labile fraction of cardiac glycogen is
then no longer used and the glycogen
pool increases.38,39 Additional glucose
available would be shunted to glyconeogenesis. Lackey and colleagues40
discussed the close relation between
myocardial glycogen levels and the
amount of ketone bodies present.
Shipp and associates35 showed, by car
bon-14 labelling, that glucose rather
than fatty acids was the source of
glycogen when both were given to a
normal heart and that optimal glyco
gen deposits were obtained when the
myocardium was supplemented by
both glucose and fatty acids together.35
It appears therefore that through
specific composition of diets, such as

Myocardial Glycogen ( g% )
-t

r----------------A

> 0.4 < 0.4

FIG. 3—Myocardial glycogen was
significantly (P < 0.01) elevated and
liver glycogen depleted in starved rats
compared with those fed chow.
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Spontaneous
Contractions

8

1

Asystolic or
V-fib

0

4

FIG. 4— Cardiac responses during 30
minutes of normothermic aortic crossclamping. Spontaneous contractions =
synchronized mechanical contraction of
left ventricle with corresponding QRS
complex. Cardiac standstill and ventri
cular fibrillation (V-fib) were confirmed
by electrocardiogram.

FIG. 5— Cardiac
function
(stroke
work index, myocardial contractility) 30
minutes after cessation of cardiopulmo
nary bypass (30 minutes normothermic
aortic cross-clamping and 30 minutes
reperfusion). Hearts with higher myo
cardial glycogen (> 0 .4 g%, hatched
bars) had significantly (P < 0.001) bet
ter functional recovery than those with
< 0 .4 g% myocardial glycogen (white
bars). Standard error of mean represents
variations within each group.
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fat and carbohydrate together, which
may play synergistic roles, one should
be able to affect the glycogen con
tent in the myocardium.
The data illustrate the different pat
tern in the response of the heart ver
sus the liver to nutrition, perhaps re
flecting the homeostasis and protec
tive action of the body towards con
serving the heart. It also gives an
indication of the strong drive for the
heart’s reliance on free fatty acids,
which are increased in starvation, as
the fuel source, forcing glycogen to
remain in storage.
Previous reports using isolated
heart-muscle preparations have shown
that higher glycogen stores resulted
in improved hemodynamic function
during ischemia and anoxia. We de
cided to use the in-vivo normothermic
cardiopulmonary and aortic crossclamped heart as a model without
the intervention of the protective ef
fects of chemical cardioplegia and
hypothermia. This was done to elim
inate other factors and to maximize
the metabolic consequences of myo
cardial ischemia. The canine model
was chosen to study myocardial per
formance because this species could
be subjected to cardiopulmonary by
pass and global ischemia in the form
of aortic cross-clamping, thus simulat
ing conditions encountered in cardiac
surgery.
Diet was not manipulated in the
canine study and all dogs had normal
hearts preoperatively. Significant (P
< 0.001, y2 test) association could be
established between a myocardial gly
cogen level greater than 0.4 g% and
better left ventricular function during
aortic cross-clamping as well as the
recovery of myocardial contractility
and stroke work index after the ische
mic period. There was no significant
correlation between myocardial tissue
lactate, blood lactate or glucose values
and myocardial performance.
A nutritional preparation that
would optimally raise myocardial gly
cogen, shown now to improve cardiac
tolerance to ischemia, is indeed feas
ible. Such a preparation, if successful,
could be a useful clinical adjunct in
preparing patients for cardiac surgery,
as well as for those suffering from
unstable angina with risk of imminent
myocardial infarction.
Conclusions

This study, although preliminary,
revealed that: (a) caloric malnutrition
in the form of starvation increased
myocardial glycogen levels, (b) with
adequate caloric intake the composi
tion of the diet is important in af

fecting the myocardial glycogen
stores, (c) different dietary regimens
alter both hepatic and cardiac glyco
gen independently of one another,
(d) hearts with higher myocardial gly
cogen levels are better able to tolerate
an episode of global ischemia, (e) the
optimal composition of a dietary regi
men that would maximally increase
myocardial energy stores and also
provide adequate total body nutrition
is unknown and requires further in
vestigation.
We are indebted to Mr. Roger Sam
son, CP, Ms. Daniele Richer and Ms.
Mimi Winsberg for technical assistance.
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Continuous Monitoring of Mixed Venous Oxygen
Saturation in Cardiac Surgery
W.R.E. Ja m ie s o n , m d , f a c s , frcs [ c ], K .W . T u r n b u l l , m d , f r c p [ c ], A .J. L a r r ie u ,
W.A. D odds , m d , f r c p [c ], J.C. A l l is o n , m d , f r c p [ c ] and G.F.O. T y e r s , m d , fa c s ,

Serial measurement of mixed venous
oxygen saturation is useful in the care
of critically ill patients. It is an
index of cardiac output and overall
tissue perfusion. Previously, lack of
refinement of the technology for
continuous monitoring of mixed
venous oxygen saturation deterred
its clinical application. The authors
evaluated the Oximetrix Shaw™
catheter oximeter system between May
1980 and April 1981 in 84 high-risk and
moderately high-risk patients. Fifty-four
had undergone only myocardial
revascularization while 30 had
undergone valvular or combined
procedures. In 20 patients with
compromised left ventricular function
(mean ejection fraction of less than
40°/o) continuous mixed venous oxygen
saturation was compared to
hemodynamic parameters in an
intraoperative and early postoperative
study. The results indicated that
satisfactory mixed venous oxygen
saturation (more than 65% ) correlated
with normal hemodynamic measure
ments including cardiac output
and cardiac index. In general, a fall
in mixed venous oxygen saturation
of more than 10% was noted before the
mean blood pressure, heart rate or
pulmonary capillary wedge pressure
changed. Cardiac output, cardiac index,
systemic vascular resistance and
left ventricular stroke work index
w ere found to change in association
with a change in mixed venous oxygen
saturation. A fall (mixed venous
oxygen saturation less than 65%)
can be related to: (a) abnormal
hemodynamic status — reduced cardiac
output, hypotension, elevated
systemic vascular resistance and
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arrhythmias, (b) abnormal oxygen
demand — shivering, suctioning,
positioning and pyrexia and (c)
abnormal oxygen supply — anemia,
airway obstruction and altered
diffusion of oxygen at the alveolar
capillary membrane. The Oximetrix
system proved reliable. Mixed
venous oxygen saturation is a
nonspecific indicator of hemodynamic
status. Continuous monitoring of
the mixed venous oxygen saturation
facilitates optimal patient manage
ment by immediately alerting intensive
care personnel to the development
of inadequate tissue perfusion.

Les mesures seriees de la saturation
en oxygene du sang veineux mele
contribuent utilement aux soins donnes
aux patients gravement malades.
Ceci constitue un index du debit
cardiaque et de I'irrigation sanguine
globale des tissus. Prealablement,
le manque de raffinement de la
technologie pour la surveillance
continue de la saturation en oxygene
du sang veineux mele differait de
■'application en clinique. De mai 1980
a avril 1981, les auteurs ont evalue
I'oxymetre Oximetrix Shaw™ chez
84 patients a risque eleve ou
moderement eleve. Cinquante-quatre
avaient subi une revascularisation
myocardique uniquement, alors que les
30 autres avaient eu une intervention
valvulaire ou une operation mixte.
Chez 20 patients qui presentaient une
fonction ventriculaire gauche alteree
(avec une fraction d'ejection moyenne
de moins de 40% ), la mesure continue
de la saturation en oxygene du sang
veineux mele a ete comparee aux
parametres hemodynamiques dans
une etude couvrant la periode
peroperatoire et postoperatoire
precoce. Les resultats indiquent qu'une
saturation en oxygene du sang veineux
mele satisfaisante (de plus de 65%)
montre une bonne correlation avec
des mesures hemodynamiques
normales, dont le debit cardiaque et
I’index cardiaque. En general, une chute
de la saturation en oxygene du sang
veineux mele de plus de 10% a ete
notee avant qu'il n'y ait de changement
de la tension arterielle moyenne,
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de la frequence cardiaque et de la
pression capillaire pulmonaire. On
a observe qu'il y avait changement
dans le debit cardiaque, I'index
cardiaque, la resistance vasculaire
generate et I’index du travail
ventriculaire gauche relie avec le
changement de la saturation en
oxygene du sang veineux mele. Une
chute (une saturation en oxygene
de moins de 65% ) peut etre reliee a:
a) un etat hemodynamique anormal —
diminution du debit cardiaque,
hypotension, augmentation de la
resistance vasculaire generate et
arythmie, b) une demande anormale
en oxygene — frissons, aspiration,
mise en position ou pyrexie et c)
un apport d'oxygene anormal —
anemie, obstruction des voies
respiratoires et alteration de la
diffusion de I’oxygene au niveau de
la membrane capillaire alveolaire.
Ce systeme d'oxymetrie s'est avere
fiable. La saturation en oxygene
du sang veineux mele est un
indicateur non specifique de I’etat
hemodynamique. Sa surveillance
continue permet un traitement optimum
du malade en informant le personnel
des soins intensifs prestement
du developpement d'une perfusion
inadequate des tissus.

T h e usefulness o f serial measurements
o f m ixed venous o x yg e n saturation
(S v o 2) in the care o f critica lly ill pa
tients has been docum ented by m any
investigators.1'18 Betw een 1959 and
1970, reports addressed the relation
o f S v o 2 to cardiac output.13,16'17'19,50 In
1973 M artin and associates4 reported
on the d evelo p m en t o f a tw o-elem ent
fib erop tic
catheter
that
measured
S v o2,
b u t'
m easurem ents
w ere
often inaccurate because on ly tw o
wavelengths o f light w e re used. T h e y
showed that S v o 2 was a useful co rre 
late o f cardiac output and overall tis
sue perfusion. T h e developm en t o f a
new fib erop tic catheter oxim eter (O x i
m etrix S h aw ™ catheter oxim eter sys
tem; O xim etrix, Inc., M oun tain V ie w .
C a lif.) has allo w ed accurate continu
ous m on itorin g o f S v o 2 in the pul
m onary artery o f patients w h o un
d ergo cardiac surgery.
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Technique for Continuous
Measurement of Svo2

Patients and Methods

Between May 1980 and April 1981.
The Shaw™ catheter oximeter sys continuous measurement of Svo2 was
tem consists of a signal processor, a carried out in 84 patients (69 men, 15
coded optical module and a fiber women) ranging in age from 40 to 76
optic catheter. The oximeter system years (mean 57.9 years). Fifty-four
is a spectrophotometric instrument patients underwent only myocardial
that uses the standard technique for revascularization while 30 had valv
measurement of blood oxygen satura ular or combined procedures. The
tion. The fiberoptic catheter we used surgical procedures included coronary
was of 7.5-F diameter, containing two artery bypass (54), coronary artery
plastic fiberoptic light guides and was bypass with resection of a left ventri
a balloon-tipped, flow-directed, ther cular aneurysm (9), coronary artery
modilution, pulmonary artery cath bypass with valve replacement (7),
eter. It can be inserted percutaneous- single valve replacement (9), double
ly in a peripheral vein. The optical valve replacement (3) and valve re
module contains three light-emitting placement with ascending aortic aneu
diodes, providing the source for three rysmectomy (2). The average number
wavelengths of red and near-infrared of grafts placed per patient was 3.3.
light (range 600 to 1000 /xm). Each The patients selected for evaluation
wavelength of light is pulsed in se of the Svo2 had severe coronary ar
quence at 244 cycles per second tery disease with obstruction of the
through a single optical fibre within left main artery, congestive heart fail
the catheter to illuminate the blood ure, inadequate contractility or un
flowing past the catheter tip. The light stable angina, or both, or severe insuf
reflected by the blood is transmitted ficiency of the aortic and mitral valves
along the second optical fibre to a or mitral stenosis with pulmonary hy
photodetector in the optical module. pertension.
Repeated hemodynamic assess
These light signals are then converted
to electrical signals that are amplified ments were performed in conjunction
and transmitted to the processor. The with Svo2 monitoring in 20 of the 84
processor then samples these signals patients. The mean age of this sub
and from the intensities of the three group of patients was 59.7 years.
wavelengths of reflected light, com The majority had atherosclerotic
putes and displays the average mixed heart disease with compromised left
venous oxygen saturation for the pre ventricular function but normal cere
ceding 5 seconds. This average is up bral and renal function. The mean
dated every second and is displayed preoperative ejection fraction was
in the digital readout on the processor 39.7 ± 0.2% (standard deviation) and
display panel and recorded on a self- the left ventricular end-diastolic pres
contained, two-speed strip chart re sure was 21.2 ± 9.1 mm Hg. Most
of these patients were taking nitrates
corder.
and ^-blocking agents. The patients
Audible and visible alarms are trig were premedicated with triazolam or
gered when oxygen saturation is out diazepam and morphine, 10 mg intra
side either the low or high limits that muscularly 60 to 90 minutes before
can be selected by the operator. The operation. The technique for anesthe
system also has an “artefact condition” sia consisted of induction with diaze
alarm that is triggered when the in pam (10 to 15 mg intravenously), thio
tensity or character of the reflected pentone (50 to 150 mg intravenously),
light differs from that expected from succinylcholine (100 mg) or pancuro
flowing blood. This may occur during nium bromide (0.1 mg/kg), oxygen
insertion or when the catheter tip and gentle intubation. Anesthesia was
impinges on a vessel wall or is par maintained with morphine (45 mg) in
an intravenous drip, nitrous oxidetially obstructed by debris.
oxygen inhalation, pancuronium bro
Before insertion, calibration of the mide and intermittent administration
system requires correction of the fi- of halothane. Fentanyl citrate in
beroptics to the optical module and incremental doses (to a total of 10
positioning of the tip against a refer mg/kg) was added after cardiopul
ence surface within the tray. The sys monary bypass was instituted. Ventila
tem is electronically calibrated within tion was controlled (Paco2 30 to 40
30 seconds. The system can also be mm Hg) and no muscle relaxant re
calibrated in vivo by independently versal was used at the end of the
measuring the Svo2 from the pulmo procedure.
nary artery blood sample and then
Myocardial protection was provided
correcting the reading on the micro by using systemic hypothermia (30°C),
processor.
multidose hypothermic potassium (25

meq/1) crystalloid cardioplegia arid
topical hypothermia with cold crystal
loid solution. Myocardial temperature
was maintained between 10° and
20°C.
The study was designed to compare
hemodynamic parameters with Svo2
values at predetermined periods: (a)
before induction of anesthesia, (b) 15
minutes after induction of anesthesia,
(c) after the sternotomy, (d) 15 min
utes and (e) 30 minutes after cardio
pulmonary bypass and (f) 15 minutes
after admission to the recovery room
or intensive care unit. Additional eva
luations were made when important
changes in Svo2 (more than 10%)
were noted during the postoperative
period. At each designated period.
Svo2 arterial blood gases, blood pres
sure, right atrial pressure, pulmonary
capillary wedge pressure and tempera
ture were recorded. Thermodilution
cardiac outputs were measured and
cardiac index, systemic vascular re
sistance, pulmonary vascular resist
ance and rate pressure product were
calculated. Observations were made
postoperatively to assess the effects of
chest physiotherapy, positioning, en
dotracheal tube suctioning and post
operative shivering.
Statistical evaluations were made
using shared variance, multiple corre
lation, Student’s /-test and trend anal
ysis.
Results

The mean cardiopulmonary bypass
time for the 20 patients in the sub
group who underwent comparative
analysis was 151.3 ± 58.1 min
utes. Tables I and II give the data
obtained during the sample periods.
Heart rate was increased (P < 0.05)
after cardiopulmonary bypass. Mean
blood pressure and pulmonary capil
lary wedge pressure decreased after
sternotomy (P < 0.05). Cardiac
index did not change significant
ly throughout. Systemic vascular
resistance and left ventricular stroke
work index increased significantly (P
< 0.05) after sternotomy but re
turned to postinduction values after
the end of bypass with the exception
of left ventricular stroke work index
which was increased in the recovery
room (P < 0.05). The rate pressure
products increased significantly (P <
0.05) after sternotomy and after by
pass.
Intraoperative and postoperative in
terventions were required to maintain
satisfactory tissue perfusion in many
instances. The need for inotropic
agents or vasopressors and vaso
dilators was often first indicated
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by a decrease in Svo2. In the post
sternotomy period, one patient re
ceived inotropic agents and four re
ceived vasodilators and at the 15minute period after cardiopulmonary
bypass five patients received inotropic
agents and one received vasodilators.
At the 30-minute period after cardio
pulmonary bypass, 9 patients were
receiving inotropic agents or vaso
pressors and 1 was receiving vaso
dilators, while in the recovery room
11 and 13 were receiving these drugs
respectively.
At the designated observation pe
riods there was no significant dif
ference in cardiac index or SvOi>. In
terpretation of therapeutic needs based
on mixed venous oxygen saturations
correlated well with hemodynamic
measurements including cardiac out
put and cardiac index. There were
high shared variances (R2 > 0.9) and
even higher nonselective multiple cor
relations (R > 0.95) between the mul
tiple variables.
The hemodynamic profiles for the
various observation periods are shown
in Fig. 1. In the total group of 84
patients, changes in Svo2 of more
than 10% were often found to pre
cede changes in hemodynamic status
during the postoperative recovery pe
riod. A fall in Svo2 was noted before

the mean blood pressure, heart rate
or pulmonary capillary wedge pres
sure changed. Cardiac output, sys
temic vascular resistance, cardiac in
dex and left ventricular stroke work
index were found to have deteriorated
after any persistent downward trend
in Svo2. When the Svo2 was noted
to be falling, evaluation of hemo
dynamic parameters was neces
sary to determine whether (a) preload
(central venous pressure, pulmonary
capillary wedge pressure and left
atrial pressure) was inappropriate, (b)
afterload (systemic and pulmonary
vascular resistance) was elevated or (c)
myocardial contractility (left ventri
cular stroke work index) was altered.
The Svo2 value was also helpful in
delineating otherwise unsuspected car
diac tamponade. Typically, cardiac
tamponade was characterized by
elevated filling pressures, reduced car
diac output, elevated systemic vascular
resistance and falling Svo2. However,
distinct pressure abnormalities were
lacking in three patients thought to
have low cardiac output with elevated
afterload. Vasodilators caused the
Svo2 to plummet in these patients, in
contrast to their beneficial effect in
patients with reduced myocardial
function without tamponade. Inotropic
agents and volume were only of

modest benefit and typically, the Svo2
continued to fall until the cardiac tam
ponade was surgically relieved. In
other cases where altered myocardial
contractility or inappropriate preload
were delineated as the cause of the

FIG. 1— Hemodynamic profiles for
various observation periods. 1 = prein
duction (Svo2, 85.3 ± 3.1%), 2 = post
induction (Svo2, 74.0 ± 1.6%), 3 "
poststernotomy (Svo2, 73.7 ± 1.7%),
4 = 15 minutes postbypass (Svo2, 74.0
± 1.48%), 5 = 30 minutes postbypass
(Svo2, 70.6 ± 1.41%), 6 = recovery
room (Svo2, 71.6 ± 1.1%).

T a b le 1--C a rd io va scu la r R e sp o n se s and M ix e d V e n o u s O x y g e n Saturations, M ean (SD)
P o stb yp a ss, m in
M ea su rem e nt

Preinduction

Postinduction

P o s ts te m o to m y

15

30

H e a rt rate, beats/min
M e a n blood pressure,
m m Hg
P u lm o n a ry capillary
w e d g e pressure,
m m Hg
M ix e d ve no us o x y g e n
saturation, %

75.5 (16.0)

65.8 (14.9)

70.5 (15.7)

89.3 (19.7)*

85.7 (14.0)*

86.8 (18.5)*

86.3 (11.3)*

68.3 (11.0)

97.3 (20.7)*

84.3 (13.5)*

81.4 (12.2)*

100.0 (18.0)*

18.7 (5.9)*

12.7 (6.0)

18.3 (6.0)*

18.2 (5.9)*

18.6 (6.4)*

15.2 (5.1)

85.3 (7.6)*

74.0 (7.1)

73.7 (7.8)

74.0 (6.6)

70.6 (6.3)

71.6 (5.1)

R e c o ve ry roo m

* P < 0.05, Student's f-te st (com pared w it h postinduction values).

Ta b le I I - C ardiovascular Indices and M ix e d V e n o u s S aturations, M ean (SD)
Posttaypass, m in
M ea su rem e nt
C ardiac output, llm in
C ardiac index,
l/min ■m 2
S ys te m ic vascular
resistance, d yn e
s e c cm '5
L e ft ventricular stro k e
w o r k index,
g m -m lm 2 - beat
R a te pressure product,
m m Hglbeat - m in
M ix e d venous o x y g e n
saturation, %

Preinduction

Postinduction

P o stste rn o to m y

15

30

R e c o ve ry roo m

4.37 (1.59)

4.40 (1.66)

4.02 (0.87)

5.26 (0.56)

3.38 (1.13)

3.23 (0.91)

2.73 (0.53)

1.77 (0.54)

1.67 (0.35)

2.32 (0.93)

2.32 (0.91)

2.13 (0.56)

1238 (108)

1617 (526)

2334 (598)*

1448 (561)

1399 (521)

1752 (459)

34.0 (10.9)

21.0 (10.9)

28.5 (12.2)*

23.5 (9.1)

23.8 (10.8)

30.2 (10.6)*

8568 (463)

6599 (155)

9443 (267)*

10367 (339)*

9607 (181)*

12 302 (392)*

85.3 (7.6)*

74.0 (7.1)

73.7 (7.8)

74.0 (6.6)

70.6 (6.3)

71.6 (5.1)

* P < 0.05, Student's f-te st (com pared w it h postinduction values).
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falling Svo2, appropriate management
corrected the Svo2 (Figs. 2 and 3).
Continuous monitoring of the Svo2
showed the effect of several nursing
maneuvers, such as chest physiother
apy (Fig. 4), endotracheal suctioning
and turning the patient (Fig. 5). A
profound decrease in Svo2 with shiv
ering (extensive increase in metabolic

demands for oxygen) is illustrated in
Fig. 6.
The hospital mortality for the 84
patients was 4.8% (4 patients). Three
died of low output syndrome, one of
chronic renal failure following double
valve replacement and aortocoronary
bypass, the other died of systemic
candidiasis following resection of a
recurrent left ventricular false aneu
rysm for endocarditis. In this group
of high- and moderately high-risk pa
tients the intra-aortic balloon pump
was used in five patients with four
survivors. The three patients who died
of low output syndrome were not sup
ported by the intra-aortic balloon
pump because of peripheral vascular
disease or surgeon’s preference.
The Oximetrix catheter was re
liable and relatively easy to insert and
to position. The development of
serious arrhythmias during the place
ment was usually not a problem.
Discussion

The role of serial measurements
of mixed venous oxygen saturation
(Svo2) has been extensively docu
mented as an indicator of cardiac out
put and tissue perfusion.1"18 The ade
quacy of oxygen supply to the tissues

FIG. 2— Improvement in Svo2 value
with institution of dopamine (arrow).

FIG. 3—Improvement in Svo, with
infusion of plasma.
FIG. 5—Decreases in Svo2 with oral
tracheal tube suctioning and positioning
of patient (arrows).
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is reflected by the tissue oxygen ten
sion that is maintained.15 This can be
closely monitored by measuring the
mean venous oxygen tension of blood
returning from the tissues; the tension
varies greatly because of individual
organ demands. The mean venous
oxygen tension is reflected by the
Svo2 of blood in the pulmonary artery
following admixture in the right ven
tricle.
The Fick formula for calculating
cardiac output delineates the relation
of cardiac output to mixed venous oxy
gen saturation: cardiac output =
oxygen consumption -F arteriovenous
oxygen difference. The arteriovenous
oxygen difference indicates the extent
to which cardiac output matches tis
sue metabolism requirements. It is
obtained by subtracting the venous
oxygen content (hemoglobin level X
venous saturation) from arterial oxy
gen content (hemoglobin level X ar
terial saturation). Thus cardiac out
put = oxygen concentration -f hemo
globin X arterial saturation - hemo
globin x venous saturation. It be
comes clear that the Svo2 varies direct
ly with cardiac output when arterial
oxygen content, hemoglobin and oxy
gen consumption by the tissues re
main constant. For example, if cardiac
output falls, the ratio between oxygen
consumption and cardiac output will
rise and the Svo2 value will fall.
As indicated previously, this close
and definite correlation between
Svo2 and cardiac output has been
clinically established by numerous in
vestigators. From 1959 to 1970, five
reports documented the preliminary
investigation of Svo2 as a useful clin
ical parameter.13-1617'19'20 Boyd and as
sociates,13 in 1959, reported that the
measurement of oxygen saturation in
mixed venous blood from the pul
monary artery was the single most
helpful measurement in evaluating the
status of the postcardiotomy patient.
In their group of postoperative pa
tients, an Svo2 value above 60% sep
arated those with adequate from those
with inadequate cardiac output. Mc
Arthur and associates20 found similar
results in their group of patients who
underwent open-heart procedures and
further categorized their observations:
an Svo2 of 60% to 70% indicated
circulatory competence, 50% to 60%
reduced myocardial efficiency and
40% to 50% circulatory failure.
Scheinman and associates,16 and Muir
and associates17 found similar results
in groups of medical patients, with
the lowest mean Svo2 found in pa
tients with left ventricular failure and
cardiogenic shock.
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The pioneering work of these in
vestigators was widely recognized.
However, the disadvantage of fre
quent and intermittent determinations
on single blood samples requiring ma
terials and personnel precluded its
widespread use in the critical care
setting.
The availability of fiberoptics has
permitted the development of cath
eter oximeters based upon the prin
ciples of spectrophotometry — as the
oxygen content of the erythrocytes de
creases, there is a progressive change
in their colour from scarlet to purple.
If light of different wavelengths illu
minates the blood, the amount of
reflected or backscattered light, at
each wavelength, is dependent upon
the colour and, therefore, the oxygen
level of the blood. Since approximate
ly 98% of the oxygen in the blood
is chemically combined with hemo
globin in erythrocytes, the absorption
of red and infrared light is substan
tially different for oxygenated and
deoxygenated hemoglobin and varies
for different wavelengths of light
within this red/infrared spectrum. The
relative amounts of oxygenated and
deoxygenated hemoglobin can then be
calculated by measuring the relative

absorption of light at selected wave
lengths.
In 1973 Martin and associates4 de
veloped a two-element fiberoptic cath
eter. They reported a correlation co
efficient of 0.985 between an in-vivo
oximeter and a laboratory determined
oxygen saturation. They indicated that
a mean venous oxygen saturation of
60% is probably within the acceptable
range and they suggested treatment
designed to improve cardiac output if
the mean venous oxygen saturation
falls to 40% or less. The development
of the three-element fiberoptic cath
eter (Oximetrix Shaw™ catheter oxi
meter system) has facilitated the
clinical application of Svo2 and elim
inated the inaccurate measurements
that often occurred with the twoelement catheter.
Before 1980 the clinical application
of the Svo2 value was primarily in
infants.5’21'24 Parr and associates21 in
1975 reported that mortality follow
ing cardiac surgery in infants is more
reliably predicted using cardiac index
and Svo2 together than either meas
urement alone. They stated that in
terventions were necessary if the car
diac index fell below 2.0 l/min«m2 or
the Svo2 was below 30 mm Hg. In
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1978 de la Rocha and associates,5 in
assessing the status of 11 children fol
lowing cardiac surgery, found that
the Svo2 was a useful guide in estim
ating cardiac index. They believed
that if the metabolic rate, pulmonary
gas exchange and hemoglobin level are
unaltered, the Svo2 will vary directly
with cardiac output. Wilkinson and
associates23'24 reported in 1978 and
1979 that umbilical artery oximeter
evaluation of oxygen saturation of
85% to 95% indicated a stable state
in the management of infants with
respiratory distress syndrome and
avoided frequent blood sampling for
arterial blood gases.
Krauss and associates,9 in 1975, re
ported in 19 adult patients a correla
tion of 0.78 between the cardiac index
and the continuous measurement of
Svo2. They concluded that Svo2 was
a reliable indicator of cardiac output
and that its determination could re
duce the frequency with which the
cardiac output needs to be measured.
A similar relationship between cardiac
index and Svo, has been reported
by others.1’5'12’25’20 Kazarian and Del
Guercio,12 reporting in 1980 on 10 se
riously injured patients, found that
Svo2 is a function of cardiac output,
intravascular volume and peripheral
resistance, correlating oxygen deliv
ered to the cell and oxygen con
sumed by the cell. This report showed
that an Svo2 of 70% represented pro
vision of total tissue requirements.
In 1981 two reports indicated the
reliability of the Oximetrix System
used in our study.10,11 Beale and asso
ciates10 reported that regression anal
ysis of paired in vivo and in vitro
Svo2 measurements revealed no loss
of accuracy with time or changes in
body temperature, hemoglobin level
and cardiac output. They noted that
a decline in Svo2 preceded deteriora
tion in the clinical state of the patient.
In the same year, Waller and asso
ciates11 showed that if oxygen content
and total body oxygen consumption
were maintained, Svo2 reflected car
diac output. A 5% change in Svo2
correlated with a change in cardiac
output as indicated by cardiac index
and left ventricular stroke work index.
Mixed venous oxygen saturation is
a nonspecific indicator of the ade
quacy of cardiac output and tissue
perfusion. Another nonspecific indi
cator of adequate circulation, the peri
pheral or “toe temperature,”2’27 is
particularly reliable in infants and a
temperature falling below 35°C repre
sents inadequate cardiac output and
tissue perfusion. The peripheral tem
perature is inadequate for “beat-to-
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beat” assessment, while the Svo2 is an
appropriate assessment of current cir
culatory status. Hemodynamic track
ing, as advocated by Barash,28 Ross
and Braunwald29 and Lappas and as
sociates,30 must be instituted when the
Svo-> starts to fall so that the cause
can be determined and appropriate
management begun.
The normal range of Svo2 is 65%
to 80%, which indicates normal he
modynamic status and normal oxygen
supply and demand. A falling Svo2
of 55% to 65% may be related to
(a) abnormal hemodynamics with re
duced cardiac output, hypotension,
elevated systemic vascular resistance
and arrhythmias; (b) abnormal oxy
gen demand associated with shivering,
suctioning, pyrexia and positioning
and (c) abnormal oxygen supply due
to anemia, airway obstruction and re
duced pulmonary venous oxygen sat
uration. A rising Svo2 of 85% to
95% may indicate abnormal hemo
dynamics, such as elevated cardiac
output or systemic vascular resistance,
but it can indicate catheter wedging
or migration.
Conclusions

The mixed venous oxygen satura
tion has no fixed relation to any vari
able of myocardial function. It rep
resents the hemodynamic status of the
patient and each hemodynamic vari
able must be assessed if there are
changes of more than 10% in the
Svo2 value. Mixed venous oxygen sat
uration facilitates optimal patient
management by identifying early ma
nifestations of inadequate tissue per
fusion.
The statistical analyses of Dr. Todd
Rogers and Mr. Ray Tomasiuk are grate
fully acknowledged. Our appreciation is
extended to Ms. Gayle Henderson for
preparation of the manuscript.

References
1. A rmstrong RF, S t . A ndrew D, Cohen SL,
Secker W alker J, Cobbe SM, L incoln
JC R : C ontinuous m onitoring of mixed
venous oxygen tension ( p vO$) in cardio
respiratory disorders. Lancet 1978; 1 : 632-4
2. P rakash O, M eij SH. van der B orden
SG. C lementi G , M ak J : C ardiovascular
m onitoring w ith special emphasis on mixed
venous oxygen m easurem ents. Acta Anaesthesiol Belg 1978; 29: 253-8
3. M ithoefer JC , R amirez C, C ook W : The
effect o f mixed venous oxygenation on
arterial blood in chronic obstructive pul
m onary disease: the basis for a classifica
tion. A m R ev R espir Dis 1978; 117: 259-64
4. M artin W E, C heung PW . Johnson CC,
W ong K C :
C ontinuous
m onitoring of
mixed venous oxygen saturation in man.
A n esth A nalg (C leve) 1973; 52: 784-93
5. de la Rocha A G , E dmonds JF, W illiams
W G, Poirier C , T rusler G A : Im portance
o f m ixed venous oxygen saturation in the
care of critically ill patients. Can J Surg
1978; 21: 227-9
6. S hoemaker WC. C zer LSC: Evaluation of
the biologic importance of various hem o
dynamic and oxygen transport variables:
which variables should be monitored in
postoperative shock? Crit Care M e d 1979:
7: 424-9
7. W ilson R F: G et the venous blood too.
A m Surg 1978; 44: 396-400
8. H ansen J F , H esse B, C hristensen N J:
Enhanced sym pathetic nervous activity after
intravenous propranolol in ischaemic heart
disease: plasm a noradrenaline splanchnic
blood flow and m ixed venous oxygen satu 
ration at rest and during exercise. E u r J
Clin Invest 1978; 8: 31-6
9. K rauss X H , V erdouw PD . H ughenholtz
PG , N auta J : On-line m onitoring of mixed
venous oxygen saturation after cardiothoracic surgery. T horax 1975: 30: 636-43
10. B eale PL, M cM ichan JC , Marsh H M ,
G ill JC , Southorn PA : C ontinuous m on
itoring o f mixed venous saturation
in
critically ill patients (abstr). A nesthesiology
1981; 55: A113
11. W aller JL , K aplan JA , Bauman
DI,
C rover JM : C linical evaluation of a new
fiberoptic c ath eter oxim eter (abstr). Ibid:
A133
12. K azarian KK, D el G uercio LRM: T h e use
o f mixed venous blood gas determ inations
in trau m atic shock. A n n E m erg M e d 1980;
9: 179-82
13. B oyd A D , T remblay RE, Spencer
FC ,
B ahnson H T : Estim ation o f cardiac output
soon after intracardiac surgery with card io 
pulm onary bypass. A nn Surg 1959; 150:
613-26
14. S isk AW , J ohnson TD, P olen TA, T ucker
JD , W atkins G: The influence of hypoxia
and metabolic alkalosis on oxygen tension

in the m ixed venous blood and cardiac o u t
put. A n t Surg 1978; 44: 794-803
15. F inch C A , Lenfant C : Oxygen tra n sp o rt
in m an. N Engl J M e d 1972; 286: 407-15
16. Sch einm an M M , B rown M A, Rapaport E:
C ritic a l assessm ent o f use of central venous
oxygen saturation as a m irro r o f m ixed
venous oxygen in severely ill cardiac pa
tients. C irculation 1969 ; 40: 165-72
17. M uir A L , K irby BJ, K ing AJ, M iller
H C : M ixed venous oxygen satu ratio n in
relatio n to cardiac o u tp u t in m yocardial
in fa rc tio n . B r M ed J 1970; 4: 276-8
18. S tanley T H , Isern -A maral J : P eriodic
analysis of mixed venous oxygen tension
to m o n ito r the adequacy o f perfusion during
and a fte r cardiopulm onary bypass. Can
A n a esth S o c J 1974; 21: 454-60
19. L aF arge C G , M iettinen O S: T he estim a
tion o f oxygen consum ption. C ardiovasc
R es 1970; 4: 23-30
20. M cA rthur KT, C lark LC jr , L yons C,
E dwards S: C ontinuous recording o f blood
oxygen saturation in open-heart operations.
Surgery 1962; 51: 121-6
21. P arr G V , B lackstone E H , K irklin JW :
C ard iac perform ance and m ortality early
after in trac a rd ia c surgery in infants and
young children. C irculation 1975; 51: 86774
22. T homsen A: C alculation of oxygen s a tu ra 
tion o f m ixed venous blood in infants.
Scand J Clin Lab In v e st 1978; 38: 389-92
23. W ilkinson AR, P hibbs RH , G regory G A :
C o n tin u o u s in vivo oxygen s a tu ratio n in
new born infants and pulm onary disease: a
new fib e ro p tic catheter oxim eter. C rit C are
M e d 1979; 7: 232-6
24. Idem : C ontinuous m easurem ent o f oxygen
s a tu ratio n in sick new born infants. J P ediatr
1978; 93: 1016-9
25. Sturm JA, Lewis FR jr , T rentz O,
O estern H J, H empelman G, T scherne H:
C ard io p u lm o n ary p aram eters and prognosis
after severe m ultiple traum a. J T raum a
1979; 19: 305-18
26. A llardyce DB: Sym posium on intensive
care. 1. M onitoring of the critically ill su r
gical p a tie n t. Can J Surg 1978; 21: 75-8
27. K night RW , O pie J C : T he big toe in the
recovery room : peripheral w arm -up p a t
terns in children after open-heart surgery.
Can J S urg 1981; 24: 239-42
28. B arash P G : The hem odynam ic tra c k in g
system : a m ethod of d a ta m anagem ent and
guide fo r cardiovascular therapy. A n e sth
A nalg (C leve) 1980; 59: 169-74
29. R oss JJ, B raunwald E : T he study of left
v e n tric u la r function in m an by increasing
resistance to ventricular ejection w ith angiotension. Circulation 1964 ; 29: 739-49
30. L appas D G , P owell W M jr , D aggett
W M : C ard ia c dysfunction in the p e rio p e ra 
tive p e rio d : pathophysiology, diagnosis, and
tre a tm e n t. A nesthesiology 1977; 47: 117-37

NOTICES
Surgical Symposium

The division of general surgery,
University of Ottawa School of
Medicine will hold its fourth annual
November Surgical Symposium at the
Hotel Plaza in Hull, Quebec, No
vember 12 and 13, 1982. The program
will deal with a wide variety of com
mon surgical problems. In addition to
local faculty, guests will include Dr.
Lewis Flint, professor of surgery,

University of Louisville; Dr. Lloyd
MacLean, professor of surgery, Mc
Gill University; and Dr. Peter Cruse,
professor of surgery, University of
Calgary.
For additional information contact
Dr. J.L. Wellington, Chairman, Pro
gram committee, November Surgical
Symposium, Department of surgery,
Ottawa General Hospital, 501 Smyth
Rd.. Ottawa, Ont. K1H 8L6.

American Association for
Hand Surgery

The 12th annual meeting of the
American Association for Hand Sur
gery will be held at The Hyatt Regency
Maui, Maui, Hawaii, October 7-10,
1982. For further information contact
Jean Kiefer, CPS, Central Office,
2704 Marshall Ct., Madison, Wise.
53705; phone (608) 238-3630.
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ELEMENTAL HIGH NITROGEN NUTRITION
HAS NEVER BEEN SIMPLER...
Better
Convenience in Ready-to-Feed Form
Flexical HN is the only elemental diet to provide
commercially sterile nutrition in liquid form. No powder
to reconstitute. Eliminates sedimentation during tube
feeding. Available with exclusive closed delivery
system.

IN A CONTROLLED TRIAL:
“RETENTION OF ABSORBED
NITROGEN WAS...16 TIMES
GREATER THAN VIVONEX HN.”2

30 %

Better
Clinically Proven Protein Source
Flexical HN supplies the preferred protein source
(primarily hydrolyzed casein) of 30% peptides and
70% free amino acids,1 a more fully and effectively
utilized form for malabsorption problems than the
100% free amino acids in Vivonex HN.t
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100%
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Necrotizing Pancreatitis in Renal Transplant Patients
M. B urnstein ,

md ,

D. Salter ,

Acute necrotizing pancreatitis
developed in 5 of 405 patients who
underwent renal transplantation.
All five patients were taking
immunosuppressive medication
(azathioprine and steroids). Three
patients also received rabbit antithymus
serum. Alcohol ingestion or
cholelithiasis did not play any
causative role in the pancreatitis,
which began between 7 days and
13 months after renal transplantation.
The delay from the time of admission
for pancreatitis to surgical exploration
was a mean of 17 days. Operative
findings included pancreatic necrosis,
hemorrhage and abscess formation.
All five patients died of the
complications of necrotizing
pancreatitis — persistent sepsis,
respiratory and renal failure, upper
gastrointestinal bleeding and
disseminated intravascular coagulation.
This review demonstrates that
prolonged conservative therapy in
renal transplant patients with
necrotizing pancreatitis is associated
with high mortality. The authors
believe that earlier surgical intervention
will lead to increased survival.
Une pancreatite necrosante aigue
est apparue chez 5 de 405 patients
qui avaient subi une greffe renale.
Les cinq malades recevaient des
immunosuppresseurs (azathioprine et
steroi'des). Trois patients recevaient
aussi du serum de lapin a activite
anti-thymique. L'ingestion d'alcool ou

md ,

C. C ardella ,

md , frcp [c ] and

une cholelithiase n'ont joue aucun
role etiologique dans I'apparition de
la pancreatite qui est survenue
de 7 jours a 13 mois apres la
transplantation renale. Le delai moyen
ecoule entre I'admission pour
pancreatite et I'exploration chirurgicale
a ete de 17 jours. A I'operation, les
constatations comprenaient necrose
pancreatique, hemorragie et formation
d'abces. Les cinq patients sont
morts des complications de la
pancreatite necrosante — infection
persistante, insuffisance renale et
respiratoire, saignements des voies
gastro-intestinales superieures et
congulation intravasculaire disseminee.
Cette revue demontre qu'un
traitement conservateur prolonge
chez les greffes du rein atteints de
pancreatite necrosante est accompagne
d'une forte mortalite. Les auteurs
croient qu'une intervention chirurgicale
plus precoce pourrait ameliorer
la survie.

Acute necrotizing pancreatitis is an
uncommon complication of renal
transplantation, occurring in less than
2% of cases.1 The overall mortality
is more than 70%. We have reviewed
our experience at the Toronto West
ern Hospital and report on five renal
transplant patients who had acute
necrotizing pancreatitis.
Patients

Between July 1967 and November
1981. 405 patients underwent renal
transplantation. Seven patients suf
From the departments of general surgery fered from pancreatitis postoperativeand• nephrology, Toronto Western
ly. In two the pancreatitis was mild
Hospital, University of Toronto,
with
abdominal pain and elevated se
Toronto, Ont.
rum amylase levels and resolved with
Presented at the 4th annual meeting
in 3 days. The other five patients had
of the Canadian Association of General acute necrotizing pancreatitis and the
Surgeons, Toronto, Ont., Sept. 18, 1981 course of the disease in each case is
Accepted for publication Mar. 23, 1982 described below.

H.S. H im al ,

md , facs , frcs [c ]

failure due to focal glomerulonephritis.
For 2 years he was maintained on hemo
dialysis. Then he underwent renal trans
plantation from a cadaver donor. Immu
nosuppression consisted of steroids, aza
thioprine and rabbit antithymus serum.
Forty-eight hours later pyrexia and severe
abdominal pain developed and the serum
amylase level increased to more than 600
IU (normal 0 to 150 IU). The patient
continued to deteriorate and hypotension
and respiratory insufficiency developed.
Seven days after transplantation he un
derwent exploratory laparotomy. Necro
tizing pancreatitis and gangrene of the
distal ileum and right colon were found.
The necrotic ileum and colon were re
sected, an ileostomy was created and the
peripancreatic area was drained. The
patient died 1 month after transplanta
tion, of persistent sepsis and multiple
organ failure.
Case 2

A 33-year-old man had renal failure
due to progressive membranous glome
rulonephritis. He was placed on hemo
dialysis and subsequently underwent re
nal transplantation. Immunosuppression
consisted of steroids and azathioprine.
Four months later he was admitted to
hospital with abdominal pain and jaun
dice. The serum amylase level was great
er than 600 IU. Management consisted
of intravenous therapy, nasogastric suc
tion and administration of antibiotics.
The patient slowly improved, but 6
weeks later abdominal pain and jaundice
returned; respiratory insufficiency and a
temperature pattern of sepsis developed.
When abdominal exploration was carried
out. diffuse necrotizing pancreatitis was
found. The peripancreatic space was
drained and supportive therapy provided
but the patient died.
Case 3

A 63-year-old man suffered from
chronic renal failure due to polycystic
kidney disease. He underwent bilateral
nephrectomy and was maintained on
hemodialysis until he received a cadaver
kidney transplant. Immunosuppression
Reprint requests to: Dr. H.S. Himal,
consisted of steroids, azathioprine and
Ste. 103, Toronto Western Medical
Case 1
rabbit antithymus serum. One year later,
Building, 25 Leonard Are., Toronto,
Ont. M5T 2R2
A 49-year-old man had chronic renal he was admitted with upper abdominal
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pain and fever. The serum amylase level
was 400 1U. Computerized tomography
showed that he had pancreatitis and a
right nephric space abscess. Percutaneous
drainage of the abscess was unsuccessful.
The elevated serum amylase level and
spiking fever persisted, respiratory
insufficiency developed and 11 days
after admission exploration was carried
out. Necrotizing pancreatitis and a right
nephric space abscess were found. The
abscess was evacuated and the peripancreatic space was extensively drained.
Despite re-exploration for a perforated
colon and vigorous systemic therapy, in
cluding administration of Trasylol, the
patient’s course was continuously down
hill and he died 14 days after the initial
laparotomy.
Case 4
A 54-year-old woman had renal fail
ure due to chronic pyelonephritis. She
was placed on hemodialysis until she
received a cadaver renal transplant. Im
munosuppression consisted of steroids
and azathioprine. Six weeks after trans
plantation, abdominal pain, jaundice, per
sistent fever and elevated serum amylase
level developed. This clinical picture
persisted and 3 weeks after the initial
episode of pancreatitis, laparotomy was
performed. Diffuse necrotizing pancrea
titis was found and extensive retroperi
toneal drainage was carried out. Disse
minated intravascular coagulation and
acute respiratory distress syndrome de
veloped and she died.
Case 5
In a 44-year-old man, chronic endstage renal disease secondary to membranoproliferative glomerulonephritis de
veloped. He was on hemodialysis for
8 months and then received a kidney
from his brother. Immunosuppression
consisted of steroids, azathioprine and
rabbit antithymus serum. An acute ab
domen developed 14 weeks after trans
plantation and his serum amylase level
was 650 IU. Antibiotics and hyperali
mentation were given. Three weeks later,
exploration revealed extensive necro
tizing pancreatitis, and, in spite of vigor
ous supportive management, he died.

Discussion
Necrotizing pancreatitis is a serious
complication in the patient who has
received a renal transplant. In 1964,
Starzl and associates2 reported five
cases of pancreatitis; three died and
in one case, necrotizing pancreatitis
was the main cause of death. In 1966,
Tilney and associates3 described two
renal transplant patients who had
hemorrhagic pancreatitis. One patient
had pancreatitis 11 months after
transplantation. Vigorous conservative
therapy was instituted. When sudden
deterioration 10 days later necessi
tated laparotomy, acute hemorrhagic
548

pancreatitis was found. Progressive
sepsis led to death. In the second pa
tient pancreatitis developed 9 months
after transplantation. The patient died
1 week later. Autopsy revealed
marked necrosis of the pancreas. In
1968, Penn and colleagues4 reported
one patient with pancreatic abscess 3
months after transplantation. R e
peated drainage led to eventual re
covery.
In 1970, Johnson and Nabseth5
reported a patient who had fatal nec
rotizing pancreatitis months after
renal transplantation. Review of the
literature at that time revealed 23
cases of acute pancreatitis; 12 of
the 23 patients died. Since then, there
have been many reports of pancreati
tis associated with renal transplanta
tion. Renning and associates6 reported
5 patients, all of whom died, Penn
and associates7 reported on 10 pa
tients with only 1 survivor, Corrodi
and associates8 reported 3 patients
with 1 survivor, Fernandez and
Rosenberg9 reported 2 patients, both
of whom died, and Taft and asso
ciates10 described 6 patients of whom
4 died of severe necrotizing pancrea
titis.
The etiology of pancreatitis in pa
tients who receive a renal transplant
remains obscure. Operation, renal
failure, immunosuppressive medica
tion, alcoholism, cholelithiasis and
infective agents all play a role. Post
operative pancreatitis is a well-recog
nized entity. Although pancreatitis
occurs most commonly after gastric
resection or biliary tract explora
tion,1113 it can also develop after sur
gery distant from the pancreas (coro
nary artery bypass, abdominoperineal
resection, herniorrhaphy).14 In all these
patients, pancreatitis usually develops
within 10 days of operation and is
almost always of the necrotizing hem
orrhagic type with high mortality. The
etiology of postoperative pancreatitis
in patients who have had biliary tract
or gastric surgery is related to mani
pulation around the head of the pan
creas leading to reflux of duodenal
contents into the pancreatic duct.15
Our case 1 falls into the category of
postoperative pancreatitis.
Renal failure is also associated with
pancreatitis.
Robinson
and
col
leagues16 reported four patients with
chronic stable renal failure who had
the clinical and biochemical features
of pancreatitis. All four died. Hyper
parathyroidism is commonly asso
ciated with uremia and the hypercal
cemia resulting from hyperparathy
roidism probably led to pancreatitis
in these four patients.

The intensive immunosuppressive
regimen in renal transplant patients
is the most likely explanation for pan
creatitis in this group. It is well rec
ognized that steroids may cause
pancreatitis. In 1956, Stumpf and
associates17 and Bencosme and Laza
rus18 reported pancreatitis in rabbits
given cortisone. In an autopsy review
by Carone and Liebow19 of 54 patients
treated with corticotropin or adrenal
steroids, 16 had histologic evidence of
acute pancreatitis. Following this re
port, sporadic cases appeared attribut
ing pancreatitis to steroid therapy.20'22
In 1961 Nelp23 reviewed the literature
and presented six cases of acute pan
creatitis associated with the adminis
tration of steroids. In most cases, the
pancreatitis was severe with high
mortality. The mechanism is probably
related to alterations in pancreatic
secretion in patients receiving ste
roids.24
Azathioprine can also cause pan
creatitis. Hum e25 first documented the
role of azathioprine in acute pancrea
titis
after
renal
transplantation.
Nogueira and Freedman,26 Kawanishi
and colleagues,27 Paloyan and asso
ciates28 and Huizenga and associates29
each presented patients with inflam
matory bowel disease who were taking
azathioprine. All had acute pancrea
titis which resolved when the drug
was withdrawn. The clinical picture
recurred after challenge with azathio
prine. Rapid improvement after cessa
tion of azathioprine and abrupt recur
rence after rechallenge with a single
dose suggests a hypersensitivity reac
tion. Infectious agents can also play a
role in the pathogenesis of pancreati
tis.30,31 Viral infections such as
mumps, especially during septicemia,
can cause pancreatitis. These cases
are usually mild and resolve when the
infection is controlled. Under condi
tions of immunosuppression, the pan
creas can become infected with vi
ruses. Tilney and associates3 and Van
Geertruyden and Toussaint32 cultured
cytomegalic inclusion viruses from the
pancreas of patients with pancreatitis.
These inclusion bodies have also been
found in pancreatic cells of patients
without histologic evidence of p an 
creatitis.8
Alcoholism and cholelithiasis or
choledocholithiasis
are
common
causes of pancreatitis. In none of the
five patients described in this report
was there any evidence of any of
these conditions.
The management of acute hem or
rhagic necrotizing pancreatitis in the
nontransplant atient is controversial.
Most would accept that vigorous con-
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servative therapy should be the initial
approach. The contentious aspect is
the role of surgery. In the early part
of the century, various authors sug
gested early operation,33,34 but this
concept fell into disrepute when sev
eral reports were published indicating
that the conservative rather than the
surgical approach to acute pancreatitis
resulted in decreased morbidity and
mortality.35,36 In the late 1960s the
pendulum began to swing towards ear
lier operation specifically to prevent
deterioration in critically ill pa
tients.37,38
Many recent reports have com
pared early operation and conserva
tive management in patients with
acute hemorrhagic pancreatitis. Jordan
and Spjut14 discussed 37 patients with
hemorrhagic pancreatitis. Sixteen pa
tients who underwent medical therapy
all died of the complications of pan
creatitis. Of 21 patients who under
went operation for pancreatitis, 9
survived. Frey39 reported 68 patients
with pancreatitis. Of 16 who under
went operation, 6 survived while all
52 patients who did not, died. Other
reports have stressed the importance
of early operation. Warshaw and as
sociates40 described 38 patients with
acute necrotizing pancreatitis who
underwent early operation; 25 sur
vived. White and Heimbach41 de
scribed 30 patients with hemorrhagic
pancreatitis who underwent early
operation because medical therapy
failed. Twenty-four of the 30 patients
180%) survived.
The important concept that should
be stressed in cases of necrotizing
pancreatitis is that early operation in
critically ill patients will lead to in
creased survival. The difficulty here is
to identify certain prognostic features
that will select the high-risk patient
who will benefit from early operation.
Jacobs and associates42 in a retrospec
tive study of 519 cases of acute pan
creatitis found that sepsis, respiratory
insufficiency and renal failure were
poor prognostic signs and led to
notable mortality.
In the five patients presented in
this report the mean delay between
admission for pancreatitis and sur
gical exploration was 17 days. Con
servative therapy was prolonged in
spite of the fact that sepsis, decreased
renal function and respiratory insuf
ficiency were present in all five pa
tients. Operation was considered too
risky in these critically ill patients on
maximum immunosuppression. This
policy of prolonged conservative man
agement was undoubtedly a major
factor in the 100% mortality.
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Clinical Applications of Biomaterials

The 33rd Consensus Development
Conference, on clinical applications of
biomaterials, will be held at the Na
tional Institutes of Health in Bethesda,
Maryland, November 1-3, 1982.
This open forum will assess the
value of currently used tests for compatability and short- and long-term
performance of biomaterials, consider
the ways by which biomaterials are
introduced into clinical care and de
termine whether currently used bio
materials fulfill the needs of the clini
cian.
Consensus Conferences of the Na
tional Institutes of H ealth bring
together biomedical investigators, prac
tising physicians, consumers and re
presentatives of public interest groups
to provide a scientific assessment of
drugs, device* a n d procedures, and to
evaluate their safety and effectiveness.
For registrjtion or further informa
tion contact John W. Boretos, Building
13, Rm. 3Wl3, N ational Institutes of
Health, BethfMa, Md. 20205.
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Because “biphasic infection”
threatens to complicate surgery
of the large bowel...

control sepsis with
an antibiotic to arrest primary
gram-negative aerobic infection
in combination with

■m

Product Monograph available on request.

Adenocarcinoma of the Appendix
B asil B aeta ,

m d , fr c s [ c ],*

The experience in Hamilton, Ontario,
with adenocarcinoma of the appendix,
between 1974 and 1980, is re
viewed and the findings are
compared with those of a previous
report from Hamilton. There were
seven patients (five men and two
women) in the current series. The
average age was 55.6 years. The
unusual presenting signs and symp
toms of this tumour are noted; the
diagnosis is rarely made preoperatively.
This tumour often cannot be disting
uished from cecal or ileal malignant
tumours. Detailed histologic exa
mination of all specimens is essential
to identify epithelial types and to
plan treatment. While appendectomy
alone may suffice for tumours
confined to the appendiceal mucosa,
radical right hemicolectomy is still
the standard therapy. The authors'
study shows no improvement
in preoperative diagnosis, or in
prognosis, over the earlier report.
The authors recommend (a)
that this condition be considered
in the diagnosis of any appendiceal
mass that is not obviously inflamma
tory, and (b) the frequent use of
frozen-section examination to confirm
the diagnosis.
L'ensemble des cas d'adenocarcinome de I’appendice
traites a Hamilton, Ontario,
entre 1974 et 1980 est passe
en revue, et les constatations
sont comparees a celles d'un rapport
prealable emanant de Hamilton.
Sept patients (cinq hommes et
deux femmes) constituent la presente
serie. Leur age moyen etait
de 55.6 ans. Les signes et
symptomes inhabituels de cette
tumeur apparaissant a la consultation
sont notes; le diagnostic est
rarement pose en preoperatoire.
Cette tumeur, souvent, ne peut etre
distinguee des tumeurs malignes
du caecum ou de I’ileon. Un examen
histologique detaille de tous
les prelevements est essentiel pour

W il l ia m H . B a r n es ,

m d , f r c s [ c ]* a n d

identifier les types epitheliaux et
pour planifier le traitement.
Alors que I’appendicectomie
seule peut etre suffisante dans
les cas de tumeurs confinees a la
muqueuse appendiculaire,
I'hemicolectomie droite radicale
demeure le traitement standard.
Comparativement au rapport prealable,
I'etude des auteurs ne revele
aucune amelioration quant au
diagnostic preoperatoire ou au
pronostic. Les auteurs recommandent
a) que cette affection soit
envisagee dans le diagnostic
de toute masse appendiculaire qui
n'est pas manifestement
inflammatoire et b) le recours
frequent a I'examen des coupes
en congelation pour confirmer
le diagnostic.

D J . D e sa ,

md|

of the appendix came from four of
the six participating hospitals in
H am ilton: Hamilton Cancer Clinic
four patients, and M cMaster U niver
sity Medical Centre, St. Joseph’s
Hospital and Chedoke Hospital one
patient each.
Five of the seven patients were men.
The average age was 55.6 years.
The case histories of these seven
patients are outlined briefly below:

Case Reports
Case 1
A 63-year-old man underwent modi
fied right hemicolectomy for small bowel
obstruction caused by a mass in the walls
of the cecum and ileum. Dissection of
the cecal mass showed a tubular appendix
filled with glairy mucus with a grossly
thickened, sclerotic wall, continuous with
cecum (Figs. 1 and 2). The appendix
was infiltrated by a well-differentiated
adenocarcinoma with abundant mucin
production and small colloid lakes of
colonic type. There was invasion of the
ileum. No primary cecal mucosal ab
normality was noted.
This patient was alive and well 9
months after operation.

While adenocarcinoma of the colon
is a common tumour, primary adeno
carcinoma of the appendix is unusual.
Uihlein and McDonald1 reported 144
tumours of the appendix at the Mayo
Clinic from 1910 to 1943 of which
88.2% were carcinoid, 8.3% malig
nant mucocele and 3.5% adenocarci
noma. Collins2 found 41 cases of ap
pendiceal tumours in 50 000 specimens
(0.08%).
An unusual presentation of this
tum our prompted us to review the
Hamilton experience and the Eng
lish literature. Our study included all
patients presenting with adenocarci
noma of the appendix (exclusive of
carcinoid) in the Hamilton area from
Jan. 1, 1974 to Dec. 31, 1980. Qizilbash3 documented the Hamilton ex
perience up to 1974 and our study
did not include any patients pre
viously reported by him.
The seven cases of adenocarcinoma

Roentgenography after a barium ene
ma in a 51-year-old man showed a cecal
mass, diagnosed as carcinoma of the
cecum. He underwent a right hemi-

FIG. 1— Cross-section of appendix,
showing mucinous deposits.

FIG. 2— Photomicrograph of appendix,
showing well-differentiated adenocarcino
ma (periodic acid-Schiff, reduced by
67% from X30).

Case 2
This 48-year-old man with acute ap
pendicitis underwent appendectomy, then
10 days later a right hemicolectomy.
The appendix was found to contain prim
ary mucoid adenocarcinoma. Ileocolic
lymph nodes also contained tumour.
Three years later he suffered a pa
thologic fracture of T10 for which he
received radiotherapy. Otherwise he is
well, at the time of writing.
Case 3
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reports on the variety of epithelial
abnormalities of the appendix.1,3,7-11
The appendix may be the site of hy
perplastic epithelial lesions, villous
adenomas and frank carcinomas. The
carcinomas may be locally invasive,
with infiltration of adjacent structures
and may metastasize. Malignant
change may occur in villous adenomas
(as we believe happened in our case
7) and. as in the colon, it is necessary
to consider the possibility of malignant
Case 4
An inflammatory mass in the right transformation in the other epithelial
lower quadrant of a 58-year-old man abnormalities.9,11 The problem of mu
was managed by incision and drainage. cinous cystadenoma and mucinous
Two months later laparotomy was per cystadenocarcinoma has been dis
formed. An unresectable mucin-secreting cussed by Gibbs11 who showed that
adenocarcinoma was found. The patient
the former is akin to the villous adeno
died 8 months after operation and no ma, while the latter is a signet-ring,
autopsy was performed.
colloid carcinoma. Detailed histologic
examination in all cases of “muco
Case 5
cele of appendix” and “pseudomyxo
An 85-year-old man underwent ap ma peritonei” is essential.
pendectomy for acute appendicitis. A
Wolff and Ahmed5,6 in 1976, found
well-differentiated polypoid adenocarci 20% of patients with adenomatous
noma was found that invaded the sub lesions of the appendix who had an
mucosa of the appendix. Seven months
later carcinoma of the bladder was associated and quite separate primary
treated by radiotherapy. Lung metastases adenocarcinoma of the colon. A tho
then developed for which radiotherapy rough search of the colorectum should
also was given. The patient died 3 years therefore be carried out when benign
appendiceal adenomas are found.
after the appendectomy.
The classification of primary epi
Case 6
thelial tumours of the appendix set
Right ovarian cancer was diagnosed forth by Aranha and Reyes7 is useful.
The controversy surrounding the
preoperatively in a 44-year-old woman.
She underwent hysterectomy and bilateral
terms “mucocele” and “pseudomyxo
salpingo-oophorectomy. One week later
ma peritonei” is well debated else
right hemicolectomy was performed.
where.12,13
Widely disseminated adenocarcinoma of
The prognosis of adenocarcinoma of
the appendix or cecum was found. She
the appendix correlates with the histol
received radiotherapy to the pelvis but
died of metastases 3 months after opera ogic differentiation and the degree of
invasion according to Dukes’ classifi
tion.
cation.14 Didolkar and Fanous15 point
ed out that perforation of the ap
Case 7
This 41-year-old woman had a pre pendix in itself does not imply a poor
operative differential diagnosis of ap prognosis, although perforation at the
pendiceal abscess or torsion of the right tumour site does adversely affect the
ovary. Appendectomy, which included a outcome. The site of location of the
cuff of cecum, was performed and 1 tumour in the appendix does not af
month later she underwent right hemi fect survival.
colectomy. There was a moderately wellSince few centres have a large
differentiated adenocarcinoma in a pre enough series, Andersson and associ
existing villous adenoma of the appendix, ates,16 in 1976, collected 39 cases of
probably confined to the appendiceal
wall since the lymph nodes contained no colonic type primary adenocarcinoma
of the appendix from the literature
tumour cells. The patient was alive and
between 1956 and 1973 and added 12
well 4 years after the operation.
personal cases. Of the total of 51
patients, 26 were treated by ap
Discussion
pendectomy alone; 12 (46%) sur
Carcinoma of the vermiform ap vived 5 years. Right hemicolectomy
pendix is usually diagnosed only after was performed in 25 patients and 15
a thorough examination of the re (60%) survived 5 years.
It is now standard therapy to per
sected specimen. It is rarely diag
nosed preoperatively, because it is form a radical right hemicolectomy
for adenocarcinoma of the appendix.
difficult to separate the signs and
symptoms of an appendiceal tumour This is done at the first operation if
from those of the cecum or ileum.4’6 the diagnosis is confirmed then or 2
weeks later if the diagnosis is made
There are, however, several detailed

colectomy. A moderately well-differen
tiated adenocarcinoma of the appendix
with pericolic abscess was found. The
lymph nodes also contained tumour
cells.
Twenty months after operation the
tumour recurred, associated with bowel
obstruction. The involved bowel was re
sected. but 6 months later bowel ob
struction recurred and he died shortly
thereafter.
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from permanent sections. Appendec
tomy alone may suffice when the
tumour is confined to the appendiceal
mucosa, but each patient should be
considered individually. The rationale
for radical right hemicolectomy lies
in the fact that the lymphatic and
hematogenous drainage of the ap
pendix are the same as those of the
cecum.
The 2-week delay between appen
dectomy and hemicolectomy is purely
empirical.
We recommend that adenocarcino
ma should be considered in the dif
ferential diagnosis of any appendiceal
mass that is not obviously inflamma
tory and that frozen sections be ob
tained to confirm the diagnosis. The
question of the primary site of the
tumour as cecal or appendiceal, is
unimportant, since the treatment is the
same. The surgeon must also be ready
to reoperate should an initial appen
dectomy reveal an unsuspected appen
diceal carcinoma.
There has been no documented
study of the value of adjuvant ther
apy (chemo- or radiotherapy) in this
disease.
The Hamilton experience appears
similar to that of other centres. The
rarity of this lesion and the need for
adequate early treatment justifies con
tinued vigilance.
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Should Prophylactic Antibiotics Be Given
Perioperatively in Acute Appendicitis without Perforation?
M. G iacomantonio, md,*
The authors question the need to give
prophylactic antibiotics perioperatively
in all cases of acute appendicitis
without perforation to reduce the rate
of wound infection. A retrospective
study of 82 patients showed a wound
infection rate of 4.8%; 3 of 53 patients
who did not receive antibiotics had
a wound infection compared with
t of 29 patients who received
antibiotics. A prospective double-blind
clinical trial was performed comparing
the results of perioperative adminis
tration of cefamandole and placebo.
One of 21 patients who received
the placebo had a wound infection;
none of the 21 patients given
cefamandole had infection. Thus, the
authors conclude that, although reports
in the literature suggest that
antibiotics given perioperatively
decrease the rate of wound infection
in acute appendicitis without
perforation, the incidence of such
infection is too low to warrant routine
administration. They suggest that
such antibiotic use be reserved for
those suspected of having more
serious disease.

R.
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and D.A.

retrospective portant sur 82 patients
a revele un taux d’infection de
plaie de 4.8%; 3 patients sur 53 qui
n’avaient pas regu d’antibiotiques
avaient developpe une infection de
plaie comparativement a 1 patient
sur 29 qui avaient repu des
antibiotiques. Une etude clinique a
double-insu a ete realisee comparant
les resultats de ('administration
peroperatoire de cefamandole au
placebo. Un patient sur 21 au placebo
a eu une infection de plaie; aucun
des 21 patients qui ont recu du
cefamandole n'a eu d'infection. En
consequence, les auteurs concluent
que malgre les publications suggerant
que les antibiotiques administres dans
la periode peroperatoire reduisent le
taux des infections de plaie dans
les cas d'appendicite aigue non
perforee, I’incidence de ces infections
est trop faible pour en justifier
I'administration systematique. Ils
suggerent que ces antibiotiques
devraient etre reserves pour les cas
oil Ton soupconne une atteinte plus
serieuse.

R eprint requests to: D r. D.A. Gillis,
D epartm ent of surgery, The Izaak
Walton Killam H ospital for Children,
5 8 5 0 University Ave., PO Box 3073,
H alifax, NS B3J 3G 9

Wound infection is an important per
sisting complication of appendectomy.
In gangrenous and perforated appen
dicitis wound infection causes serious
morbidity and every effort is war
ranted to eliminate this complica
tion.1"3 Systemic antibiotics given pe
rioperatively,4 delayed wound closure1
and antibiotics applied directly to the
abdominal wound5 have all reduced
the rate of wound infections in per
forated appendicitis.
The problem of wound infections
in acute appendicitis without perfora
tion is not clearly defined. Some re
ports6,7 suggest an appreciable infec
tion rate while others1,8 suggest that
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Les auteurs mettent en question la
necessity d’administrer des antibiotiques en prophylaxie dans la
periode peroperatoire dans tous les
cas d’appendicite aigue non perforee
dans le but de reduire la frequence
des infections de plaie. Line etude
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the infection rate is relatively low. As
a result, some4,6'7 recommend giving
antibiotics systemically preoperatively
in all cases of appendicitis, whereas
others suggest using antibiotics only
in suspected perforation.1
In an attempt to solve this dilemma,
we carried out a retrospective review
of all cases of appendicitis over a 10month period to determine the wound
infection rate in acute appendicitis
without perforation. Further, during
the latter part of this period, a double
blind, randomized, prospective trial
was started to compare the use of
cefamandole (Mandol) given perioper
atively with a placebo to determine its
efficacy in reducing the wound infec
tion rate in acute appendicitis without
perforation.
Patients and Methods

All patients in the study were in
the pediatric age range. The usual
surgical procedure for acute appendi
citis without perforation performed at
our institution is through a muscle
splitting incision in the right lower
quadrant, with inversion of the appen
diceal stump and primary wound
closure. Antibiotics are not given pre
operatively unless perforation is sus
pected.
Wound infection was defined as the
presence of pus in the wound or
wound pain, tenderness or erythema
of sufficient magnitude to interfere
with the patient’s well-being or to
prolong hospital stay. Cases of read
mission to hospital for wound infec
tion were also included. This defini
tion pertained to both the retrospec
tive and prospective studies.
Patients who at operation had con
ditions other than acute appendicitis
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without perforation
from the study.

were removed

Retrospective Study
The charts of all 109 patients oper
ated on with either the pre- or post
operative diagnosis of appendicitis
over a 10-month period (February
1980 to December 1980) were re
viewed. We noted the pre- and post
operative diagnosis, whether antibio
tics were given, the pathologist’s re
port, the method of wound closure,
the postoperative course, the presence
or absence of wound infection, the
length of hospital stay and the results
of culture of infected wounds.
Prospective Study
Forty-two patients admitted with
the diagnosis of acute appendicitis
without perforation were given one
dose of either cefamandole (25 mg/kg)
(21 patients) or a placebo (21 pa
tients), intramuscularly or intrave
nously, shortly before operation. If
an acutely inflamed appendix with no
perforation was found at operation,
the same drug (cefamandole or place
bo) was given immediately postoperatively and again 6 hours later. The
vials of drug or placebo were pre
pared by the pharmacy and numbercoded. The vials were distributed ran
domly to consecutive patients. No one
caring for the patients was aware
which drug had been given. Permis
sion for entry into the study was first
obtained from the parent or guardian.
No patient allergic to cephalosporins
or penicillin was included in the trial.
Results
Retrospective Study
Of the 109 charts reviewed only 82
patients had a postoperative diagnosis
of acute appendicitis without perfora
tion; 21 had a perforated appendix,
5 had a normal appendix and 1 had
primary peritonitis. Twenty-nine pa
tients received antibiotics and 53 did
not. No drains were used and all
wounds were closed primarily.
There was one (3.4%) wound in
fection in the group of patients given
antibiotics and three (5.6%) in the
nonantibiotic group. The overall
wound infection rate was 4.8%.
The organisms grown from the
wound infections were usually a mix
ture of enteric organisms. No unusual
pathogens were identified.
The length of hospital stay aver
aged 4.3 days for patients who had
no wound infection or other com
plication and 11.3 days for patients
with wound infection postoperatively.
556

with suspected acute appendicitis
without perforation would not be jus
tified in view of the low infection
rate without antibiotics. It is unrealis
tic to assume the infection rate could
Prospective Study
be reduced to zero.
The diagnosis of perforated appen
There were no wound infections in
the 21 patients given cefamandole and dicitis can be made in the majority
only one infection in the group given of cases by careful clinical assessment
placebo. The organisms grown were and the leukocyte count.1,3 Although
also a mixed enteric flora, primarily the wound infection rate in acute ap
Escherichia coli. There were no im pendicitis without perforation may be
portant complications or untoward ef lowered with perioperative adminis
fects of either cefamandole or the tration of antibiotics, the low infec
tion rate associated with no antibiotics
placebo.
does not warrant their use in all pa
tients. If the clinical impression at the
Discussion
time of diagnosis suggests more seri
The reported wound infection rate ous disease such as a gangrenous or
in acute appendicitis without perfora perforated appendix, appropriate pre
tion ranges from less than 3% 5 to operative antibiotic coverage is war
29%.4 These differences are difficult ranted.
to explain. Nevertheless, depending
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vary. It is possible that a reason for the
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of wound infection. The rate of in Co. (Canada) Ltd. for their help with the
fection will be less if only those cases prospective study.
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There were two cases of pelvic ab
scess postoperatively, but there was
no death or other serious sequelae of
infection.
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Cefamandole in Gastroduodenal Surgery: a Controlled,
Prospective, Randomized, Double-Blind Study
R.T. L ewis, mb , frcs[c], facs,* C.M. A llan, md, frcs[c], FACs,f R.G. G oodall, md,
B. M arien, md, frcs [c] ,| M. P ark, md, F R C s [ c ] , f W . Lloyd-S mith , md , frcs [c ],
F.M. W lE G A N D , M D , F R C S [C ], F A C S f
Acceptance of the value of antibiotic
prophylaxis in gastroduodenal surgery
is growing, but only one controlled,
double-blind study justifying this is
available. In this second, controlled,
randomized, double-blind study
60 patients underwent urgent and
elective gastroduodenal operations.
Among 32 patients receiving
cefamandole perioperatively for
prophylaxis, only 1 subsequently had
a wound infection, but wound
infections occurred in 8 of the
28 patients who received a placebo
(P < 0.01). Infection rates were
higher in contaminated wounds and
in urgent operations than in
clean-contaminated wounds and
elective surgery. The results confirm
the value of antibiotic prophylaxis
in this setting.
La valeur de ('utilisation prophylactique
des antibiotiques en chirurgie
gastro-duodenale est de plus en plus
acceptee; toutefois il existe une
seule etude controlee a double-insu
en demontrant le bien fonde. Dans
cette deuxieme etude controlee,
randomisee, a double-insu, 60 patients
ont subi des operations gastroduodenales urgentes ou non urgente.
Parmi les 32 patients qui ont repu
en peroperatoire de la cefamandole
en prophylaxie, 1 seul a par la suite
developpe une infection de plaie
alors que de telles infections sont
survenues chez 8 des 28 patients
qui ont requ du placebo (P < 0.01).
Les taux d'infection etaient plus
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eleves dans les cas de plaies
contaminees et dans les operations
d’urgence que dans les plaies non
souillees et les interventions non
urgentes. Ces resultats confirment
I'utilite prophylactique des antibiotiques
dans ce type d’operation.

Although several workers1'* have
shown that antibiotics given prophylactically are of value in gastroduode
nal surgery, there is still considerable
doubt of their precise worth.5 This is
probably because, until recently, most
evaluations of antibiotic prophylaxis
have shown serious defects in design.
In a critical review of 131 articles,
reporting clinical trials of systemic
antibiotic prophylaxis from 1960 to
1976, Chodak and Plaut6 found only
6 that generated evaluable data, and
could draw no conclusions on the
value of antibiotic prophylaxis in gas
troduodenal surgery. Up to Septem
ber 1979, Hirschmann and Inui7 could
find only one study that examined
antibiotic prophylaxis in gastroduo
denal operations in a prospective, con
trolled,
randomized,
double-blind
fashion, with explicit criteria for se
lection of patients and outcomes and
with statistical analysis of data. We
therefore set up a rigid protocol at
the Queen Elizabeth Hospital in
Montreal, in September 1977, to de
termine the value of the second-gen
eration cephalosporin, cefamandole, in
patients who were to undergo gastro
duodenal operations.
Patients and Methods
All patients scheduled to undergo
emergency or elective gastroduodenal
surgery for peptic ulcer disease, tu
mours or gastroduodenal bleeding
were considered candidates for this
study. Patients were excluded if in
formed consent was refused, if they
had received antibiotics in the preced
ing 2 weeks or if they were allergic
to penicillin. Those included were
then randomly assigned to receive
cefamandole intravenously in the peri
operative period or an identically
packaged placebo, 2 g 1 hour before
operation, 2 g when called to the
operating room and 2 g 5 hours after
operation. The antibiotic and placebo

frcs [c], facs .J
and

F A esf

had previously been prepared, and
randomized using standard statistical
tables (Eli Lilly & Company [Canada]
Ltd., Scarborough, Ont.). Upon com
pletion of the study, the code retained
by the hospital pharmacy was broken
and the identity of the assignments
was then revealed.
For each patient, the blood hemo
globin level, leukocyte and differential
counts and blood urea nitrogen and
serum creatinine values were deter
mined preoperatively, on the second
postoperative day and thereafter as
indicated. Serum bilirubin and alka
line phosphatase levels were deter
mined sporadically. At operation, the
degree of wound contamination was
noted8 and specimens were obtained
for culture from the stomach contents
and from the subcutaneous tissues of
the wound before closure. The wound
was routinely inspected by infection
control personnel 5 and 7 days after
operation. A wound infection was
diagnosed when pus drained from the
wound;9 a specimen of the pus
was then obtained for culture. Red,
tender or indurated wounds were fol
lowed until these signs resolved spon
taneously (uninfected) or the wound
drained pus. A further follow-up re
port on the wound was obtained from
the patient’s surgeon 1 month after
operation. Nonspecific postoperative
pulmonary and urinary tract infec
tions were diagnosed by clinical find
ings with the aid of chest roentgeno
grams, sputum culture or urine cul
ture as indicated. For each patient, the
age, sex, weight, height, duration of
preoperative stay, operative diagnosis,
operative procedure, assigned low- or
high-risk category for postoperative
infection10 and duration of operation
were noted. A risk index of postoper
ative infection was calculated as sug
gested by Davidson and colleagues.11
Ideal body weight for height was de
termined from tables12 and the per
centage actual body weight of the
ideal was calculated. Statistical evalu
ation was carried out where indicated
by Student’s r-test and by x2 analysis.
Results
Sixty patients completed the proto
col. When the code was broken, 32
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had received cefamandole and 28 the
placebo. The groups were evenly
matched for age, sex, weight, pre
operative blood lymphocyte count and
Davidson risk index (Table I); for
operative diagnosis and risk of post
operative infection according to in
dications for operation (Table II) and
for urgency of surgery, operative pro
cedure and degree of wound conta
mination (Table III).
Wound infections occurred in eight
patients who received the placebo, but
in only one patient in the cefamandole
group (P < 0.01). The wound infec
tion in the cefamandole group was
due to Staphylococcus pyogenes, while
the infections in the placebo group
were caused by S. pyogenes in one
patient, Staphylococcus epidermidis
in another, coliform organisms in four
patients, and streptococci in two. In
six of the nine patients with wound
infections, similar organisms had been
grown from the stomach contents
(Table IV). The development of sepsis
postoperatively was related to the po
tential degree of wound contamina
tion and to the urgency of operation;
no association was observed between
postoperative infection and the weight
of the patient, the preoperative blood
lymphocyte count or Davidson risk
index (Table V). Postoperative respi
ratory infections occurred in three
patients who received cefamandole
and in seven who received the placebo
(P > 0.1); urinary tract infections
were found in only two patients in
the cefamandole group, but in eight
patients in the placebo group (P <
0.02). No complications due to the
use of cefamandole were recognized.

is unusual to find a low intragastric
pH even in patients who undergo
operation for duodenal ulcer and pain
resistant to medical treatment.14 Or
ganisms grown from the stomach were

T ab le 1 - C o m p a riso n o f Patient G ro u p s
C e fa m a n d o le
F actors

(n =

Age, yr*

5 7 .5 ±

S e x , m aleffem ale

32)
2.5

W e igh t, actuallideal, % *

105 .7 ±

P la c e b o

t

(n = 28)

valu e

61.4 +

18114

3.6

0.92

14114
4.5

05.9 +

1785 ±

153

1504 +

129

1.39

17.3 ±

1.6

17.1 ±

1.9

0.1 0 2

4.3

P re o p e ra tiv e blood
ly m p h o cy te s, m m 3*
R is k index. % *
'M e a n ±

sta n d a rd deviation.

T a b le 1 1 -C o m p a ris o n o f P a tie n t G ro u p s -

D ia g n o sisJ risk

D ia g n o s is and R is k o f In fe ction
C e fa m a n d ole

P la c eb o

(n = 32)

(n = 28)

D ia g n o s is
Intractable d uodenal ulcer

6

4

G astric u lce r

4

2

G astric tu m o u r

9

13

P erforated d uo d e n a l ulcer

3

2

G astric o u tle t o b stru ction

5

3

B le e d in g peptic ulcer

5

4

H igh

24

22

Low

8

6

R is k b a se d o n in d icatio ns
fo r s u rg e ry

T ab le Il l- C o m p a r is o n o f P a tie n t G ro u p s -

P ro c e d u re s and W o u n d s
C e fa m a n d ole

P ro ce d u re fW o u n d

(n = 32)

P la c eb o
(n =

28)

Proce dure
E m e rge n c y

7

5

Elective

25

23

G astric re se c tio n

23

22

9

6

N o g a stric re se c tio n

Discussion

W o u n d cla ssifica tio n

Continuing doubts about the value
of antibiotic prophylaxis in gastroduo
denal surgery are justified by the fact
that only in one study, by Polk and
Lopez-Mayor,1 were stringent criteria
for inclusion and critical evaluation
followed.7 The present, controlled,
double-blind study examines antibiotic
prophylaxis in urgent as well as in
elective gastroduodenal operations and
confirms their worth. While the total
numbers are small, the groups studied
were well matched, exclusions were
few and the results obtained are of
statistical significance. The frequency
of wound infection found in the pa
tients who received the placebo is
high, but approximates that previously
reported.1-4
The dominant factor determining
the risk of postoperative wound infec
tion was the degree of contamination.
In gastroduodenal operations, other
investigators” have related this to the
562

extent of bacterial growth in the stom
ach and to intragastric pH. We did
not investigate this finding. But now
that the histamine Hi receptor anta
gonist, cimetidine, is used widely, it

C ontam inate d
Cle an-contam inate d
W o u n d in fe ction ln o w o u n d infection
*P <

7

5

25

23

1/31

8/20*

0.01.

T a b le I V - -B a c t e r io lo g y B a cte rio log y

S to m a c h and S u b c u t a n e o u s Fat
C e fa m a n d ole

P la c eb o

G a stric co nte n t
C olrfo rm s*
G ra m -po sitive c o c c it
B a c t e r o id e s

sp

6

7

10

10

2

0

sp

5

4

N o g ro w th

9

7

C a n d id a

S u b c u t a n e o u s fat
E s c h e r ic h ia c o l i *

1

1

G ra m -po sitive c o c c it

6

7

sp

1

0

N o g ro w th

19

16

5

4

C a n d id a

N o t done
* C o lifo rm s =

E s c h e r ic h ia c o l i

and P r o t e u s , E n t e r o b a c t e r , K l e b s i e l l a o rga n ism s,

t G ra m -po sitive c o cc i = Stre p toc occ i, S t a p h y l o c o c c u s p y o g e n e s , S t a p h y l o c o c c u s e p id e r m id is and peptostrep tococci.
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similar to those responsible for pro
ducing wound infections. In six pa
tients, the stomach was clearly the
source of contaminating organisms;
one patient with postoperative contact
dermatitis adjacent to the wound had
an .S', epidermidis wound infection,
probably from the skin flora. We
have previously reported on the
prevalence of coliform organisms as
well as normal gram-positive flora of
the stomach in these wound infec
tions.4 The present study confirms
these findings. Because of the small
number of postoperative infections
and incomplete data, the statistical
significance of positive culture of the
subcutaneous tissues could not be cal
culated.
The reduced frequency of postoper
ative urinary tract infections in pa
tients receiving antibiotics prophylactically has been reported previously.15
But since the present study did not
examine the role of the indwelling
Foley catheter in the urinary tract
infections observed, the significance
of our finding is uncertain.
The choice of cefamandole for pro
phylaxis was predicated on its , in
creased spectrum of activity against
gram-negative organisms, when com
pared with the activity of the firstgeneration cephalosporins. Since this
broader spectrum is achieved at the
expense of efficacy against staphylo
cocci,16,17 it is of interest that the
single failure of prophylaxis in the
cefamandole group was in a patient
with a staphylococcal infection. The
first-generation cephalosporin, cefazolin. is effective against the gram
negative bacilli that usually cause
wound infections after gastroduodenal
operations; it is also more effective
than cefamandole against staphylococ
ci and achieves higher serum concen
trations and better tissue penetration
than does cefamandole.18 Further, it
now appears that a single dose of a
suitable antibiotic may suffice for

prophylaxis.7 Whether a single dose
of an antibiotic such as cefazolin is
as effective as multiple doses in pre
venting postoperative infections in
elective gastroduodenal surgery re
mains to be shown.
Conclusions

Patients who undergo elective or
emergency gastroduodenal operations
for peptic ulcer disease, tumour or
gastroduodenal bleeding are at sub
stantial risk of having postoperative
wound infection.
The main source of these infections
is operative contamination from the
stomach contents.
Cefamandole given intravenously in
the perioperative period reduces this
risk of wound infection.
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NOTICES
continued from page 549
Sterling Bunnell Memorial
Lectureship Program

The Sterling Bunnell Memorial Lec
tureship was established in 1961 in
honour of a surgeon who was worldrenowned for his work in reconstruc
tive surgery of the hand. Lecturers
are selected on the basis of significant
achievement in reconstructive surgery
of the upper extremity.
On Nov. 4 and 5, 1982 the depart
ment of orthopaedic surgery, Univer
sity of California School of Medicine
at San Francisco will commemorate
the 100th anniversary of Sterling
Bunnell’s birth by inviting previous
guest lecturers to discuss the changes
in the surgical treatment of the upper
extremity that have taken place re
cently. The faculty will include: J.H.
Boyes, P.R. Lipscomb, L.W. Milford,
R.G. Pulvertaft and D.C. Riordan.
Subjects to be discussed will in
clude: soft tissue cover and transplan
tation of tissue, rheumatoid arthritis,
tendon ruptures and lacerations, crush
fractures and dislocations, congenital
anomalies, nerve lesions, and tendon
transfers for the paralyzed upper ex
tremity.
This program is sponsored by Ex
tended Programs in Medical Educa
tion, and will meet the criteria for
ACCME/ AMA/CMA Category
1
(formal) continuing education credit.
For further information, write: Ex
tended Programs in Medical Educa
tion, University of California School
of Medicine, Rm. 569-U, Third and
Parnassus, San Francisco, CA 94143,
or call (415) 666-4251.

THE CANADIAN JOURNAL OF SURGERY

563

NOW IN STROKE

-4

The Advantages of ENTROPHEN*
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To reduce the risk
of stroke

with reduced risk
of stomach upset

Now, ENTROPHEN* is
indicated for reducing the risk
of recurrent transient ischemic
attacks or stroke in men who
have had transient ischemia
of the brain due to fibrin
platelet emboli. At present
there is no evidence that
ASA is effective in reducing
transient ischemic attacks
in women, or is of
benefit in the treatment
of completed strokes
in men or women.
Inhibition of platelet
cyclooxygenase activity
by a single dose of
ENTROPHEN*-10
was comparable to
that of plain ASA,
although the effect was
delayed, reflecting the
delayed appearance of
ASA in the plasma.1

When you prescribe
ASA for long-term use,
it is important not to create
additional problems for
your patients.
While they may benefit
from the therapeutic
effect of ASA, there is
still a potential for
gastric irritation and
upset, particularly
when the regimen calls
for continuous daily
dosage.
Clinical experience
has shown that
ENTROPHEN*, coated
with POLYMER 37*
reduces gastric distress
in long-term treatment
with high doses of ASA.
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TABLETS

entrophen*
(acetylsalicylic acid tablets, USP)
Enteric-coated with POLYMER 37*
Anti-inflammatory— Analgesic Agent
Platelet Aggregation Inhibitor
DESCRIPTION
ENTROPHEN* is an enteric-coated tablet contain
ing acetylsalicylic acid coated with POLYM ER 37*.
a partially esterified polyvinyl alcohol.
ACTION
Acetylsalicylic acid (ASA| has analgesic, anti
pyretic and anti-inflammatory properties.
In rheumatic diseases, although the analgesic and
antipyretic effects are useful, the major purpose
for which ASA is used is to reduce the intensity of
the inflammatory process. Inhibition of prosta
glandin synthesis may be involved in the anti
inflammatory action of ASA.
ASA also alters platelet aggregation and release
reaction by inhibiting prostaglandin synthesis
Thromboxane A2 is an essential step in platelet
aggregation. ASA prevents Thromboxane A2 for
mation by acetylation of platelet cyclooxygenase.
This inhibition of prostaglandin synthesis is
irreversible and affects platelet function for the
life of the platelet.
The POLYMER 37* coating substantially resists
disintegration in aqueous fluids having a pH lower
than 3.5 for a period of at least 2 hours and is
capable of disintegrating in aqueous fluids having
a pH of at least 5.5 in from 10 to 30 minutes. Thus,
POLYMER 37* coating effectively inhibits the
release of ASA in the stomach, whilst allowing the
tablet to dissolve in the upper portion of the small
intestine for absorption from the duodenal area.
Clinical experience has shown that POLYMER 37*
coated acetylsalicylic acid diminishes or eliminates
gastric distress during long-term treatment with
high doses of ASA.
INDICATIONS
ENTROPHEN* is indicated whenever gastric
intolerance to ASA is of concern.
ENTROPHEN* is indicated for the relief of signs
and symptoms of the following:
Osteoarthritis
Rheumatoid arthritis
Spondylitis
Bursitis
and other forms of rheumatism
Musculoskeletal disorders
Rheumatic fever, however, penicillin and other
appropriate therapy should be administered
concomitantly.
ASA is generally considered to be the primary
therapy for most forms of arthritis.
ENTROPHEN* is also indicated for reducing the
risk of recurrent transient ischemic attacks or
stroke in men who have had transient ischemia of
the brain due to fibrin platelet emboli. At present
there is no evidence that ASA is effective in
reducing transient ischemic attacks in women, or
is of benefit in the treatment of completed strokes
in men or women.
CONTRAINDICATIONS
Sensitivity to the ingredients
Active peptic ulcer
Patients who had a bronchospastic reaction to
ASA or non-steroidal anti-inflammatory drugs.
WARNINGS
ASA is one of the most frequent causes of
accidental poisoning in toddlers and infants.
ENTROPHEN* should, therefore, be kept well out
of the reach of all children.
PRECAUTIONS
Salicylates should be administered with caution
to patients with asthma and other allergic condi
tions, with a history of gastrointestinal ulcerations,
with bleeding tendencies, with significant anemia
or with hypoprothrombinemia.
Salicylates can produce changes in thyroid
function tests.
Acute hepatitis has been reported rarely in
patients with systemic lupus erythematosus and
juvenile rheumatoid arthritis with plasma sali
cylate concentrations above 25 mg/100 mL

Patients have recovered upon cessation of
therapy.
Use in Pregnancy
ASA does not appear to have any teratogenic
effects. ASA has been found to delay parturition
in rats This effect has also been described with
non-steroidal anti-inflammatory agents which
inhibit prostaglandin synthesis.
High doses (3 g daily) of ASA during pregnancy
may lengthen the gestation and parturition time.
Because of possible adverse effects on the
neonate and the potential for increased maternal
blood loss, ASA should be avoided during the last
three months of pregnancy.
Drug Interactions
Caution is necessary when ENTROPHEN*
and anticoagulants are prescribed concurrently, as
ASA may potentiate the action of anticoagulants.
Salicylates may potentiate sulfonylurea hypo
glycemic agents. Large doses of salicylates may
have a hypoglycemic action, and thus, affect the
insulin requirements of diabetics.
Although salicylates in large doses are uricosuric
agents, smaller amounts may depress uric acid
clearance and thus decrease the uricosuric
effects of probenecid, sulfinpyrazone and
phenylbutazone.
Sodium excretion produced by spironolactone
may be decreased in the presence of salicylates.
Salicylates also retard the renal elimination of
methotrexate.
ADVERSE REACTIONS
Gastrointestinal reactions: nausea, vomiting,
diarrhea, gastrointestinal bleeding and/or ulcera
tion. Ear reactions: tinnitus, vertigo, hearing loss.
Hematologic reactions: leukopenia, throm bo
cytopenia, purpura. Dermatologic and Hypersen
sitivity reactions: urticaria, angioedema, pruritus,
various skin eruptions, asthma and anaphylaxis.
Miscellaneous reactions: acute reversible hepatotoxicity, mental confusion, drowsiness, sweating
and thirst.
SYMPTOMS AND TREATMENT
OF OVERDOSAGE
Symptoms
In mild overdosage these may include rapid and
deep breathing, nausea, vomiting (leading to
alkalosis), hyperpnea, vertigo, tinnitus, flushing,
sweating, thirst and tachycardia. (High blood
levels of ASA lead to acidosis.) Severe cases may
show fever, hemorrhage, excitement, confusion,
convulsions or coma, and respiratory failure.
Treatment
Treatment is essentially symptomatic and sup
portive. Administer water, universal antidote and
remove by gastric lavage or emesis. Force fluids
(e.g., salty broth) to replace sodium loss. If the
patient is unable to retain fluids orally, the alkalosis
can be treated by hypertonic saline intravenously.
If salicylism acidosis is present, sodium bicar
bonate intravenously is preferred because it
increases the renal excretion of salicylates.
Vitamin K is indicated if there is evidence of
hemorrhage. Hemodialysis has been used with
success.
Respiratory depression may require artificial
ventilation with oxygen. Convulsions may best be
treated by the administration of succinylcholine
and artificial ventilation with oxygen. Central
nervous system depressant agents should not
be used.
Hyperthermia and dehydration are immediate
threats to life and initial therapy must be directed
to their correction and to the maintenance of
adequate renal function. External cooling with
cool water or alcohol should be provided quickly
to any child who has a rectal temperature over
104°F.
DOSAGE AND ADMINISTRATION
Analgesic; antipyretic
Up to 2.925 g daily as necessary.
Anti-inflammatory
Because the suppression of inflammation in
creases with the dose of salicylate even beyond
the point of toxicity, the therapeutic objective is
to employ as large a dose as possible short of
toxicity. Most patients will tolerate blood salicylate
levels in the range of 20 to 25 mg per cent. The
most common reason for failing to obtain a
therapeutic response to ASA is the administration
of inadequate doses.

The generally accepted way to achieve effective
anti-inflammatory salicylate blood levels of 20 to
25 mg per cent is to titrate the dosage by starting
with 2.6 to 3.9 g daily, according to the size, age
and sex of the patient. If necessary, the dosage is
then gradually adjusted by daily increments of
0.65 g until symptoms of salicylism e.g., auditory
symptoms, occur. Then, the dosage is decreased
by 0.65 g daily until these symptoms disappear
and maintained at that level as long as necessary.
In adults the median dose at which tinnitus
develops is 4.5 g per day, but the range extends
from 2.6 to 6.0 g per day.
Intermittent administration is ineffective. Patients
should be advised not to vary the dose from day
to day depending on the level of pain because
that often fluctuates independently of the intensity
of the inflammation. A continuous regimen of
0.65 g four times daily is considered to be
minimum therapy for adults. ENTROPHEN*
should be administered four times daily. For night
time and early morning benefits, the last dose
should be given at bedtime.
Once m a in te n a n ce dose is e sta b lis h e d ,
ENTROPHEN*-15 may be useful to encourage
patient compliance.
Optimally, salicylate therapy should be monitored
by periodic blood salicylate level determinations.
If this is not practical, the appearance of auditory
symptoms in the form of tinnitus or deafness are
acceptable as an indication of the maximum
tolerated salicylate dose.
There is an inverse relation between blood
salicylate levels at which auditory symptoms
appear and the age of the patient. In the young
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Urolithiasis in Children
S. O’R egan,

mb , frcp [c ],

Between 1971 and 1980, 55 children with
urolithiasis were assessed and
treated. Pediatric urolithiasis accounted
for 1:4090 hospital admissions. Forty
percent of patients had no identifiable
predisposition to urolithiasis. Eight
patients presented with hematuria in
the absence of renal colic suggesting
that pediatric urolithiasis, although
uncommon, is an important cause of
painless hematuria.
Entre 1971 et 1980, 55 enfants
souffrant d'urolithiase ont ete
examines et traites. L'urolithiase
pediatrique compte pour 1:4090
hospitalisations. Quarante pourcent
des malades n'offraient aucune
predisposition identifiable a l'urolithiase.
Huit patients ont ete regus alors
qu’ils presentaient une hematurie
en I'absence de colique renale,
suggerant ainsi que bien que rare,
l'urolithiase pediatrique est une cause
importante d'hematurie indolore.

In the 19th century, urolithiasis in
both adults and children was common
in the West.1 The incidence decreased
markedly in the early 20th century,2
and the present low incidence of renal
stones in children is illustrated by the
relative paucity of reports in the litera
ture during the past 30 years.3"12 In
1951, Lattimer and Hubbard18 found
no urinary calculi in children in 23 835
admissions to Babies’ Hospital in New
York. An incidence of urolithiasis
ranging from 1 in 10003 pediatric ad
missions in Britain15 to 1 in 7600 pe
diatric admissions in the United States9
has been described. However, a recent
editorial19 has suggested that pediatric
urolithiasis is either increasing in in
cidence or is becoming increasingly
recognized as a distinct entity. Be
cause of the varying incidence of pe
diatric urolithiasis in the US and the
lack of similar data in Canada, there
being only one analysis of pediatric

Y. H omsy ,

md, frcs[c] and

urolithiasis available,16 we have as
sessed retrospectively the incidence of
urolithiasis in children admitted to the
Hopital Sainte-Justine in the decade
1971 to 1980.
Patients and Methods

From Jan. 1, 1971 to Dec. 31, 1980,
55 children with proven urinary stones
were admitted to Hopital Sainte-Jus
tine in Montreal. Clinical, laboratory
and other data were analysed and re
viewed, and the data compared with
those of other recently published se
ries.
Findings

The age of the 55 children at the
time of admission ranged from 13
months to 19 years (mean 10 years,
8 months) with a male-to-female ratio
of 1:1. In analysing the available data
we classified all 55 cases of urolithias
is on the basis of possible etiologic
factors (Table I): nine children in
group 1 had congenital abnormalities
that might predispose to stasis, infec
tion or other factors, which might
in turn predispose to urolithiasis;
group 2 consisted of seven patients
with a metabolic abnormality, either
congenital or acquired; in group 3
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were 10 children with acquired uri
nary abnormalities or other condi
tions that would predispose to stone
formation; group 4 consisted of 29
children in whom there was no known
etiologic factor.
The incidence of congenital, meta
bolic and other identifiable etiologic
factors was equal in the two sexes and
accounted for over 47% of all cases
of urolithiasis. Abdominal pain with
hematuria, infection, dysuria and
enuresis were the predominant symp
toms associated with stone presenta
tion (Table II). Painless macroscopic
hematuria occurred in eight patients.
As expected, the incidence of infection
was high in all groups, particularly
those in which there was an identi
fiable etiologic factor: 7 children in
group 1, 5 in group 2 and 7 in group

T a b le I I - P r e s e n t i n g S y m p to m s and S ig n s
No. of
S y m p to m fs ig n

c h ild re n

M a c r o s c o p ic h e m a tu ria ,
p a in le s s

8

A b d o m in a l p a in and
h e m a tu r ia

22

In fe c tio n

32

D y s u ria

1

E n u re s is

1

N o . of
G ro up
1

2

E tio lo g y

p a tie n ts

C o n g e n ita l

B oys

G irls

9

5

4

M e g a u re te r

1

1

0

E c to p ic k id n e y

1

1

0

R e flu x

5

2

3

M e d u lla r y s p o n g e k id n e y

2

1

1

M e ta b o lic

7

4

3

C y s tin u ria

2

1

1

O x a lo s is

1

0

1

C ro h n 's d is e a s e

1

1

0

F a n c o n i s y n d ro m e

1

0

1

1

1

0

1

1

0

10

5

5

5

2

3

H a n d -S c h u lle r-C h ris tia n

D u c h e n n e m u s c u la r
d y s tro p h y

3

O th e r re c o g n iz a b le c a u s e s
N e u r o g e n ic b la d d e r (due
to p a ra p le g ia )
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3; 13 of 29 children in group 4 also
had infection. The predominant organ
ism was Escherichia coli (21), followed
by Streptococcus faecalis (15) and Pro
teus sp. (11 children). Neisseria, Pseudo
monas and Klebsiella organisms were
identified in two patients each. There
was almost equal incidence of stones
in the right and left kidneys (Table
III). In four patients there were stones
in both kidneys. There were six stones
in the left ureter and three in the right.
Several patients had recurrent stones.
Operation was performed on 22 chil
dren (Table IV). The two with bladder
stones, one with a neurogenic bladder
the other with a cystine calcium stone,
required surgical removal of the stone.
The majority of stones were of the
idiopathic type, that is without any
apparent predisposing factor, apart
from hypercalciuria noted in five
cases. Many of the stones were small
so major operative intervention was
uncommon. It was required mainly
for those who had large stones asso
ciated usually with congenital anato
mic abnormalities. A limited number
of stones were available for chemical
analysis, because most in the idiopa
thic group were exceedingly small and
many were passed spontaneously out
side hospital. Of seven stones analysed,
four contained calcium oxalate and
two struvite.
Table Ill-Site of Calculi
Site
Kidney
Right
Left
Bilateral

No.
18
16
4

Kidney + ureter,
right and left

4

Ureter
Right
Left
Bilateral

3
6
1

Ureter, left +
urethra (multiple)

1

Bladder

2

Table IV-Operative Procedures Performed
No.
Operation
8
Pyelolithotomy
3
Nephrolithotomy
Pyelonephrolithotomy
1
3
Ureterolithotomy
4
Vesicolithotomy
Nephrectomy, nephroureterectomy,
heminephrectomy
3

Discussion
This retrospective survey demon
strates a frequency of urolithiasis in
children in Quebec of 1 in 4090 pe
diatric hospital admissions. There was
no identifiable cause for the condition
in 53% of the 55 children. The in
cidence of pediatric urolithiasis in
previously reported series has ranged
from 1 in 100015 to none in more than
21 000 hospital admissions.18 A recent
survey16 indicated an incidence of 1 in
1380 hospital admissions in New
foundland.
In our series, eight patients pre
sented with macroscopic painless
hematuria. Iitaka and West20 described
four patients with this presenting
symptom, supporting the finding that
urolithiasis in children may present
with hematuria in the absence of renal
colic. However, in these cases, radiologic investigation can usually dif
ferentiate urolithiasis from other
causes of painless hematuria such as
glomerulonephritis or malignant tu
mour.
Of interest was the high rate of
infection especially in those with pre
disposing metabolic factors. More
over. in children with no definitive
cause, 45% had associated infection,
a rate much higher than that pre
viously reported.5’16 When the stones
were passed the infection resolved and
did not recur. The predominant or
ganism in patients with infection was
E. coli followed by S. faecalis and
Proteus sp., which was noted especially
in patients with associated neurologic
deficits such as neurogenic bladder.
In these patients, stones were recur
rent in spite of efforts to maintain
urine sterility by prophylactic admi
nistration of antibiotics.
The incidence of urinary tract ab
normalities associated with pediatric
urolithiasis in previously reported se
ries has ranged from 9%
to
70% .5'6’8-10’12-15 In Newfoundland 18%
of patients had anatomic abnormali
ties of the genitourinary tract.16 In our
series, 14 (25%) had predisposing
anatomic abnormalities, including con
genital and acquired ones. In contrast
to the findings of the Newfoundland
study, five of our patients had meta
bolic disorders (cystinuria, oxalosis
and renal tubular acidosis). The inci
dence of metabolic disorders asso
ciated with urolithiasis has ranged
from 0% to 38% in other series.6’10
In only 5 of 14 in whom 24-hour uri
nary calcium was measured was there
hypercalciuria (i.e., daily excretion of
calcium greater than 4 mg/kg). None
of these patients had evidence of hy
perparathyroidism, in contrast to the

observations of Wenzl and colleagues12
who noted hyperparathyroidism or
hyperadrenocorticism in four of five
hypercalciuric patients. A family his
tory of urolithiasis was elicited in the
case of 10 (34%) of the 29 patients
with idiopathic urolithiasis, a rate
lower than that noted in other series
(36% to 44% ).10’16
The major concerns in the manage
ment of urolithiasis in children are
immediate treatment and prevention of
recurrence. Obviously stones causing
obstructive uropathy, or those too
large to pass spontaneously require
surgical removal. However, a high
percentage of stones may be passed
spontaneously. The major problem is
preventing recurrence. The recurrence
rate in children appears lower than in
adults; it is reported to be between
16% and 44% :3/1 In patients with
cystinuric stones, a high fluid intake
with urinary alkalinization and, if ne
cessary, penicillamine are required.
Elimination of stasis, if possible, with
prophylactic antibiotic therapy may
aid in preventing recurrence of stones
in patients with infection-associated
calculi. Thiazide diuretics may be of
value in patients with renal-leak hyper
calciuria. The decision to prescribe
lifelong thiazide therapy in children
with documented renal hypercalciuria
with stone formation is, in the ab
sence of recurrent stone formation, a
difficult one because of the side-effects
of thiazide therapy such as hyper
uricemia and hyperglycemia. However,
recently it has been noted that in chil
dren with hypercalciuria who have
macroscopic hematuria and are at risk
of developing stones, the hematuria
rapidly resolves when they are treated
with thiazides.21 Despite this observa
tion the place of thiazide therapy for
these children is still uncertain.
In summary, urolithiasis in children,
though not a common phenomenon,
is extremely variable in its presenta
tion and thus must be included in the
differential diagnosis of conditions
such as acute abdominal pain and
painless hematuria.
Investigations
should include radiologic study of
the urinary tract by intravenous
pyelography and voiding cystogram,
investigation of possible metabolic
causes by determination of serum cal
cium, phosphate, uric acid, electro
lytes and creatinine levels in addition
to the 24-hour urine level of calcium,
uric acid, oxalate and creatinine ex
cretion for determination of calciumto-creatinine excretion ratio.22 A pro
file of urinary aminoacid excretion in
addition to urinalysis will detect cy
stinuria.
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BOOK REVIEWS
continued from page 520
bibliography, which has been conve
niently divided into sections on the basis
of systems but considers separately the
neck, the spine and contents, and the
skeletal system.
Truly an atlas, most pages contain up
to six illustrations. The figures are not
quite up to the standard found in jour
nals of radiology but nevertheless have
reproduced well on the good quality
paper. They are clearly labelled with
letters and small arrows and can be fol
lowed easily with the text. There is
minimal use of long lines to the peri
phery of figures which is so irritating
in many other atlases. Clear line draw
ing assist the reader.
There are 14 chapters separated into
“normal” and “abnormal” for each area;
only the chapter on the upper extremities
has no “abnormal” section. However, the
type of bony and soft tissue abnormal
ities encountered in the upper limb are
illustrated in the section on abnormal
lower extremities. The trunk is treated
in orderly manner by proceeding caudally from neck to pelvis with additional
chapters on the retroperitoneal compart
ments and fasciae.
Most of the scans were made on the
body of a 48-year-old man using an EMI
5005 machine (320 x 320 matrix). In
many areas either positive contrast me
dium or air was injected into tubular
structures such as arteries, veins and
biliary system, but one must be careful
to read the explanation at the beginning
of each chapter because the contrast
material used is not uniform.
Films of frozen sections made at the
same level as the scans appear alongside
them. Because the development of new
generations of computerized tomography
(CT) scanners has been so rapid over
the past few years the tomograms do
568
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not show the structures as clearly as is
now possible although in general they
are of reasonably good quality.
The abnormal scans demonstrate the
usefulness of CT and the authors’ com
ments concerning their own experience
are an added bonus. An important as
pect of body CT is the correct manipu
lation of the window setting to obtain
both good pictures and diagnosis. This
is well illustrated by the authors with
respect to liver metastases and should
always be considered by anyone review
ing CT scans. Two pitfalls for the un
wary, namely pseudodilatation of the
pancreatic duct caused by a fat plane
and an unusual configuration of the
spleen mimicking a tumour of the pan
creatic tail, are further valuable points.
An interesting demonstration of the
intra- and extraperitoneal spaces follow
ing perforation of the colon with extra
vasation of barium is afforded by both
conventional roentgenograms and CT
scans. Some illustrations of cadaver
studies showing air in the retroperitoneal
tissues are also included. One important
omission is that of normal lung studies.
The machine settings demonstrate the
mediastinal anatomy well but a further
series showing the lung vasculature
would be helpful.
Rarely is one able to comment posi
tively on the cost of a good book. For
US $19.95 in paperback, this atlas is
extremely good value and will be most
useful to anyone who uses CT, either
to the imager as an aid to anatomy and
pathology or to the clinician as an in
dication of the potential of the modality.
D .J. M a r t in ,
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Effects of Magnesium Infusions on Magnesium
and Nitrogen Balance during Parenteral Nutrition
Jo e l B. F r e e m a n , m d , f r c s [ c ], facs , M ario n F. W it t in e , b sc , L ew is D. S t e g in k , ph d and
E d w a rd D. M a s o n , m d , facs

The effects of magnesium infusions on
urinary and fecal magnesium excretion,
serum magnesium and nitrogen balance
were examined in seven well-nourished
and three nutritionally depleted
adult surgical patients receiving total
parenteral nutrition. They were
maintained on constant nitrogen and
caloric intake for 14 ± 2 days.
Magnesium doses ranged from 0 to
664 mg/d and were given in varying
crossover patterns. In both groups,
urinary magnesium excretion increased
as the amount of magnesium infused
increased but, at comparable
magnesium infusions, depleted patients
excreted significantly less magnesium.
Renal conservation was most
pronounced in well-nourished patients
on magnesium-free intake and in
depleted patients given 70 mg
magnesium daily. Urinary magnesium
losses were 40 ± 5 mg/d and
33 ± 8 mg/d, respectively, in these
two groups. Endogenous fecal
magnesium excretion was minimal
and ranged from 2 to 38 mg/d.
At each level of magnesium intake,
serum levels of well-nourished patients
were normal. With infusions of less
than 200 mg/d, serum magnesium
concentrations in depleted subjects
averaged 1.6 mg/dl. Reduced urinary
magnesium excretion as well as
borderline serum levels measured in
depleted adults suggest that the
magnesium dosage should be higher
than that usually recommended during
total parenteral nutrition. In both
groups a positive correlation between
magnesium and nitrogen balance
was noted.
Les effets des perfusions de
magnesium sur l'excretion urinaire et
fecale du magnesium, la concentration
serique du magnesium et le bilan
azote ont ete etudies chez sept
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patients chirurgicaux adultes
bien nourris et chez trois patients
souffrant d'une carence nutritionnelle
et recevant une alimentation
parenterale totale. Tous ont repu
un apport calorique et azote
constant pendant 14 ± 2 jours.
Les doses de magnesium ont varie
de 0 a 664 mg/j et ont ete
administrees selon diverses
sequences de chasse-croise.
Dans les deux groupes, I’excretion
urinaire de magnesium a augmente avec
les quantites de magnesium perfusees
mais, pour des perfusions
comparables de magnesium,
les patients carences excretaient
significativement moins de magnesium.
La conservation par le rein etait
la plus marquee chez les patients
bien nourris qui ne recevaient pas
de magnesium et chez les patients
carences recevant 70 mg/j de
magnesium. La perte urinaire
de magnesium etait de 40 ± 5 mg/j
et de 33 ± 8 m g/j respectivement
pour les deux groupes. L'excretion
fecale endogene du magnesium
etait minime et variait de 2 a 38 mg/j.
A chaque niveau d'apport de
magnesium, les niveaux seriques
chez les patients bien nourris
etaient normaux. Avec des
perfusions de moins de 200 mg/j, les
concentrations seriques de
magnesium chez les sujets
carences etaient de 1.6 mg/j
en moyenne. L'excretion urinaire
reduite du magnesium ainsi que
les taux seriques limites mesures
chez les adultes carences indiquent
que la dose de magnesium devrait
etre plus eleve que celle qui est
habituellement recommandee
durant I’alimentation parenterale
totale. Chez les deux groupes,
une correlation positive a ete
observee entre le magnesium
et le bilan azote.

Magnesium, the major intracellular
divalent cation, is a vital cofactor in
numerous enzymatic reactions and is
required for protein synthesis, neuro
muscular function and cellular integ
rity. The healthy adult human body
contains 20 to 30 g o f this metal, of
which only 15% is rapidly exchange
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able and therefore available to supply
deficient tissues.1'2 Magnesium defi
ciency is manifested by various clin
ical and biochemical symptoms, in
cluding nausea, dizziness, depression,
muscular weakness and convulsions.1,4
Low serum levels o f magnesium, cal
cium and potassium, low magnesium
concentrations in muscle, bone and
red cells, reduced urinary excretion
o f magnesium and calcium, and ex
cessive potassium losses in the urine
have all been found in cases of mag
nesium deficiency. Because o f its bio
logic importance, a daily magnesium
intake o f 300 to 350 mg is recom 
mended for adults on oral diets.5 O f
this ingested amount, 30% to 50%
is absorbed and utilizable.2,8'7
During parenteral nutrition the
amount o f magnesium that should be
infused is not known with certainty.
Manifestations o f magnesium deple
tion have becom e evident after pro
longed intravenous feeding with mag
nesium-free fluids and during gastro
intestinal suctioning.1'8 As a result, the
suggested parenteral magnesium re
placement ranges from 48 to 600 mg
(4 to 50 meq) daily.0 Our purpose was
to determine the optimal level o f
magnesium for infusion during total
parenteral nutrition in nourished and
nutritionally depleted surgical pa
tients. W e measured the effects o f
varying doses o f magnesium (0 to 664
m g/d ) on excretion, serum concentra
tion and nitrogen balance.
Patients and Methods

Ten patients were studied postoperatively for 14 ± 2 days. Based
on nutritional and medical histories,
they were assigned to two groups:
morbidly obese well-nourished pa
tients (n = 7) having a mean pre
operative weight o f 130.1 ± 9.6 kg
and nutritionally depleted patients
(n = 3) who had an average weight
o f 41.2 ± 6.3 kg. Table I summar
izes the clinical data for each group.
Total
parenteral
nutrition was
started at 08:00 hours on the morning
following operation. The solutions
consisted o f 2 5% dextrose with the
nitrogen being derived from either
4.25% crystalline amino acids (Fre-
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amine II [8.5%]; McGaw Labora
tories, Glendale, Calif.) in six patients
or 5% protein hydrolysate (Arnigen;
Baxter Travenol Laboratories of Can
ada Ltd., Malton, Ont.) in four pa
tients. The average nitrogen intake
was 17.7 g/d. The source of added
magnesium was magnesium sulfate
heptahydrate (Eli Lilly & Co., Indi
anapolis, Ind.) (2 ml of 50% solution
contains approximately 100 mg or 8
meq of magnesium). Individuals on
protein hydrolysate received 24 mg of
magnesium per litre of protein solution.
This was considered in all calculations.
Analysis of crystalline amino acid and

glucose solutions revealed no detec
table amounts of magnesium. Five
patients received two or more levels
of magnesium intravenously in a va
riety of crossover patterns.
Depleted patients received not less
than 6 meq of magnesium daily. Oral
intake was restricted to distilled water.
All nutrients, including electrolytes,
minerals and vitamins were given
through the subclavian vein with a
constant infusion pump at a rate of
125 ml/h. Nitrogen, calcium, phos
phorus and caloric intakes were main
tained constant throughout each study
period. Each patient received 10 ml

Table 1 -Clinical Data

of fat and water-soluble vitamins
daily.
Spectrophotometric analyses for
magnesium were performed daily on
24-hour urine aliquots and also on
serum every 3 days.10’" Urinary crea
tinine concentration was measured
daily to assure complete collections.
Stools were analysed for magnesium
by atomic absorption flame photo
metry.12 Nitrogen in urine, feces and
nasogastric fluid, as well as the nitro
gen content of the amino acid and
protein hydrolysate solutions, was de
termined by the microKjeldahl meth
od. Nitrogen balance was calculated
on the basis of total nitrogen infused
minus the sum of urinary, fecal and
nasogastric nitrogen losses.

Group
Clinical feature
Sex distribution,
femalelmale
Age, yr*
Preoperative weight, kg*
Procedure
Gastric bypass
Sphincteroplasty
Multiple small bowel
resections leading to
malabsorption

Nourished

Depleted

611
36 + 4
130.1 ± 9.6

2/1
50 ± 6
41.2 ± 6.3

7
1

2

'M ean ± standard error of mean.

Table 11-Effect of Infused Magnesium on Urinary and Serum
Magnesium* Levels in Seven Nourished Patients!
Magnesium
infused, mg/d
73
97
196
369
390
664

0
±
+
±
±
±
±

0
0
1
0
4
0

Urinary loss of
magnesium, mgld
40
139
75
184
332
230
608

±
±
±
±
+
±
+

5
16
6
15
23
14
47

Magnesium
balance, mg/d
40
-66
+22
+12
+37
+ 160
+56

±
±
±
±
±
±
±

5
16
6
14
23
10
47

Serum level of
magnesium, mg/dl
1.8
1.8
2.0
2.1
2.3
2.5
2.2

*Values expressed as mean ± SEM.
tEach patient was studied for 14 + 2 days at the infusion rate shown in the left-hand column. During
the study period magnesium infusion rates were doubled for several 48-hour periods in three of the
seven patients and then returned to normal infusion levels, to confirm the results.

Table Ill-Effect of Infused Magnesium on Urinary
and Serum Magnesium Levels* in Three Nutritionally Depleted Patientsf
Magnesium
infused, mg/d
70
172
263
369

±
±
±
±

3
1
5
0

Urinary loss of
magnesium, mg/d
33
76
184
253

±
±
±
±

8
27
12
38

Magnesium
balance, mg/d
+37
+ 96
+79
+ 116

±
±
+
±

10
26
10
38

Serum level of
magnesium, mg/dl
1.5
1.6
1.9
2.3

'Values expressed as mean ± SEM.
tEach patient was studied for 12 to 28 days. The magnesium infusion rates (left-hand column) were
doubled for 48-hour periods and returned to normal to confirm the results. Rates required to attain
positive magnesium balance were lower than in well-nourished subjects (see Table II). The magnesium
infusion of 369 mg is a mean of the crossover studies from three patients. The high positive
magnesium balance indicates that further increments of magnesium infusion should not be given.

Results

Very little intravenously adminis
tered magnesium is lost through
feces.1,6 Hence, stools collected over
any 24-hour period were selected at
random for analysis. Our results in
dicated a range of 2 to 38 mg of
magnesium for each period. This con
firmed previous data and pointed to
urinary losses as the principal factor
in determining magnesium balance.13
Since fecal and dermal losses were
negligible, magnesium balance was
taken to be the difference between
infused magnesium and total daily
urinary magnesium loss.
In nourished subjects a dose of 0
to 72 mg of magnesium daily resulted
in a negative balance (Table II). When
the dosage was raised to 96 mg, a
positive balance of 22 ± 6 m g/d was
noted. At all daily intakes greater
than 97 mg, magnesium balance was
positive. The highest positive balance,
160 ± 10 mg/d, was attained when
390 mg of magnesium was infused.
Increasing the dose to 664 m g/d
raised urinary magnesium output and
yielded a lower, but still positive bal
ance. In contrast to the nourished pa
tients, depleted subjects receiving 70
mg of magnesium daily were in posi
tive balance (Table III). Urinary losses
at this intake were minimal (33 ±
8 mg/d). As magnesium input was
increased, there was a greater output
in the urine. A dosage of 369 m g/d
resulted in the optimal positive bal
ance of 116 ± 38 mg/d. At this in
take, serum levels rose to 2.3 mg/dl.
In depleted subjects receiving 70 or
172 mg of magnesium daily, serum
levels were borderline low. When
magnesium-free total parenteral nu
trition or 73 m g/d of magnesium was
administered to nourished patients,
the average serum levels were 1.8
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mg/dl. At higher infusions, serum
levels rose to normal ranges. A dose
of 664 mg/d did not raise serum mag
nesium concentrations above the nor
mal range.
With the exception of anorexia,
clinical signs and symptoms of mag
nesium deficiency were not apparent
in any of the patients studied. The
amount of magnesium given intra
venously not only affected serum
levels and urinary output of this
macro-metal, but also exerted a con
siderable influence on urinary nitro
gen. Crossover studies involving both
the nourished and the depleted sub
jects demonstrated a direct positive
correlation between magnesium and
nitrogen balance (Table IV). Plotting
magnesium and nitrogen balances
gave a straight line graph with a cor
relation coefficient of 0.982 for the
nutritionally depleted patients.
Discussion
In nourished and depleted patients,
urinary magnesium excretion was pro
portional to the amount infused. How
ever, at comparable intakes, the uri
nary magnesium output of depleted
subjects was consistently lower than
that of nourished subjects. This con
firms Shils’ data which showed that
the simplest measurement of magne
sium deficiency was a decrease in
urinary excretion.4
Infusion of 72 mg of magnesium
or less, in nourished patients, resulted
in a negative balance. Approximately
100 mg of magnesium daily was re
quired to maintain a positive balance
and normal serum values. However,
at intakes of 70 to 172 mg/d in de
pleted subjects, not only was renal
conservation prominent but serum
magnesium levels were borderline low.
Only when the dose was increased to
369 m g/d were values equivalent for
both depleted and nourished subjects.
At a daily infusion of 390 mg of mag
nesium, optimal positive balance was
attained in the nourished subjects.
Further increases did not improve
balance, but resulted in greater uri
nary magnesium losses. An intake of
369 m g/d yielded a high positive
magnesium balance and favourable
serum levels in depleted subjects.
The finding of low urinary magne
sium excretion in depleted patients
was not unexpected. Most macro- and
trace-metal
deficiency
syndromes
share this characteristic. Of note,
however, was the observation that
urinary excretion levels rose and were
apparently dose-responsive to paren
teral magnesium administration. This
572

suggested that in depleted or wellnourished patients, the urinary excre
tion mechanism is quick to adjust it
self to parenteral loading or, alter
natively, that cellular utilization mech
anisms are easily overloaded and re
spond by allowing excessive macro
metals to be excreted in the urine
even though body stores may not be
completely replete. Clearly, the best
reflection of magnesium deficiency is
a decrease in urinary magnesium ex
cretion. On the other hand, even
though body stores are probably still
being replaced during parenteral in
fusion, the excess magnesium is lost
in the urine and represents adminis
tration that exceeds the body’s util
ization capabilities.
Assuming that kidney function in
our patients was normal, we can infer
from our results that a daily dose of
approximately 390 mg of magnesium
during total parenteral nutrition
would be salutary for both depleted
and well-nourished subjects postoperatively. This amount would also cover
losses via feces and sweat, which are
estimated to be 15 m g/d.14 The ad
ministration of 8 ml of 50% magne
sium sulfate supplies this amount
since a 2-ml vial of 50% magnesium
sulfate contains 100 mg or 8 meq of
magnesium. In the rare instance that
protein hydrolysates are used, the in
herent content of 24 mg magnesium
per litre of hydrolysate must be taken
into account. Most catabolic patients
are magnesium deficient even though
this deficiency may not be reflected by
serum levels. Severe deficiency will
also be more common in infants, who
have reduced body stores, in alco
holics and in parenterally fed patients
receiving magnesium-free solutions
particularly when there are on-going
gastrointestinal losses.
Clinically, magnesium deficiency

may present with nausea, anorexia,
dizziness or weakness. All of these are
common in parenterally fed patients
and may in themselves prevent conver
sion from parenteral to enteral feeding.
In addition, magnesium deficiency may
also be confused with hypocalcemia
and may be associated with a posi
tive Trousseau or Chvostek’s sign,
tremors or, rarely, convulsions.
Most magnesium deficient patients
have low serum magnesium levels.
However, a low urinary magnesium
excretion represents a more accurate
reflection of total body magnesium
depletion.3 Urinary magnesium will be
less than 3 m eq/d (36 mg) after 5
to 7 days of a magnesium-free diet.
However, monitoring serum magne
sium is still important during magne
sium repletion. While such serum
levels may not accurately reflect body
magnesium stores, they are none the
less vital in order to prevent magne
sium intoxication. This may occur
with excessive magnesium infusion,
renal failure or after repeated enemas
with magnesium salts.
We chose morbidly obese patients
undergoing elective gastric bypass to
represent a normal, well-nourished
study group having similar degrees of
operative trauma. Magnesium is not
stored in adipose tissue to any great
extent. These obese patients essen
tially had magnesium balances similar
to those reported by Macbeth and
Mabbott15 who measured magnesium
balance postoperatively in lean pa
tients.
The positive correlation of magne
sium balance with nitrogen balance
observed in this study is noteworthy.
It suggests that as magnesium balance
accrued, more magnesium was avail
able for cytoplasmic synthesis, al
though this needs to be confirmed by
more complicated labelling methods.

Table IV—Effect of Increased Magnesium Infusions on Magnesium
and Nitrogen Balance* - Crossover Studies!
Magnesium
infused, mgld

Magnesium
balance, mgld

Nitrogen
balance, gld

0
97 ± 0

-41 ± 5
+28 ± 17

-5.1 ± 1.2
+ 3.4 ± 0.3

0
386 ± 8

-47 ± 23
+ 171 ± 52

+2.4 ± 0.2
+ 3.3 ± 0.8

195 ± 2
394 ± 0

+27 ± 24
+ 150 ± 72

-4.5 ± 1.1
+ 1.4 ± 0.4

270 ± 0
369 ± 0

+ 62 ± 10
+ 116 ± 38

+0.3 ± 0.3
+ 1.0 ± 0.6

'Values expressed as mean ± SEM.
tCarried out for 48 hours on four of the seven well-nourished patients.
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Magnesium is required as an activator
or cofactor for many oxidative and
enzymatic systems essentia] to inter
mediary metabolism, and also for nu
cleic acid synthesis. Hence, its salutary
effect on nitrogen balance was not
unexpected. Two patients (Table IV)
had unrealistic improvements in nitro
gen balance in response to magnesium
positivity. However, two variables
were present: the administration of
more magnesium and the reversal of
a negative nitrogen balance in mark
edly depleted patients. Such depleted
patients require only small amounts of
nitrogen to produce marked positive
changes in nitrogen balance. When
all crossover data comparing magne
sium balance were compared by cor
relation coefficient, a straight line
curve (r = 0.83> was obtained. This
correlates well with recent studies
which have shown that muscle magne
sium contents are decreased in pro
tein-calorie malnutrition.16
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BOOK REVIEWS
continued from page 568
ATLAS OF PELVIC SURGERY. Clif
ford R. Wheeless, Jr. 399 pp. Must.
Lea & Febiger, Philadelphia, 1981.
$81. ISBN 0-8121-0727-6.

This book comes from one of the best
known and most respected centres of
gynecologic surgery in North America.
It continues the surgical tradition stem
ming from TeLinde and reflects a back
ground of training from a wide range of
master gynecologists. One can expect
from Dr. Wheeless a high standard of
surgical expertise and those expectations
are fully realized.
Dr. Wheeless systematically covers a
wide range of gynecologic surgical tech
niques and has not hesitated to include
some procedures that might be dismissed
as of purely historical interest. The spec
trum covered is comprehensive and in
cludes a number of current technical
procedures that are not in the main
stream of surgery — for example, laser
surgery or cryosurgery of the cervix. Few
procedures have been excluded, although
it is noteworthy that the section on tubal
surgery is limited and makes no refer
ence to microsurgical techniques. The
text is strongest in those sections that
deal with standard procedures and lapa
roscopy. To some extent the coverage is
too comprehensive and unselective and
some rather minor, even trivial, surgical
procedures receive specific mention, such
as the division of adhesions by laparo
scopy.
The text is well written in simple,
easily understood language. Procedures
are outlined with admirable clarity. How
ever, the illustrations are of more vari
able quality and are not always easy
to follow. Some could have been omitted
or replaced by photographs — for ex
ample, the presentation of views obtained
at the time of diagnostic laparoscopy.
This book can be safely recommended
to all practising clinicians who will find
it invaluable as a reference for unfami
liar and infrequently performed opera
tions, or even to review one’s standard
practice of regular surgical procedures.
The book is essentially a technical ma
nual and does not deal with indications
for surgery nor with pre- and postopera
tive management. To this extent its value
for residents is limited and they may
prefer other standard textbooks that take
a wider approach.
This book has formidable competition.
Other texts of operative gynecology are
more comprehensive in their approach
and are better illustrated. For some
purposes, it will be necessary to refer to
a more specialized text, for example, to
understand radical pelvic surgery for
malignant diseases or in reconstructive
tubal surgery or for a helpful approach
to a new technical procedure. The ac
count of some newer techniques is in-
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• Non-system ic action
• Does not interfere with normal digestive processes
(e.g. the absorption of essential nutrients, vitamins,
or drugs)
• Does not encourage a "laz y bow el" or
lead to laxative dependency - can be
used long term
• Causes no "embarrassing" urgency
• Provides natural source,
water-absorbing fibre which produces
bulk in the colon and

HELPS NORMALIZE
BOWEL IRREGULARITY.
Available in unfavoured Powder or effervescent, low-calorie
Instant Mix (lemon-lime or orange flavour)

CASE 4

A CASE
FOR METAMUCIL:
"THE HEMORRHOID PATIENT

Extensive Neurofibromatosis of the
Abdominal Wall, Penis and Scrotum
Walter J. P eters ,
The authors describe a rare case of
neurofibromatosis involving the
abdominal wall, scrotum and penis.
Penile and scrotal involvement
precluded any form of sexual activity.
Neurosarcomatous degeneration in
the region of the abdominal wall was
successfully treated by radical
excision and skin grafting. Secondary
reconstruction of the penis and
scrotum allowed relatively normal
sexual activity.
Les auteurs decrivent un rare cas
de neurofibromatose avec atteinte de
la paroi abdominale, du scrotum
et du penis. Les atteintes du penis
et du scrotum empechaient toute
forme d'activite sexuelle. On a traite
avec succes la degeneration
neurosarcomateuse de la region de
la paroi abdominale par excision
radicale et greffe cutanee. La
reconstruction secondaire du penis
et du scrotum a permis une activite
sexuelle relativement normale.

Neurofibromatosis (von Recklinghau
sen’s disease) is a hereditary (mendelian dominant) hamartomatous dis
order, characterized by the develop
ment of numerous soft tissue tumours
in the form of multiple neurofibro
mas. It was first described by von
Recklinghausen1 in 1882, who showed
that the tumours arose along cutane
ous nerves. It was subsequently shown
that they developed from the nerve
sheath and that the main cell type
was the Schwann cell.2,3 Although
these tumours most commonly involve
the skin, they may involve any organ
or tissue from skin to viscera and
may be associated with cranial, peri
pheral or visceral nerves.2,3
The cutaneous lesions of neuro
fibromatosis are frequently only one
manifestation of a generalized consti
tutional disorder. There may be mul
tiple cafe-au-lait spots,2 also skeletal
developmental anomalies, pulmonary
changes, mental retardation, involveFrom the division of plastic surgery,
Toronto General Hospital, Toronto,
Out.
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ment of other systems and association
with various syndromes.3,4 The trade
mark of von Recklinghausen’s disease
is the neurofibroma, which may be of
two types. Patients with plexiform
neurofibromatosis are considered to
have von Recklinghausen’s disease,
even if this lesion is the sole mani
festation of the disease.2,5 Nonplexiform neurofibromas may or may not
be associated with neurofibromatosis.2
Patients in the latter group must show
cafe-au-lait pigmentation before a de
finitive diagnosis of neurofibromatosis
can be made.2
Visceral involvement with neuro
fibromatosis is relatively uncommon;6
most frequently involved is the digest
ive tract.2-3 Neurofibromatosis in
volving the urinary tract is rare.7 The
present paper describes an apparently
unique case of extensive neurofibro
matosis of the abdominal wall, penis
and scrotum.

Case Report
A 22-year-old man requested penile
reconstruction because of lack of penile
length (Fig. 1). His penis was only about
1.5 cm long whether flaccid or erect. He
had not had sexual intercourse. He re
ported only one ejaculation — during
his sleep. There were no complaints or
symptoms related to the urinary tract.
A massive pigmented lesion involving

FIG. 1—Appearance of
wall, scrotum and penis.

md, frcs[c]

his abdominal wall, penis and scrotum
was present at birth and had enlarged
in proportion to his body size. He also
had multiple, discrete, small cafe-au-lait
spots (Fig. 1). There was slight gyneco
mastia. The abdominal wall revealed a
firm, tender, erythematous, round mass
in the right lower quadrant which the
patient had noted 2 months previously.
The findings on karyotyping and endo
crine investigation were normal.
Under general anesthesia, an excisional biopsy of the new abdominal lesion
was carried out. Quick section revealed
malignant degeneration to neurosarcoma,
so extensive excision of the abnormal
tissue from the abdominal wall and
suprapubic areas was done. Skin was
grafted over exposed deep fascia. Penile
reconstruction was deferred. Subsequent
histologic sections showed cells that ap
peared to arise from nerve sheaths.
There was obvious malignant degenera
tion with marked pleomorphism of nu
clei and nucleoli.
The patient remained free of further
malignant degeneration for 2 years. His
initial problem of lack of penile length,
which persisted, was aggravated by sub
sequent scrotal swelling and resulting
suprapubic scar hypertrophy (Fig. 2).
His penis and scrotum were explored
and then reconstructed. The penis and
testicles were found to be bound
down
within
the
black,
fleshy,
spongy neurofibromatous tissue filling
the scrotum. When the bulk of this
tissue was removed, relatively normal

abdominal
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FIG. 2—Following first excision.
/
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H G . 3—Penis and testes after removal of bulk of neurofibromatous tissue.

appearing penile and testicular structures
were found (Fig. 3). A simulated erection
with a tourniquet (Fig. 4) showed a
penile length of 15 cm.
The bulk of the neurofibromatous
tissue and about 80% of the scrotum
were removed. The skin on the glans
and distal penile shaft were preserved
and the remaining shaft was resurfaced
with a split-thickness skin graft. The
scrotum was reconstructed using ad
vancement flaps from the remaining
posterior and inferior scrotal tissue (Fig.
5).

FIG. 6—Appearance 6 months after
operation.

FIG. 4— Erection simulated with tourniquet.

About 2 months after operation, fol
lowing genetic counselling, the patient
began to experience normal sexual ac
tivity. During the subsequent 2 months,
he had sexual relations with three mem
bers of the opposite sex. Six months
after operation (Fig. 6) he developed an
apparently lasting, regular, mutuallyrewarding relationship with a single
partner.
Discussion

The findings and progression of von
Recklinghausen’s disease are extreme
ly variable and unpredictable.4 M ost
frequently, it is relatively quiescent.
Many cases are mild or with only a
single lesion (formes frustes2) and
probably go unrecognized. It may be
a chronic progressive disease with ini
tial manifestations in infancy or child
hood.7 Isolated cases make up about
half those reported in the literature
and it is impossible to distinguish
them clinically from familial cases.4
Involvement of the urinary tract is
rare: only about 35 cases have been
reported.5 8’9 The bladder has been the
commonest site,7 but isolated cases
have been reported with involvement
of prostate, urethra, spermatic cord,
penis and tunica albuginea.10 O ur pa
tient is unique because of his extens
ive involvement, which masked a
relatively normal reproductive system.
Malignant degeneration in von
Recklinghausen’s disease was first re
ported by Hosoi11 in 1931 who noted
an incidence of 13%. Subsequently,
numerous reports have documented
malignant degeneration, the incidence
ranging from 3% to 29% A12-14 Most
commonly, malignant degeneration
occurs in neurofibromas of large
nerve trunks.15 It is rare in cutaneous
neurofibromas and was seen in only
2 of 678 patients in one study.16 H is
tologically, most malignant tum ours
in neurofibromatosis have the appear
ance of anaplastic fibrosarcomas and
give no indication of their origin from

a neurofibrom a.15,16 In our patient,
the pattern of neurofibrom a was still
present, with an increase in the num 
ber and pleomorphism of nuclei. This
finding is suggestive of an early ma
lignant lesion.12
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Solitary Diverticulitis of the Right Colon
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Inflammation of a solitary diverticulum
of the right colon is uncommon;
approximately 500 cases have been
reported.
A 72-year-old woman underwent
laparotomy for possible appendicitis.
Unexpectedly, a mass was found
in the ascending colon close to the
ileocecal junction. Carcinoma was
suspected and right hemicolectomy
was done. The pathological diagnosis
was acute suppurative solitary
diverticulitis with perforation and
pericolic abscess.
From his case and a review of the
literature the author concludes that
inflammation in a solitary diverticulum
of the cecum is a distinct entity.
Its etiology is uncertain, but a
congenital origin is widely accepted.
Clinically it mimics appendicitis;
at operation it is often indistinguishable
from carcinoma. Roentgenogram after
a barium enema is diagnostic. The
condition is treated by diverticulectomy,
wedge resection or colectomy.
Abscesses are drained.
L'inflammation d'un diverticule solitaire
du colon droit est peu frequent;
environ 500 cas ont ete signales.
Une femme de 72 ans a subi
une laparotomie pour une appendicite
soupconnee. Contrairement a ce qui
etait attendu, une masse a ete
decouverte dans le colon ascendant
pres de la jonction ileo-coecale.
Un cancer etant soupconne, une
hemicolectomie droite fut pratiquee.
Le diagnostic du pathologiste fut une
diverticulite solitaire aigue suppuree
avec perforation et abces pericolique.
A partir de ce cas et d'une revue
de la litterature, I'auteur conclut que
l'inflammation d’un diverticule
solitaire du coecum est une entite
distincte. Son etiologie est incertaine
bien qu'une origine congenitale
soit largement acceptee. Cette
affection ressemble cliniquement a
une appendicite; a I'operation elle
est souvent indiscernable d'un cancer.
Le diagnostic peut etre etabli a la
radiographie apres lavement baryte.
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Le traitement est soit par diverticuiectomie, resection cuneiforme ou
colectomie. Les abces sont draines.

The general uncertainty of the nature
of solitary diverticulitis of the right
colon close to the ileocecal valve is
reflected in the number of names by
which it has been described: non
specific ulcer, solitary cecal ulcer,
acute cecitis, phlegmonous cecitis,
acute cecal diverticulitis.1 Although
12% of cases occur in the ascending
colon,2 it is commonly called cecal
diverticulitis.
The disease is uncommon. Potier3
described the first case in 1912. The
latest review4 states that approximate
ly 460 cases have been recorded in
the English literature. With the addi
tion of another 40 cases since then,5'10
the total now stands at approximately
500 cases. The lesion is probably
commoner than the figures sug
gest;1’11'12 some cases are unreported
or unrecognized, but some can be
found buried in reports on appendi
citis; for example, in a series of 1000
laparotomies for appendicitis,13 two
patients had perforated cecal diverti
culitis, one had nonperforated diverti
culitis and two had cecitis of u n 
known cause.
The diagnosis is rarely made preoperatively and is usually encountered
unexpectedly at operation for appen
dicitis. Greaney and Snyder14 reported
an incidence of 1 in every 500 celi
otomies for acute abdominal com 
plaints. Treatment is also difficult be
cause frequently the lesion resembles
a neoplasm and a radical resection
is carried out under adverse condi
tions. Any surgeon operating on a
patient with an acute abdomen should
be aware of this lesion.

Case Report
A 72-year-old woman was admitted
with a 48-hour history of abdominal
pain aggravated by movement. Initially
the pain was in the upper abdomen, but
shifted to the right lower quadrant on
the day of admission. She had no nausea
or vomiting but was anorexic. She had
a normal bowel movement on each day
of her illness.
The patient was well nourished and
in no distress. Her temperature was
37.5°C. She had moderate tenderness in
the right lower quadrant with some
guarding and rebound tenderness.
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Her hemoglobin level was 13.4 g/dl.
the leukocyte count 12.5 x 10V1 with
79% neutrophils. Urinalysis gave nega
tive results and abdominal roentgeno
grams showed no abnormality.
A provisional diagnosis of appendicitis
was made. Preoperatively she was given
2 g of cefoxitin intravenously. At opera
tion the appendix appeared normal. Ex
ploration revealed a mass measuring
5 x 8 cm in the posteromedial wall of
the ascending colon close to the ileocecal
junction. As a carcinoma could not be
ruled out, right hemicolectomy was
done. The wound was closed by the
delayed primary suture technique. Cefox
itin was continued every 6 hours postoperatively for 4 days.
The patient’s recovery was smooth.
Roentgenography after barium enema 2
months later did not reveal any other
diverticula. She has remained well.
Examination of the resected specimen
showed a solitary diverticulum of the
ascending colon, which had perforated
and formed a pericolic abscess. The
ostium was 3 cm from the ileocecal
valve. It contained fecal material. Micro
scopic examination showed acute sup
purative diverticulitis.

Discussion
Solitary diverticula should not be
confused with multiple diverticulosis
of the colon. In a study of norm al
subjects in Oxford, England, the in
cidence of diverticulosis was found
to be 7.6% in those under the age
of 60 years and 35% in those older
than 60.15 The disease is rare in de
veloping countries.16 It invariably in
volves the sigmoid colon and in ex
tensive diverticulosis, the proximal
bowel is affected in continuity.17 The
cecum is thus involved in 4% of cases
and diverticulosis is found on roent
genography after barium enem a.18
In contrast, certain characteristics
of right-sided diverticula make them
a distinct entity. They are uncommon.
In Williams’ series18 they constituted
only 1% of cases. Nearly 80% occur
in the area from 1 cm proximal to
2 cm distal to the ileocecal valve.11
They are usually solitary. W hen left
sided disease is also present it appears
in older patients. Hughes17 suggested
that the combination may be coinci
dental and unrelated.
Etiology
The etiology of solitary diverticula
remains uncertain, although a conge-
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nital origin is widely accepted.2’5-"-12-19
The theory of congenital origin is
based on embryologic studies done in
the early part of this century.20 An
outgrowth of the cecum develops in
the sixth week and atrophies by about
the seventh week. If this “transient
appendix” fails to disappear, a diverti
culum or a duplication of the appen
dix results.21'03
To support their thesis, proponents
of a developmental antecedent quote
the age at which the disease occurs.
It has been reported in a 3-year-old
girl.24 In a review of 318 cases,2 the
average age of patients was 41.4 years
which is about 10 years less than for
left colon diverticulosis. The incidence
does not increase with age.17
Solitary diverticula are also thought
to be of the congenital or true variety
because of the presence of muscle in
the wall. Schnug25 believe that they
were similar in origin to a Meckel’s
diverticulum and contained all layers
of the intestinal coat. Because he was
unable to find any muscle apart from
the muscularis mucosae, Hughes17 has
questioned this concept. He cited Ed
wards20 who pointed out that so-called
congenital jejunal diverticula have hy
pertrophy of the muscularis mucosae.
Unfortunately, in many cases, the
wall tissue cannot be identified with
certainty because it has been de
stroyed by inflammation.
Pathologic Features

Solitary diverticula may measure
up to 15 mm in diameter at the os
tium.17 Characteristically, they have a
shorter and wider neck than the mul
tiple variety. They contain fecaliths
or fecal material that may initiate
the inflammatory process by obstruct
ing the lumen.2 Once started, the le
sion may progress to gangrene and
perforation. Anteriorly situated diver
ticula are likely to lead to generalized
peritonitis; if posteriorly placed they
tend to be localized and produce an
inflammatory mass resembling can
cer.27
D iagnosis

Clinically, the disease mimics acute
appendicitis. In the first review of the
world literature, Anderson28 collected
99 cases. The correct diagnosis was
made in only 6% — patients whose
appendix had already been removed;
in 84% appendicitis was suspected.
Diverticulitis and carcinoma are the
next most frequent diagnoses, made in
an almost equal number of cases.
Most patients have pain in the right
lower quadrant of the abdomen. The
580

duration of pain may be 24 to 72
hours, but some may have recurrent
attacks over many weeks or months.
Nausea and vomiting are not com
mon. A few have melena.
On physical examination there is
tenderness in the right lower quadrant
and a mass may be palpable. Most
authors report moderate elevation of
temperature but, apart from leuko
cytosis, laboratory findings are usual
ly normal.
The similarity to acute appendicitis
prompted Laimon and Cohn29 to state
that, even in retrospect, it was im
possible to select notable variants in
the clinical findings to differentiate
the two conditions. Others have com
mented that the longer duration of
illness,30 the absence of nausea and
vomiting" and the lesser toxicity27
are helpful clues. Roentgenography
after barium enema has been diagnos
tic in practically all cases in which
it has been done.31 However, no pa
tient suspected of having appendicitis
will be subjected to this investigation.
Intraoperative diagnosis is also dif
ficult. Wagner and Zollinger2 found
that the correct diagnosis was made
at operation in 61.8%; in 31.4%
cancer was diagnosed. Greaney and
Snyder" classified the operative find
ings into two types: the “usual” and
the “hidden”. The first type is the
easily recognized inflamed diverticu
lum; the second is characterized by
an inflammatory mass.
To distinguish an inflammatory
from a malignant lesion, a number of
authors recommend palpating the os
tium through the normal bowel
wall.2532 xhis maneuver was done in
our case, but the lesion appeared to
have a central depression with heaped
up edges characteristic of a malignant
ulcer.
Others advise cecotomy with biop
sy and frozen section,33 or biopsy only
and treatment with antibiotics fol
lowed by reoperation if a malignant
lesion is found in the biopsy speci
men.1 Garner and colleagues4 advised
against this approach to intraoperative
diagnosis for a number of reasons:
contamination from unprepared bow
el, spread of malignant cells, the un
reliability of biopsy (many carcinomas
have an inflammatory reaction at the
periphery). Blind resection was con
sidered safer.
Treatment

■To aid in selecting the proper
operation. Wagner and Zollinger2
proposed a classification based on the
gross pathologic features, the opera
tion depending on the extent of in
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volvement of the bowel wall: if in
flammation is confined to the diverti
culum, simple diverticulectomy is
done: a wedge resection is necessary
when the surrounding bowel wall is
indurated; ileocecal encroachment re
quires ileocecal resection; and a mass
that cannot be distinguished from a
carcinoma is treated by colectomy.
Abscesses are drained and any per
foration is closed.
When a diverticulum only is re
moved, appendectomy should be done
if it can be performed easily. For the
diverticulum found incidentally at
laparotomy for another condition,
some authors advise excision or in
version. Most prefer not to treat an
asymptomatic patient when a diverti
culum is found on routine roentgeno
grams after barium enema.
Conclusions
Solitary diverticulitis of the right
colon is an uncommon condition that
is difficult to diagnose and treat. It
should be considered in the differen
tial diagnosis of a mass found unex
pectedly at operation for suspected
appendicitis.
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The Estrogen Receptor Test: a Prognostic Tool
in Primary Breast Cancer
L aurie A. L ogan , M. C hristin e C r ip p s , m d , f r c p [c ], W olfgang E. H ir t e , m d , f r c p [ c ], fa cp and
E dna F. R a p p , m d , f r c p [c ]

To evaluate the usefulness of the
estrogen receptor test as a prognostic
indicator, a retrospective study
of 134 patients with primary breast
cancer was carried out at the
Ottawa Civic Hospital. The estrogen
receptor values, measured in a
single laboratory, were correlated with
the recurrence rate and the survival
time after recurrence.
Other well-established prognostic
data, such as stage of cancer,
lymph-node involvement and meno
pausal state, have been similarly
examined to ensure that information
obtained from the estrogen receptor
test offers more than a duplication of
information from these traditional
methods. It was found that this test
is a useful prognostic tool when
used on premenopausal women. The
results of the study show that
(a) breast cancer patients having
positive estrogen receptor values
have recurrences less frequently,
Cb) among estrogen receptor-negative
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patients there is more than a 50%
chance of early recurrence in
premenopausal women compared
with less than a 20% chance in
postmenopausal women, (c) conven
tional adjuvant chemotherapy in
estrogen receptor-negative premeno
pausal patients does not prevent
early recurrence, hence, this group
requires more aggressive adjuvant
treatment and (d) the method
described by Heuson and colleagues
for estrogen receptor determination
follows the trends of better-established
tests.
Dans le but d'evaluer I'utilite
du test des recepteurs
du pronostic, une etude
retrospective de 134 patientes
atteintes d'un cancer primaire du
sein a ete menee a I'Hopital Civique
d’Ottawa. Une correlation a ete
recherchee entre les mesures des
recepteurs oestrogeniques
qui furent realisees dans un seul
laboratoire et le taux de recidive
ainsi que la periode de survie
apres une recidive.
D’autres elements pronostiques
reconnus tels que le stade clinique
du cancer, I’atteinte des ganglions
lymphatiques et I'etat menopausique
ont ete examines de fagon similaire
de fagon a s'assurer que I'information
tiree du test des recepteurs
oestrogeniques n'etait pas qu'une
repetition de celle qui est obtenue
par ces methodes traditionnelles. On

a decouvert que ce test est un
outil utile pour apprecier le pronostic
chez la femme premenopausique.
Les resultats de cette etude
montrent que a) les patientes
souffrant de cancer du sein, qui
ont un test des recepteurs
oestrogeniques positif, ont moins
souvent de recidives, b) parmi
les patientes qui ont un test
negatif, les risques d'un recidive
precoce sont de plus de 50% chez
les femmes premenopausiques
alors qu'ils sont de moins de 20%
apres la menopause, c) chez les
patientes premenopausiques dont
le test est negatif, la chimiotherapie
adjuvante conventionnelle ne previent
pas les recidives precoces et ce
groupe necessite done un traitement
adjuvant plus agressif, et d) la
methode decrite par Heuson et
collaborateurs pour la determination
des recepteurs oestrogeniques
suit les tendances des tests
mieux etablis

The determination of estrogen recep
tor status in women with breast can
cer was initiated by M cGuire and
associates' in 1975. A minimum of
500 mg of malignant tissue was re
quired and receptor levels were meas
ured in femtomoles per milligram of
tissue protein. A value less than 3
fm ol/m g was considered to be a nega
tive result; anything greater was posi
tive. Patients with estrogen receptor
positive tumours responded favourVOLUME 25, NO. 5, SEPTEMBER 1982 / THE CANADIAN JOURNAL OF SURGERY
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ably to endocrine therapy while the cancer. Women having stage II or
converse was true of receptor-negative stage III disease were subdivided into
tumours. Receptor positivity was then three categories according to the de
subdivided on the basis of the per gree of lymph-node involvement: 1,
centage of response. A level between no involvement; 2, one to three nodes
3 and 10 fmol/mg produced a 50%
involved and 3, four or more nodes
response rate. This increased to 66%
involved. Women with stage IV or in
in tumours with a value greater than operable disease were not included in
10 fmol/mg.
this study, which dealt with primary
Since 1975 the test procedure has breast cancer patients who were free
become more sensitive, necessitating a of measurable disease after resection.
change in these boundary values.
• Adjuvant therapy: Evaluation of
Lippman2 in 1979 set out the follow the response to adjuvant therapy of
ing values: 7 fmol/mg or less rep patients with varying stages of cancer,
resents estrogen receptor negativity, menopausal status and estrogen re
more than 7 but less than 40 fmol/mg ceptor values would have required a
represents moderate positivity and larger sample size and has not been
more than 40 fmol/mg represents attempted. As a matter of interest,
high positivity.
however, adjuvant therapy was cate
McGuire and associates1 have as gorized into three groups: 1, chemo
sociated the presence of highly posi therapy alone: 2, chemotherapy and
tive estrogen receptor values with a radiotherapy and 3, radiotherapy
lower frequency of recurrences. If alone. The percentages of each of
metastases do appear, women with these treatment modalities used on
estrogen receptor-positive primary tu the three groups of estrogen receptor
mours survive longer than those with values has been recorded to demon
receptor-negative primary tumours strate the current trend in treatment
regardless of menopausal stage. Post at the Ottawa Civic Hospital.
menopausal patients 'tend to have
In this study the recurrence rate
higher estrogen receptor values than and survival time after a recurrence
premenopausal women, a possible were recorded for women in each of
reason being the lack of endogenous the receptor and menopausal cate
estrogens which bind to and render un gories, and in each stage of disease.
available some of the estrogen recep Since treatment methods have not
tor sites.3
changed during the last 3 years the
results of all years were recorded to
Patients and Methods
gether. Statistical analysis was done
We carried out a retrospective using the •/* test where indicated.
study of 134 patients with histologic
ally proven primary breast cancer Results
and known estrogen receptor values, Recurrence Rales
seen at the Ottawa Civic Hospital be
The recurrence rate of the estrogen
tween 1977 and 1979. The estrogen
receptor values were estimated by the receptor-negative tumours was signif
method of Heuson and colleagues4 icantly higher (0.05 > P > 0.02) than
using the classification of Lippmann.2 that of the receptor-positive tumours
The following data were obtained: (Fig. 1).
For stage I cancer the recurrence
menopausal status, stage of cancer,
estrogen receptor status, date of mas rate was significantly lower (0.01 >
tectomy, adjuvant therapy used, date P > 0.001) than for other stages (Fig.
of recurrence if any and time from 2), but the rate for each of the other
recurrence to death or to survival at
the time of writing. In 1977, 1978
and 1979, the estrogen receptor test
was done on 28, 57 and 49 patients
respectively. For the purpose of our
study, the following definitions were
used:
• Menopausal
status:
Women
younger than 45 years were classified
as premenopausal, while those older
than 52 years were considered post
menopausal and those between 45 and
52 years were perimenopausal.
ESTROGEN-RECEPTOR VALUE,
• Stage: Postsurgical staging, done
fm o l/m g p r o t e i n
at the time of mastectomy, was used
to determine the number of axillary
F IG . 1— R ecurrence rate and estrogen
nodes, if any, that were involved with receptor value.
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stages did not differ significantly
(0.1 > P > 0.05). The recurrence
rate for patients with stage II,
TjNnMo, appeared to be substantially
lower than for patients with stage II.
T2N+, cancers.
A significantly higher recurrence
rate (0.01 > P > 0.001) was ob
served among women less than 45
years of age. The recurrence rate of
peri- and postmenopausal women did
not differ significantly (Fig. 3).
Thus, women with stage I or II
disease, no lymph-node involvement
and positive receptor values had the
lowest recurrence rates.
Survival Time after Recurrence
Irrespective of age, women of re
ceptor-negative status who died from
their cancer did so within a year of
their first recurrence. There was a dif
ference in the percentage of deaths
between the two age groups such
that approximately 50% (7 of 15) of
the premenopausal women died as op
posed to 25% (6 of 22) of the post
menopausal women.
None of the patients who had no
lymph-node involvement but had re
current tumour have died while 50%
of those with four or more lymph
nodes involved died within a year of
recurrence. The follow-up of both
groups of patients was comparable.
Twenty-two of the 134 women in
the study have had recurrent disease.
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Tables I and II compare the stage of
the cancer, age of the patient and
estrogen receptor value with the re
sponse after recurrence (survival v.
death). Women with stages I, II and
III cancers, with less than four nodes
involved, demonstrated a relatively
equal distribution of receptor values.
The majority (15 of 26) of patients
with stage II cancers having four or
more nodes involved, however, had
a receptor value less than 7 fmol/mg
while only 1 woman in this group had
a high receptor value. Of patients
having negative receptor values and
stage II cancer with four or more
nodes involved, 47% (7 of 15) had re
current disease and 4 of the 7 died
well within a year of the recurrence.
In Table II there appears to be no
relation between menopausal state,
estrogen receptor value and response
after recurrence in the 45 to 52-year
and over 52-year age groups. In the
premenopausal group, however, it is
interesting that the majority (15 of
22) had receptor-negative tumours

and of these 53% (8 of 15) had re
current disease. Of the eight recur
rences, three were stage I or II cancer
(zero to three nodes involved). The
recurrence rate for receptor-negative
tumours reflects their aggressive na
ture irrespective of stage. Eleven of
the 15 premenopausal women had re
ceived some form of adjuvant chemo
therapy.
None of the seven women who
were estrogen receptor-positive have
had recurrent tumour. Six presented
initially with stage I or II disease and
four of them were treated with ad
juvant chemotherapy.
Table III shows the present trends
in adjuvant therapy for breast cancer
at the Ottawa Civic Hospital. Radio
therapy is used to treat approximately
one third of all patients regardless of
receptor status. A combination of ra
diation and chemotherapy is not often
used. Most patients are entered into
phase 3 of the Eastern Cooperative
Oncology Group (ECOG) study or
National Surgical Adjuvant Breast

Table 1-Correlation of Estrogen Receptor Value and Stage of Cancer
Estrogen
receptor
value,
fmollmg

_________________________________ ^ta^e________________________________
I
II
II
III
III
____________
K 4 nodes)
(5*4 nodes)
« 4 nodes)
(> 4 nodes)
Total S
D Total S D Total S
D Total S
D Total S
D

>40
7-40
<7

17
6
12

1
0
2

0
0
0

20
19
18

1
3
5

0
1
0

1
10
15

0
0
4

0
0
3

2
4
3

0
0
1

0
0
0

1
1
3

0
0
0

1
0
1

Total = total no. of patients in each category, S = no. of patients with recurrence who are still alive,
D = no. of patients with recurrence who died.

Table II— Correlation of Estrogen Receptor Value
with Menopausal Status
Estrogen
receptor
value,
fmollmg

___________

>40
7 40
<7

___________________ Age,
<45

yr
45-5 2

>52

Total

S

D

Total

S

D

Total

S

D

3
4
15

0
0
5

0
0
3

11
17
14

2
1
2

0
1
0

28
19
23

1
2
2

1
0
2

Total = total no. of patients in each category, S = no. of patients with recurrence who are alive, D =
no. of patients with recurrence who died.

—

Table III--Percentage of Patients Who Received
Adjuvant Treatment
Estrogen receptor value,
fmollmg protein
Treatment
Radiotherapy
Radiotherapy +
chemotherapy
Chemotherapy

>40

7-40

<7

No adjuvant
therapy

36

33

29

24

0
10

3
28

6
27

7
6
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Project (NSABP), trials that are
studying the effects of various chemo
therapy or hormonal adjuvant regi
mens, or both, on women with tu
mours of different receptor status.
Chemotherapy has been found to in
crease the disease-free interval.
Discussion

The method for measuring the es
trogen receptor value, described by
Heuson and colleagues,4 was not
standardized but was performed in a
consistent manner in one laboratory,
but since the results of this study cor
respond with those of trials using a
standardized test, the method we used
is reasonable.
As a prognostic tool the estrogen
receptor test does not appear to be
useful for the majority of patients
with primary breast cancer who are
postmenopausal and have stage I or
II cancer. These women tend to have
a good prognosis and low incidence
of recurrence. The receptor status of
their tumours seems to be unrelated
to their stage and does not change
their initial prognosis determined
through clinical and surgical inves
tigation.
In this review there is a sim' .
lack of correlation between the ^erimenopausal group and estrogen re
ceptor values; the latter is of no use
in anticipating recurrences.
The estrogen receptor test is of
value, however, in premenopausal
women who present initially with
stage I or II cancer. In general,
women with tumour in these early
stages have recurrences less frequent
ly than do women with more locally
advanced disease. In the past such
women did not receive adjuvant ther
apy. This approach should be disre
garded in premenopausal women who
have early stage, estrogen receptor
negative cancer. Fifteen of 22 pre
menopausal patients in this study were
receptor-negative and 8 of them had
stage I or II disease. More aggressive
adjuvant therapy in these women may
decrease the number of recurrences or
increase overall survival, or both —
a goal especially desirable for women
in the prime of life.
A prospective ECOG trial was be
gun in 1978 to compare the response
of premenopausal women with stage
II cancer to three treatment regimens:
cyclophosphamide, methotrexate and
5-fluorouracil (CMF), cyclophospha
mide, methotrexate, 5-FU and predni
sone (CMFP), and cyclophosphamide,
methotrexate, 5-FU, prednisone and
tamoxifen (CMFPT). Estrogen recep
tor values were among the staging
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criteria required. It is a well-known and NSABP trials, assessing several
fact5 that although adjuvant chemo treatment regimens, may yield valuable
therapy in these women has not as results. For this reason we recommend
yet increased their overall survival it that the estrogen receptor test be done
has increased the disease-free interval. on all women with breast cancer.
Increasing the quality of life is suf
Although not dealt with in this
ficient reason to search for the opti study, there is another important rea
mal combination of chemotherapeutic son for using the estrogen receptor
and hormonal agents.
test. McGuire and associates1 and
In our review, four of the seven others have found that estrogen re
premenopausal women with receptor ceptor values are useful in indicating
positive, stage I or II disease were which women (receptor-negative) will
treated with various agents; none has not benefit from secondary treatment,
had recurrent disease. This good re such as surgical castration with its
sponse may in part be due to their inherent risks. By avoiding unpleasant,
receptor-positive status.
useless treatments we can increase
Twelve of the receptor-negative the quality of life of many such
women were also given adjuvant women.
chemotherapy, yet 8 have had recur
From this study we conclude that
rence. This suggests that premeno the estrogen receptor test done by the
pausal women with negative estrogen method of Heuson and colleagues is
receptor values should be treated with a useful prognostic tool in premeno
more aggressive regimens. The ECOG pausal women and should continue

to be used so that this relatively new
test can be studied further.
We thank Dr. W.J. Poznanski for
technical assistance, Dr. C. Danjoux for
advice and Mrs. P. Mair for secretarial
help.
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L’hyperalimentation a domicile par voie digestive
E ric P oulin ,

md, frcp [c]* et

H elene L angevin,

dt

pf

II n’existe que tres peu de rapports
dans la litterature concernant I’usage
de I'hyperalimentation a domicile
par voie digestive chez les grands
handicapes intestinaux.
Les auteurs presentent cinq malades
qui ont ete traites a domicile durant
un total de 78 mois par I'infusion
continue d’une diete elementaire
via une intubation nasogastrique. La
plupart de ces malades avaient subi
des resections massives de I'intestin.
A cause des differences de facilite
d'utilisation, de morbidite, de couts
et de complications psychologiques
par rapport aux methodes d’hyperalimentation intraveineuses a domicile,
on suggere de reserver ces dernieres
techniques pour les malades qui ont
d'abord subi un echec a la therapie
par voie digestive.

There are few reports in the
contemporary literature on the use
of home hyperalimentation by the
enteral route, especially for intestinaliy
crippled patients.
The authors describe five patients
who had a total of 78 months of
therapy by continuous nasogastric
infusion of an elemental diet at home.
The majority of the patients had
undergone massive bowel resection.
Home intravenous hyperalimentation
techniques are compared with respect
to feasibility, morbidity, cost and
psychologic impact for the patient.
Because of the differences, the authors
suggest that home intravenous
hyperalimentation should be reserved
for patients who have failed a trial
of enteral therapy.

Depuis, certains malades ne sont
hospitalises que pour des raisons d’intervention nutritionnelle, et quelques
uns necessitent ces traitements a vie
comme seul moyen de survie. Afin de
rationaliser les couts de ces hospitali
sations prolongees, on a assiste ces
dernieres annees au developpement
des techniques d’alimentation intra
veineuse a domicile.49 Nous avons
voulu evaluer la possibility d’utiliser
la voie digestive, meme apres resec
tion intestinale massive, comme mode
de traitement a domicile pour des
periodes plus ou moins etendues, et
si possible, etablir les differences dans
la facilite d’utilisation, la morbidite,
les couts et les complications psycho
logiques par rapport aux techniques
intraveineuses.

*Du service de chirurgie gene rale et
+service de dietetique, Hopital du
Saint-Sacrement, Quebec, PQ
Accepte pour publication le 4 fevrier,
1982
Les demandes de tires d part doivent
etre adressees an: Dr Eric Poulin,
Service de chirurgie generale, Hopital
du Saint-Sacrement, 1050, Chemin
Ste-Foy, Quebec, PQ C IS 4L8

Pour corriger et meme prevenir les
effets negatifs de la malnutrition, on
a vu se developper rapidement, de
pths les travaux originaux de Dudrick
et collaborateurs,1 plusieurs techni
ques d’alimentation intraveineuse tant
centrale que peripherique. De fa?on
parallele, on a obtenu des effets semblables par la voie digestive lorsque
celle-ci etait utilisable.2"1

Patients et methodes
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Nous presentons cinq malades qui
ont ete traites a I’Hopital du SaintSacrement de Quebec depuis 1978.
Presque tous ces malades ont subi une
diminution importante de leur surface
d’absorption intestinale, soit par atteinte radique, soit par resection chirurgicale pour maladie de Crohn ou
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volvulus du grele necrose. Aucun de
ces malades n’etait capable de subvenir a ses besoins nutritionnels en
ingerant une diete normale, a cause
de sa symptomatologie, de l’insuffisance des surfaces d’absorption, ou
des deux a la fois.
Presentation des cas
Cas 1.—Une femme de 51 ans porteuse d’une maladie de Crohn particulierement agressive depuis 1955, a subi

depuis, 17 hospitalisations pour diverses
complications de sa maladie. Cinq chirurgies de resection lui ont laisse 120
cm de jejunum (mesure peroperatoire,
du cote mesenterique) sans ileon, colon,
ou rectum. Elle a une jejunostomie terminale (fig. 1).
Cas 2.—Une femme de 57 ans a subi
en 1953 une hysterectomie suivie de
curietherapie pour une neoplasie du col
uterin. En octobre 1978, elle a re?u
6000 rad pour un epithelioma transitionnel de la vessie, grade II/III. Elle

developpa une enterite radique lui laissant des douleurs abdominales crampiformes et de 10 a 12 selles par jour
(fig. 2).
Cas 3.—Un homme de 28 ans a subi
en juin 1976 une laparotomie pour clas
sifier une maladie de Hodgkin (IIB). En
fevrier 1979, il s’est presente a la salle
d’urgence et il a du subir une resection
massive de I’intestin grele pour un vol
vulus necrose (fig. 3). Il lui est reste
60 cm de jejunum et 10 cm d’ileon. Un
mois apres l’operation, la quantite de
selles se limita a 5 ou 6 par jour pour
un volume variant entre 500 et 900 ml.
Cas 4.—Une femme de 60 ans est
porteuse d’une maladie de Crohn depuis
1958. Six resections intestinales pour des
complications de la maladie lui ont laisse
82 cm de grele (mesure sur le rebord
mesenterique) et le colon gauche (fig. 4).

*

A

Cas 5.—Un homme de 20 ans est
porteur d’une maladie de Crohn de
l’ileon depuis 1972. Peu tapageuse pen
dant les premieres annees, sa maladie
necessita en 1978 une hemicolectomie
droite (10 cm d’ileon) et la resection d’un
segment de jejunum (28 cm). Une
deuxieme resection de 10 cm en 1979
permit de traiter une hemorragie severe.
A l’ete 1980, une nouvelle recidive devint tellement symptomatique que toute
alimentation substantielle lui apportait
des crampes abdominales et des diarrhees tres importantes. Une remission
spontanee suivit 3 mois de traitement
continu a la diete elementaire a domicile
comnie seul apport nutritif.

y

FIG. 1—Cas 1. Representation graphique et radiologique de I'intestin restant
chez cette malade operee a multiples reprises pour maladie de Crohn (120 cm de
jejunum).

FIG. 2— Cas 2. Representation graphique et radiologique de I’atteinte radique.
A noter la stagnation, les stenoses et dilatations du grele observees 48 heures apres
le transit du grele.

FIG. 3— Cas 3. Representation gra
phique de I’intestin restant apres resec
tion massive pour volvulus necrose.

VOLUME 25, NO. 5, SEPTEMBER 1982 / THE CANADIAN JOURNAL OF SURGERY

585

Chez trois de ces cinq malades, le
debut des traitements par diete elementaire a ete precede d'une correc
tion de la phase hydro-electrolytique
du syndrome de l’intestin court et
d’une periode d’hyperalimentatiori
intra-veineuse centrale.
Les criteres de selection des mala
des pour 1’hyperalimentation a domi
cile par infusion continue d’une diete
elementaire sont presentes au tableau
I. Le protocole suivi a ete virtuellement le meme dans tous les cas: Apres
le traitement approprie, en milieu hospitalier, de la phase aigue de la maladie, des renseignements pertinents sur
la technique d’hyperalimentation par
voie digestive et une bonne prepara
tion psychologique sont fournis aux
malades. Apres avoir accepte I n te r 
vention, les patients regoivent d’une
infirmiere specialisee un enseignement
pratique sur 1’insertion d’un tube de
gavage. Deux types de tubes ont ete
utilises soit les “infant feeding tubes”
no 8 French de Argyle (Sherwood
Medical Industries, Inc., St. Louis,
Mo.) pour usage hospitalier et les nouveaux tubes lestes en silicone Keofeed (Hedeco, Mountainview, Calif.)
lorsque Ton prevoyait une periode de
traitement superieure a 2 mois. Ces
derniers coutent cependant plus cher
(0.75 vs $10.00 Can.). On enseigne
aux malades les techniques de veri
fication de la localisation du tube par
aspiration de liquide gastrique a la
seringue ou par la production d’un
bruit epigastrique lors de 1’injection
d air par le tube. Tous les malades
deviennent remarquablement habiles
et peuvent changer leur tube de ga
vage a leur gre, de fagon tres securitaire.
Une dietetiste specialisee en soins
nutritionnels intensifs apprend ensuite
aux malades a traiter les complica
tions reliees au changement de debit
de la solution (crampes, diarrhees) et
leur enseigne la technique de prepa
ration “propre mais non sterile” des
dietes elementaires a domicile.
La plupart des malades ont d’abord
subi une perfusion d’eau seulement
dans leur “intestin court”, puis une
perfusion de solute glucose a 5%
pour evaluer la tolerance intestinale.
Un programme initial de dilution des
di&tes elementaires pour ce type de
malade est presente au tableau II.
La duree de chacune des etapes est
proportionnelle a la tolerance du ma
lade et celui-ci n’est pas renvoye a
domicile tant qu’il n'atteint pas un
bilan azote positif et que 1’ensemble
de son ingestion ne correspond pas a
ses besoins nutritionnels.
A la maison, les solutions sont gar586

dees au refrigerateur et on conseille
au malade de ne pas mettre plus que
600 ml dans chaque sac pour ainsi
diminuer la proliferation bacterienne
qui se produit dans les solutions gardees trop longtemps a la temperature
de la piece.10 Cette precaution permet
aussi d’eviter les consequences ennuyeuses d’une administration subite
d’une tres grande quantite de solution
hyperosmolaire, s’il y avait malfonctionnement de la valve d’administration durant la nuit par exemple. On

conseille de plus au malade d’elever
la tete de son lit de 30° pour l’administration nocturne, afin d’eviter la
possibility d’aspiration bronchique. On
procede au lavage des sacs et tubulures a l’eau et au savon. comme s’il
s’agissait de vaisselle ordinaire, et on
les etend a secher apres les avoir
rinces a 1’eau du robinet.
Le malade, en plus de revoir son
medecin traitant, revoit aussi periodiquement la dietetiste en soins nutri
tionnels intensifs pour la correction
des problemes techniques, s’il y en a.
les evaluations nutritionnelles appropriees et pour des conseils dans la
progression vers l’alimentation normale. selon sa tolerance.
R esu ltats

Cette experience represente 78 mois
d’hyperalimentation a domicile, soit
pres de 7 annees-patients d’utilisation
a domicile de dietes elementaires en
infusion continue pour maintenir
l’etat nutritionnel chez cinq grands
handicapes intestinaux.
II n’y a eu aucune mortality et
aucun des malades n’a subi de comTableau I-C riteres de selection des malades
et contre-indications relatives de I'hyperalimen
tation elementaire a domicile par voie digestive
Criteres de selection
Echec de ('utilisation des aliments "normaux” pour se nourrir adequatement (bi
lan azote negatif)
Succes de I'alimentation enterale par infu
sion continue de diete elementaire lors
d’un sejour hospitalier
Comprehension et acceptation de la therapie par le malade et sa famille
Motivation a reussir le traitement
Autonomie de la personne
Acces facile a la consultation a I'hopital si
necessaire
Contre-indications relatives
Difficulty a avaler
Hocquet
Fistule digestive haute
Diarrhee importante
Vomissements
Diminution de I'etat de conscience
Debilite mentale

Tableau 11-Administration
progressive de la diete
elementaire

Fig. 4b

Apport

F IG . 4— Cas 4. (a) Representation
graphique du greie et du colon restants
chez cette malade ayant subi six resec
tions intestinales pour maladie
de
C rohn, (b) Recidive de 20 cm dans le
q uadrant inferieur gauche avec fistule
cutanee a bas debit non visible sur le
cliche.
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ml

1
2
3
4 et
suivants

750
1200
1500

1500
1500
1500

+300/j

+300/j
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plications techniques ou septiques reliees a la methode. Au plus, quelques
episodes de diarrhees et de crampes
abdominales nous ont ete signales par
les malades lors d’erreurs de regula
rity dans le debit des solutions. Aucun malade n’a souffert de pneumonie
d’aspiration et aucun incident hemorragique du a l’insertion ou au maintien prolonge des tubes de gavage
n’a ete observe.
Du cote metabolique, nous avons
verifie des episodes d’hypoglycemie,
de 3 a 4 heures apres l’arret de l’infusion, chez la malade (cas 1) a qui
il ne reste que 120 cm de jejunum et
une jejunostomie. Cette malade a un
calendrier d’infusion de 18 heures par
jour et au lieu de recommencer son
infusion de diete elementaire tot en
apres-midi, lors de l’apparition de
symptomes, elle consomme des liquides contenant des sucres simples afin
de pouvoir continuer ses activites a
l’exterieur.
Nous avons ete agreablement sur-

pris par la facilite ?.vec laquelle les
malades utilisent les tubes nasogastriques. Quoique la plupart des ma
lades preferent enlever leur tube de
gavage pour effectuer des sorties, une
malade (cas 1) le porte durant des
periodes prolongees, ne l’enlevant que
pour des nettoyages periodiques. Elle
ne le considere “pas plus ennuyeux et
visible qu’un appareil auditif’’.
II est aussi a noter que depuis le
debut de notre experience, aucun de
ces malades n’a du etre rehospitalise
en raison de complications dues a la
methode; au fait, les seules rehospi
talisations sont survenues chez un m a
lade (cas 3) qui a du subir une cholecystectomie, et chez une malade (cas
4) qui a presente une recidive de la
maladie de Crohn affectant 20 des
82 cm d’intestin grele qu'il lui reste.
Du cote nutritionnel, les malades
ont pu augmenter leur poids durant
la duree du traitement (tableau III)
malgre la severite de l’atteinte intestinale. La plupart se sont rapproches

Tableau 111- Profii ponderal
Poids, kg

Cas no

Longueur du grele,
cm

Habituel

Initial

Actuel

1
2
3
4
5

120
Normal mais irradie
70
82
>2 m

50
54
63
51
55

37.5
42
47
37.5
50

51
47.5
65
42
47

______

Tableau IV-Resume d'ingestion
Depense energetique
basale, Calfj*
Cas no
1
2
3
4
5

Calories infusees
a domicile, Ij
1800
1500
1200
1200
3000

1300
1200
1600
1000
1500

Autres ingestion durant
le traitement, Cal
Fin
Debut
0
700
500
500
200

500
1800
2000
800
2000

Temps
d'infusion
h/j
18
16
12
12
24

"Formule de calcui de la depense energetique basal; hommes = 66 + (13.7 x poids/kg) + (5 x
taillefcm) - 6.8 age, femmes = 655 + (9.6 x poidslkg) + (1.7 x tailielcm) - 4.7 age.

Tableau V-Caracteristiques des malades

Cas no

Diagnostic

1
2
3

Crohn
Entente radique
Volvulus et necrose
du grele
Crohn
Crohn

4
5

Debut du
traitement

Duree du
traitement a
ce jour, mo

Pronostic

mars 1978
octobre 1979

36
4

Traitement a vie
Traitement cesse

mars 1979
fevrier 1980
aout 1980

23
12
3

Traitement cesse
Traitement a vie
Traitement cesse

en de?a de 10% de leur poids habituel et, jusqu'a ce jour, on maintenu
ce poids.
II faut aussi realiser la flexibility du
traitement par infusion de diete ele
mentaire a domicile. Plus l’atteinte intestinale etait severe, plus l’ingestion
d’aliments autres que la diete elemen
taire en infusion a ete limitee. Cependant, a mesure que l’adaptation intestinale s’est faite ou que la maladie
est entree en remission, l’ingestion
d’aliments “normaux” par le malade
a augmente. Les malades eux-memes
se livrent frequemment a des expe
riences et viennent a connaitre leurs
limites en alimentation normale.
De plus, pour avoir enseigne aux
malades la redaction d’un journal dietetique periodique, la dietetiste est
parvenue a evaluer (tableau IV) la
quantite de calories ingerees par les
malades. Ainsi, elle a pu regler le
temps et le volume des infusions de
farjon a satisfaire les besoins nutritionnels.
Pour certains malades, la progres
sion qualitative et quantitative de l’in~
gestion orale d’une diete normale,
sans provoquer de nouvelle symptomatologie intestinale, s’est soldee par
1’arret de la therapie (tableau V). Cependant, deux malades necessiteront
probablement cette therapie durant
toute leur vie.
De tops les malades que nous avons
decrits, la plupart ont presente, a un
moment ou I'autre de leur maladie
chronique. des problemes psychologiques importants (tableau VI).
Cependant, a part un refus initial
de traitement exprime sous le coup
du decouragement par la plupart des
malades, et les quelques problemes
crees par les malades ayant des ante
cedents psychiatriques, l'acceptation
de la therapie a ete uniforme. Les
malades comprennent facilement les
principes de base de l’administration
des dietes elementaires et ne sont pas
effrayes par les aspects techniques
qu’ils maitrisent facilement. 11s ont de
plus la sensation d’avoir la possibility
de controler le traitement. Ils expriment egalement leur satisfaction du
fait que la therapie peut etre interrompue et reprise de fa^on abrupte,
sans probleme metabolique, s’il survient une circonstance imprevue necessitant un deplacement hors de la
maison.
Discussion
Quoique la litterature recente pre
sente plusieurs series de malades traites a domicile par alimentation intraveineuse centrale,4’6'9 elle est avare de
rapports sur les traitements a domicile
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par voie digestive est a la portee de
la plupart des milieux hospitaliers.
Si Ton se refere aux publications
qui decrivent les experiences d’hyper
alimentation intraveineuse a domi
cile,4,69 on est a meme de constater
une morbidity non negligeable et une
mortality occasionnelle par septicemie
avec ce mode de traitement. De plus,
le malade doit etre rehospitalise pour
toutes sortes de complications reliees
soit au catheter sous-clavier, a une
infection ou a une panoplie de pro
blemes metaboliques associes a l’ali
mentation intraveineuse prolongee.
Au chapitre des couts, les dietes
enterales coutent de quatre a cinq fois
moins que les solutions pour alimen
tation intraveineuse (tableau VII). Si
on ajoute a cela les couts de refrige
ration, de fabrication et de transport
des solutions, les fournitures diverses
pour les changements de pansement
sous-clavier et le temps du personnel
qui doit controler periodiquement la
qualite des soins, la note augmente
encore. A ceci s’additionnent les couts
de traitement des diverses complica
tions de la technique qui peuvent necessiter certaines periodes de rehospi
talisation.
Le cout total d’une annee de therapie intraveineuse a domicile peut
varier de $30 000 a $50 000 et peut
vraisemblablement etre de 8 a 10
fois plus important que celui de la
therapie par voie digestive.
Que la therapie nutritionnelle soit
donnee par voie intraveineuse ou di
gestive, ces malades qui requierent
une intervention nutritionnelle suscep
tible de se prolonger toute leur vie,
presentent des problemes psychologiques particuliers, surtout lorsqu’ils
sont atteints d'une affection chronique
et recidivante telle la maladie de
Crohn (tableau VIII).
Cependant, les malades qui sont a
1’alimentation intraveineuse a domi
cile doivent en plus acquerir une ex
pertise speciale qui leur apporte des
problemes particuliers. Ils deviennent
responsables des solutions intraveineuses, ils doivent surveiller un sys
teme pompe-catheter et eviter toute
infection du systeme. Ils developpent

une dependance envers la technique
et 1’equipe traitante qui provoque des
reactions depressives et une peur serieuse des complications possibles.
D’ailleurs on rapporte que la plupart
de ces malades ont des incidents serieux a raconter tels hemorragies,
thromboses du catheter et arret de la
pompe d’infusion.14,15
Malgre tous les problemes psychologiques particuliers a ces malades.
nous n’avons pas remarque de telles
reactions de dependance. de frustra
tion et de peur avec l’alimentation
par voie digestive a domicile. Il faut
dire que certaines activites tels le bain
et la douche sont limitees avec la
technique intraveineuse a cause de la
possibility de contamination du ca
theter sous-clavier; elles sont possibles,
sans restriction, avec la technique par
voie digestive. De plus, comme il n’y
a pas de problemes de transport ou
de preparation, les voyages a I’exterieur sont plus faciles. En effet, la
diete elementaire est presentee sous
forme de sachets en poudre faciles a
emporter et a preparer comparativement aux sacs ou bouteilles refrigeres
de l’hyperalimentation intraveineuse.
De par son aspect “plus naturel”.
sa technologie plus facile a compren
dre et a appliquer et sa versatility,
l'alimentation a domicile par voie di
gestive permet d’exercer avec plus de
facility un plus grand nombre d’activites. Les malades traites par voie
digestive n’ont pas 1’impression que
l’equipe traitante gere leur vie quotidienne.
-s

Conclusions

Lorsqu’un malade necessite une
technique d’alimentation intensive a

Tableau Vll-C outs par 2000 Cai/j pour 1 an
Cout, $
Diete
Non elementaire
Elementaire standard
(20 g N/l)
Elementaire surplus
proteique (40 g N/l)
Hyperalimentation
intraveineuse

Total

Par jour

1 789.00

4.90

4 380.00

13.00

8 760.00

24.00

20 075.00

55.00

1
2
3
4
5

Antecedents
+
++

Refus
initial

Reaction
depressive

Cooperation
au traitement
+++
+ ++
+++
+
+++

+++
++

-

-

+

-

-

-

+

+
-

+++

-

-

-

* - = absent, + = faible, + + = modere, + + + = important.
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Reaction
psychotique

■X

-X

Tableau VI-Problemes psychologiques*
Cas no

-c r

par infusion continue de dietes elementaires11,12 et elle est pratiquement
inexistante quant aux cas de resection
intestinale massive. Pourtant des
1976, Shaffer et collaborateurs13 rapportaient le cas d’un malade souffrant
d’un syndrome de Gardner ayant subi
1amputation massive de la majeure
partie de l'intestin grele pour envahissement mesenterique d’une tumeur
desmoide. Ce malade, a qui il ne
restait que quelques centimetres d’intestin grele, est, jusqu’a ce jour, maintenu a domicile avec 1’infusion noc
turne d’une diete elementaire par un
tube de gastrostomie (Brown RA:
Communication personnelle, 1981). T1
mene une vie active et travaille regulierement comme representant en
valeurs immobilieres.
Nous croyons done, avec la serie
de malades que nous presentons, que
le syndrome du soit-disant “intestin
court” ne devrait pas constituer, en
soi, un critere d’exclusion absolu a
cette forme de traitement a domicile.
II est toujours surprenant de constater que lorsqu’un systeme continu
de perfusion goutte a goutte est uti
lise, comme dans la methode decrite.
une quantite importante de substrat
peut etre fournie au malade et absorbee par une surface minimale d’intestin grele. Par exemple, a un debit
de 100 m l/h en infusion de 24 beures,
on peut fournir 2400 Cal au malade
en une journee et il ne faut pas une
tres grande surface intestinale pour
absorber en une heure 100 ml d’une
solution predigeree d’elements nutritifs reduits a leur plus simple expres
sion, tels sucres simples, acides ami
nes et electrolytes mono ou bivalents.
L’absorption se fait alors a un rythme
de 1.6 ml/min.
Nous croyons aussi qu’une tech
nique qui fait appel a la modification
d’une fonction familiere au malade
est plus facile a comprendre par celuici. Elle ne necessite pas une periode
d’entrainement prolongee et une in
frastructure medicale et para-medicale
onereuse comme celle decrite pour
l’alimentation intraveineuse a domi
cile. Nous croyons meme que la tech
nique d’hyperalimentation a domicile

Tableau VIII-Problem es psychologiques
des grands handicapes intestinaux
Negation de la maladie
Desespoir, depression, anxiete
Perte de fonction de l’alimentation (deuil)
Alteration de la fonction sexuelle
Alteration de I’image corporelle
Hypomanie, reactions paranoides
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domicile, nous croyons que tous les
efforts devraient etre faits pour utiliser des dietes elementaires en infusion
continue avant de songer a l’hyperalimentation intraveineuse a domicile.
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the generalist or individual called upon
to administer urgent care or treatment.
For this reason the book is valuable to
those treating emergencies without the
full back-up and potential of institutions
that have larger critical care units and
readily available specialist care.
If there is any defect in this work
it is the recommendations and proposals
put forward for situations where there
is full specialist back-up. These may
not be applicable where such help is
not available, in which case, clearly
spelled out alternative courses of ac
tion in less than optimal situations
would have helped, with perhaps some
tips on transportation of the patient.
An example of the problem is given in
airway emergencies in children. This
chapter deals with diagnosis and symp
toms well. It states that “tracheostomy
is considered radical at present” and
outlines the care as being optimum if a
nasal endotracheal tube is used by an
otolaryngologist inserted under general
anesthesia administered by an anesthetist.
While one agrees that this is the ideal,
some reference to what should be done
in less than ideal situations would be
helpful indeed. There are other exam
ples of a similar nature in the book.
I found that the most helpful sections
were those on cardiac emergencies, acute
disturbances of consciousness, shock,
trauma and acute poisonings.
In summary, this book is readable. It
is concise with little wasted paper or
words, well illustrated and beautifully
presented. Information can be found
quickly. It is one of the most up-to-date
works available for the smaller- or me
dium-sized hospital or intensive care
unit, where it should be on hand and
ready for use at any time.
John
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TECHNIQUES IN SKIN SURGERY.
Ervin Epstein and Ervin Epstein, Jr.
203 pp. Illust. Lea & Febiger, Phila
delphia; The Macmillan Company of
Canada Limited, Toronto,
1979.
$22.50. ISBN 0-8121-0677-6.

This concise text on dermatologic
surgery outlines the various surgical pro
cedures with little discussion of alter
native methods of treatment. Basic sur
gical principles are clearly outlined as are
the sections on scalpel and scissors sur
gery, shave surgery and skin biopsy tech
niques. A series of short chapters covers
endothermy and cautery excision, elec
trodesiccation, electrocoagulation, cryo
surgery, cosmetic and superficial chemo
therapy, Moh’s technique, hair trans
plantation, nail surgery, dermabrasion
and the various office procedures for
skin cancer, acne and xanthelasma,
hidradenitis, superficial cysts and rhinophyma. Each one details the indications,
contraindications, equipment required,
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preoperative preparation, procedure and
postoperative care, the advantages and
disadvantages and then evaluates the
various procedures. The authors have
included an excellent chapter on cardio
pulmonary resuscitation and there is also
a discussion on local anesthetics listing
in table form the approximate maxi
mum dose for an average adult.
Preoperative, intraoperative and post
operative illustrations would have been
of great assistance in almost every
chapter, but the authors have obviously
tried to save space. In the chapter on
cosmetic chemotherapy, the statement
“this procedure can be utilized to era
dicate wrinkles” might be misleading
since the operation will only improve,
not eliminate, this problem. The section
on hair transplantation should have in
cluded some statistics on patient satisfac
tion and the overall appearance of the
scalp postoperatively. Many surgeons
would disagree with the use of dermabra
sion for treating labial leukoplakia,
Bowen’s disease and superficial basal cell
epitheliomas. The chapter on Moh’s tech
nique is well written. The chapter on skin
cancer discusses alternative methods of
treatment including excision, electro
desiccation. radiotherapy and chemosurgery. The final chapter on rhinophyma, which is well outlined, might have
included the combination of shaving
and dermabrasion for this condition.
In summary, this textbook on derma
tologic surgery should be of value to
the medical student and resident and, as
a quick reference, to the more experi
enced clinicians who perform these pro
cedures.
H. B r u c e W i l l i a m s , m d , f r c s [ c ]
Director,
Plastic and reconstructive surgery,
The Montreal General Hospital,
Montreal, PQ
TRANSACTIONS OF THE AMER
ICAN ASSOCIATION OF GENITO
URINARY SURGEONS. Volume
LXXI. 1979. American Association of
Genito-Urinary Surgeons. 164 pp.
Illust. The Williams & Wilkins Com
pany, Baltimore; The Macmillan
Company of Canada Limited, To
ronto, $37.95, paperbound.

This book is basically a compilation of
papers presented during the 1979 an
nual meeting of the American Associa
tion of Genito-Urinary Surgeons. The
authors are leading urologists and the
work presented is, generally, original
and stimulating. Furthermore, the book
contains discussion of the papers by
knowledgeable people in the field. The
reader will find these discussions most
interesting and they will help to place
the work in its proper perspective.
The subjects discussed in this book
cover a broad spectrum and, as in
previous editions, are topical and
thought-provoking. The main advan
tage of having access to these transac
tions is to become familiar with current
investigative work taking place in lead-
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ing centres in the western hemisphere.
Unfortunately, much of this advantage
is lost because of the time lag between
presentation and publication of the book.
During this time, most of the work will
have been presented at other meetings
and published in other scientific journals,
so the urologist will find little new
in this publication. Nevertheless, I be
lieve the book should be acquired by
every medical school library to be avail
able as a reference for residents and
staff.
S aid A . A w ad ,

m d , f r c s | c]

Member,
Editorial Board.
Professor and head,
Department of urology,
Dalhousie University,
Halifax, NS
TRAUMA CARE. Edited by William
Odling-Smee and Alan Crockard. 657
pp. Illust. Grime & Stratton, Inc.,
New York; Academic Press Canada,
Don Mills, Ont. 1981. $58.50. ISBN
0-8089-1271-2.
With contributions by 19 authors, this
book is presented as a complete manual
on trauma care. The material has been
chiefly based on the experience of the

group from the Royal Victoria Hospital
in Belfast, but the principles outlined
apply to any hospital in any country.
The first 11 chapters are devoted to
general principles and include such topics
as the metabolic response to trauma,
tissue repair and renal failure after
trauma. These are set out in a straight
forward manner. Especially well pre
sented are the last 19 chapters, which
cover in a systematic fashion the recog
nition and treatment of specific injuries.
Each chapter is preceded by an action
list, which alerts the readers and pre
pares them for what is to follow. In all
sections principles are set out in a log
ical sequence. There is an abundance of
line diagrams.
This is an outstanding work. It moves
well from one chapter to the next and
reads well. It is, I believe, a complete
working manual for emergency room
physicians. It should be required study
material for surgical residents. It is a
good reference book for nurses working
in emergency rooms. The principles of
trauma would be excellent reading for
medical students in their final year.
C.M.

C

ouves

. MD.

frcs

( f. d

in

),

FRCS[C]

Kelowna General Hospital,
Kelowna, BC

CLASSIFIED ADVERTISING
As a further service to its readers
the Canadian Journal of Surgery is
pleased to accept suitable classified
advertisements. The deadline is 1
month before the issue date. Copy
should be mailed to: Canadian
Journal of Surgery, PO Box 8650,
Ottawa, Ont. K1G 0G8. Rates are
available on request.
COLON AND RECTAL SURGEON — tra in e d in
endoscopy, wanted fo r association w ith general
surgeon and procto lo gist. Established com m u
n ity practices w ith in a 80 km radius o f New York,
on the northeastern seaboard. A ssociated w ith
teaching hospitals, u n iv e rs ity a ffilia te d . S alary
and frin g e benefits, leading to fu ll partnership.
Send curriculum vitae to : Robert E. Sax, M D,
782 C lin to n Ave., Bridgeport, C onnecticut 06604,
USA.
— S82-018
ORTHOPEDIC SURGEON: PQ — M c G ill U n iv e r
s ity and Royal V ictoria H ospital — geographic
fu ll-tim e orthopedic surgeon to jo in academ ic
s ta ff o f M cG ill Faculty o f M edicine as associate
p rofe ssor w ith e quivalent s ta ff appointm ent at
the Royal V ictoria H ospital. A p p lica n t m ust have
extensive experience in undergraduate and p o s t
graduate teaching as w e ll as research tra in in g in
im m unology w ith special s k ills in c e ll c u ltu re .
A ppointm ent w ill be made in accordance w ith
Canadian Im m igration requirem ents. Please con
ta ct: Dean Richard L. Cruess, Faculty of M e d ic in e ,
M c G ill U nive rsity, 3655 Drummond St., M o n tre a l,
PQ H3G 1Y6.
— S82-017

Plastic Surgeon
•Required for an Active Staff appointment in a University affiliated hospital in Toronto.
Qualifications

Remuneration

• Fellowship in Plastic Surgery by the Royal
College of Physicians and Surgeons of
Canada.
• A minimum of one year training in microsurgery.
• Training in basic science or clinical research.

• Fee for service.
• Possible supplementary stipend
for Research activities.
Date of Appointment

• January 1st, 1983
Duties

• Active clinical general plastic surgery
hospital staff appointment.
• Supervision of microvascular Resident
Training laboratory.
• Clinical and basic science microvascular research.
• Regular clinical and academic postgraduate
teaching of Junior Rotating Interns and
Plastic Surgery Residents.

Apply to

Dr. A. Freiberg
Head, Service of Plastic Surgery
Director of Medical Education
St. Joseph’s Health Centre
30 The Queensway
Toronto, Ontario
M6R1B5

ST. JOSEPH S HEALTH CENTRE
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Claforan

IM /IV

■ (cefotaxime
fotaxime sodiui
sodium)

ANTIBIOTIC
ACTION

In v itro stu d ie s indicate th a t the bacterial action o f CLAFORAN (cefotaxim e s o d iu m l a
s e m is y n th e tic cephalosporin a n tib iotic, results fro m in h ib itio n o f cell w all synthesis,

INDICATIONS AND CLINICAL USES
CLAFORAN (cefotaxim e sodium ) m ay be indicated fo r the tre a tm e n t o f infections
beVowsuscePt'ble strains o f the designated m ic ro -o rg a n is m s in the diseases listed
Low er respiratory tract infections: pneum onia and lu ng abscess caused by
S tre p to co ccu s pne um o niae (form erly Dip/ococcus pne um o niae), o ther S treptococci
(exclud ing\Enterococci, e.g.,S. faecalis), Staphylococcus aureus (penicillinase and
n o n -p e n ic illin a se producing), Escherichia coli. H e m o p h ilu s in fluenzae, (includin g
a m p ic illin -re s is ta n t strains), and unspecified Klebsiella species.
Urinary tract infections: caused by Escherichia coli, unsp ecified Klebsiella species
(in c lu d in g K. p ne um o niae), Proteus m irabilis, in d o le -p o s itiv e Proteus, Serratia
m arce scens and Staphylococcus epiderm idis. Also, u n co m plicated gonorrhea caused
by/v. g o n o rrh o e a e in cluding p e n icillin-resista nt strains.
Bacteremia/Septicem ia: caused by Escherichia coli, unsp ecified Klebsiella strains and
S e rratia m arcescens.
Skin infections: caused b y S taphylococcus aureus (penicillin ase and non-penicillinase
p ro d u cin g ), S. epiderm idis, G roup A Streptococci, E scherichia coli, Proteus m ira b ilis
and in d o le -p o s itiv e Proteus.
Intra-abdom inal infections: caused by Escherichia coli, and unspecified Klebsiella
species.
Gynecological infections: in clu d in g pelvic in fla m m a to ry disease, e nd om e tritis and
pe lvic c e llu litis caused by E. coli, G roup A S trepto cocci and Staphylococcus
e p id e rm id is , anaerobic bacteria in cluding unspecified Peptococcus and
P e p tostreptococcus strains and som e strains o f Bacteroides fragilis. In several cases
a lth o u g h c lin ic a l cures w ere achieved, bacteriological fo llo w -u p was not available.
C lin ica l expe rience with CLAFORAN in anaerobic in fectio ns is lim ite d . CLAFORAN has
been used w ith som e success in w o u n d and in tra-abdom in al in fectio ns against som e
s tra in s o f u n id e n tifie d Bacteroides and anaerobic cocci.
CLAFORAN has been show n to be active against som e strains o f Pseudom onas.
In th e tre a tm e n t o f infections encountered in im m unosup pre ssed and granulocytopenic
patie n ts, re su lts o f therapy w ith cefotaxim e have n o t been im pressive.
CLAFORAN s h o u ld not be considered in the tre a tm e n t o f enterococcal in fections i e
Strep, faecalis.
' ‘
S p ecim ens fo r bacteriologic culture should be obtained p rio r to therapy in o rd e r to
n i A c ^ o a MldT u tify the causat.ive organism s and to determ ine th e ir suscep tibilities to
CLAFORAN. The rap y may be in stituted before results o f su s c e p tib ility studies are
kn o w n ; a n tib io tic treatm ent shou ld be re-evaluated once these results become
available.

CONTRAINDICATIONS
CLAFORAN is contraind icated in patients w h o have show n hype rs e n s itiv ity to
c e fo ta x im e s o d iu m , the cephalosporin, or the pen ic illin groups o f antibiotics.

WARNINGS
B e fore th e ra p y w ith CLAFORAN is instituted, it m ust be de te rm in e d w h eth er the patient
nas had p re v io u s hype rsensitivity reactions to cefotaxim e, cephalosporins, p e n icillins
o r o th e r drugs. CLAFORAN shou ld be given w ith cautio n to p atie nts w ith Type 1
h y p e rs e n s itiv ity reactions to p en icillin. A n tibiotics, in c lu d in g CLAFORAN should be
a d m in is te re d w ith caution to patients w h o have dem onstrated som e fo rm o f allergy
p a rtic u la rly to drugs. If an a llergic reaction to CLAFORAN occurs, the drug shou ld be
d is c o n tin u e d and the patient treated w ith the usual agents (e.g. epinephrine,
a n tih is ta m in e , pressor am ines o r corticosteroids).

PRECAUTIONS
Pregnancy: T he safety o f CLAFORAN (cefotaxim e sodium ) in pregnancy has not been
'e d' C onsequentty, use o f the drug in pregna nt w o m e n requires that the likely
b e n e fit fro m th e d ru g be w e ighe d against the possible risk to the m o th e r and fetus.
NKUrS! % M o th e rs : CLAFORAN is excreted in hum an m ilk in lo w concentrations. Caution
s n o u ld be e xercise d when th e drug is adm inistered to n ursin g m others.
Pediatric Use: T he safety and effectiveness o f CLAFORAN in in fan ts and children have
y s t been establ ished. It has, however, been used in c h ild re n a t a dosaqe range o f
100-150 m g /k g /d a y in 2-4 d iv id e d doses.
Kidney : A lth o u g h CLAFORAN rare ly produces alteration s in kid ney function, evaluation
o t renal status is recom m ended, especially in severely ill patie nts receiving high doses.
Patients w ith m a rke d ly im paired renal function should be placed on the special dosage
sched ule re co m m e n d e d under DOSAGE AN D ADMINISTRATION, because norm al
m e ta b o lite s 86 indivicJua*s are
to produce excessive serum conce ntration o f the
P ro lo n g e d use o f CLAFORAN m ay result in the o v e rg ro w th o f nonsusceptible
org a n ism s. C o nsta nt observation o f the patie nt's co n d itio n is essential. If superinfection
occurs, th e ra p y s h o u ld be discontinued and app rop riate m easures taken.
P o sitive d ire c t C o o m b 's test is know n to develop in in d iv id u a ls d u rin g trea tm ent w ith
th e ce p h a lo s p o rin g ro u p of a ntib iotics, in cluding cefota xim e sodium .
In la b o ra to ry tests a false positive reaction to glucose m ay occur w ith reducing
substances b u t n o t w ith the use o f specific glucose oxydase m ethods.

ADVERSE REACTIONS
The m o s t fre q u e n t adverse reactions encountered are:
Local (5% ) - in je c tio n site in flam m ation w ith intraveno us a d m in is tra tio n . Pain,
in d u ra tio n and tenderness after in tram uscula r injection.
Hypersensitivity (1.8%) - Rash, pruritus, fever.
G astrointestinal (1.7%) - Colitis (not pseudom em branous), diarrhea, nausea, and
v o m itin g . A fe w cases o f pseudom em branous co litis have been reported.
Hemic and Lym phatic System - M ild reversible leukopenia, granulocytopenia and
th ro m b o c y to p e n ia have been reported. Som e patients developed positive direct
C o o m b 's te s t d u rin g treatm ent w ith CLAFORAN (cefotaxim e sodium ).
G enitourinary System - M oniliasis, vaginitis.
Central Nervous System (0.2%) - Headache.
Liver - T ra n sie n t elevations in SGOT, SGPT, serum LDH, and serum alkaline
pho sp h a ta se le vels have been reported.
Kidney - Increased serum creatinine and BUN have occasionally been observed.

SYMPTOMS AND TREATMENT OF OVERDOSAGE
S ince no case o f overdosage has been reported to date w ith CLAFORAN, no specific
in fo rm a tio n on s y m p to m s or tre a tm e n t is available. T reatm ent o f overdosage shou ld be
s y m p to m a tic .
DOSAGE A N D ADMINISTRATION
CLAFORAN (c e fo ta x im e sodium ) m ay be adm inistered in tra v e n o u s ly or
in tra m u s c u la rly a fte r reconstitution (see table w ith recom m ended m ode of
re c o n s titu tio n a cco rd in g to route o f adm inistration). Dosage and route o f adm in istratio n
s h o u ld be d e te rm in e d b y suscep tibility o f the causative organism s, sev e rity o f the
in fe ctio n and c o n d itio n o f the patient.

USUAL ADULT DOSAGE OF CLAFORAN (CEFOTAXIME SODIUM)
n.iiw itou

Type of Infection

(grams)

Frequency and Roirta

Uncomplicated Gonorrhea

1

1 gram IM (single dose)

Uncomplicated infections
such as pneumococcal
pneumonia or acute urinary
tract infection

2

1 gram every 12 hours
IM or IV

Moderately severe
infections

3-4

1 gram every 6-8 hours
IM or IV

Severe infections

4-6

1 gram every 4-6 hours
IM o r IV

Infections commonly
needing antibiotics in
higher dosage
(e.g., septicemia)

6-8

2 grams every 6-8 hours IV

Life-threatening infections

up to 12

2 grams every 4 hours IV

THE M A X IM U M DAILY DOSAGE SHOULD NOT EXCEED 12 GRAMS.
A d m in is tra tio n o f CLAFORAN shou ld be continued fo r a m in im u m o f 48 to 72 hours
after the p a fe n td e fe rv e s c e s o r after evidence o f bacterial eradication has been
obtained; a m in im u m o f 10 days o f trea tm ent is recom m ended fo r infections caused by
U ro u p A beta-hem olytic S trepto cocci in o rd e r to guard against the risk o f rheum atic
Tever o r g lo m e ru lo n e p h ritis ; freq uent bacteriologic and clinical appraisal is necessary
durin g therapy o f ch ro n ic u rin a ry tract infections and m ay be required fo r several
m onths after therapy has been com ple ted ; persistent infections m ay require prolonaed
treatm ent. Doses less than those recom m en ded s h o u ld n o t be em ployed.
DOSAGE FOR PATIENTS W ITH IMPAIRED RENAL FUNCTION
Aet ^ o ^ h estir" atad creatinine clearance o f less than 20 m l/m in /1 .7 3 m 2 th e dose
° ^ i ^ i ^ ^ ^ n?iUSt k 0 ^]a*ved (see PRECAUTIONS). If serum creatinine values alone are
available, the fo llo w in g fo rm u la (based on sex, w e ig h t and age o f the patient) m av be
used to convert these values in to creatinine clearance.
Males:

Weight (kg) x (140 - age)

Females:

0.85 x above value

72 x serum creatinine

RECONSTITUTION
The fo llo w in g table is p rovid ed as a guide fo r reconstituting CLAFORAN (cefotaxim e
sodium ) fo r both in tram uscula r and intravenous adm inistration.

STRENGTH
Intramuscular
500 mg vial
1 g vial
2 g vial
Intravenous
500 mg vial
1 g vial
2 g vial
‘ Shake to dissolve.

AMOUNT OF
DILUENT TO
BE ADDED
(ml)#

APPROXIMATE
WITHDRAWABLE
VOLUME
(ml)

APPROXIMATE
AVERAGE
CONCENTRATION
(mg/ml)

2
3
5

2.2
3.4
6.0

230
300
330

10
10
10

10.2
10.4
11.0

50
95
180

Parenteral drug products sh ou ld be inspected visually fo r particulate m atter and
d iscoloration p rio r to adm in is tra tio n . S olutions o f CLAFORAN range fro m lig h t ye llo w
to amber, depending on c o nce ntration and diluen t used. The d ry pow der as w e ll as
solutions tend to darken, dep endin g on storage conditions.
For intramuscular use: CLAFORAN should be reconstituted o n ly w ith S terile W ater fo r
in jection in accordance w ith the volu m e s recom m ended in the preceding table.
For intravenous bolus use- 500 m g, 1 gram and 2 gram vials shou ld be reconstituted
CTAm e3St 10 m
any ° * the s o *u tio ns recom m ended under COMPATIBILITY/
o I A d ILI t y .
For intravenous infusion use: 1 o r 2 gram s o f CLAFORAN m ay be reconstituted
w ith 50 o r 100 m l o f any o f th e so lu tio n s recom m ended under COMPATIBILITY/STABILITY.

ADMINISTRATION
Intramuscular: CLAFORAN (cefo taxim e sodium ) should be in jected w e ll w ith in th e body
o t a relative ly large m uscle such as the upper outer quadrant o f th e buttock (i.e , gluteus
m axim us); aspiration is necessary to avoid inadvertent injection in to a blood vessel.
Intravenous: The intraveno us route is preferable fo r patients w ith bacterem ia, bacterial
septicem ia, or other severe o r life -threatening infections, or fo r patients w h o m ay be
poo r risks because o f low ered resistance resulting from such deb ilita ting c ond itions as
m aln u tritio n , trau m a, surgery, diabetes, heart failure, or m alignancy, particularly if
shock is present o r im pending.
For bolus adm in is tra tio n a s o lu tio n co n ta in in g 1 gram o r 2 gram s o f CLAFORAN can be
in jected over a period o f three to fiv e m inutes. Using an infusion system , it m ay also be
given over a lo nger period o f tim e th ro u g h the tubin g system by which the patient m ay
be receiving other in traveno us solutions. Butterfly® or scalp vein type needles are
* ° r .th,s tYP® o f in fusion. H owever, durin g infusion o f the solu tio n containing
CLAFORAN, it is advisable to disc o n tin u e te m p o ra rily the a dm in istratio n o f other
solutions at the same site.

COMPATIBILITY AND STABILITY
CLAFORAN (cefotaxim e so d iu m ) m ay be reconstituted w ith any o f the fo llo w in q and
should be used fre s h ly prepared:
Sterile W ater fo r Injection
Sodium C hloride Injection B.P.
5% D extrose Injection B.P.
Dextrose and Sodium C h loride Injection
C om pound S o dium Lactate Injectio n B.P.
If a s olution m ust be stored, o n ly th e so lu tio n prepared w ith Sterile Water fo r Injection
m ay be kept under refrig era tion (belo w 5°C) fo r no t lo nger than 24 hours. A n y unused
solutions shou ld be discarded.
CLAFORAN is com patible w ith 1 % lignocaine. O nly fresh ly prepared solutions should
be used. CLAFORAN solutions e x h ib it m a xim u m sta b ility in the pH 5-7 range.
A solution o f 1 gram o f CLAFORAN in 14 m l o f Sterile W ater fo r Injection is isotonic.
S olutions o f CLAFORAN m ust not be adm ixe d w ith am inoglycoside solutions. If
CLAFORAN and am ino glycosides are to be adm inistered to the same patient, they m ust
be adm inistered separately and not as a m ixed injection.

DOSAGE FORMS
CLAFORAN (cefotaxim e sodium ) is s upp lie d as a sterile, w h ite to pale ye llo w pow der in
vials containing 500 m g, 1.0 gram and 2.0 gram s o f cefotaxim e sodium (expressed as
acid on a d ry basis).
CLAFORAN in the d ry state shou ld be stored at room tem perature (below 30°C)
protected fro m lig h t and heat. S o lu tio n s o f CLAFORAN range from light y e llo w to
amber, depending on conce ntration and the diluen t used. The solutions tend to darken
depending on storage cond itio n s and shou ld be protected fro m elevated tem peratures
and excessive light.
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